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CHAPTER I
Introduction
Industrial and systems engineering and health services research can come together to
make important gains in health care by designing powerful capacity planning and scheduling
decision support systems. Targeting the longitudinal integration of clinical care and clinical
research studies under shared resources, this work’s goal is novel, effective methods to enable
better access to care resources, better health outcomes, and cost control. The focus is on
fundamental innovations in capacity planning, optimization of system performance metrics,
and model-based methods to achieve appointment scheduling for stochastic models of patient
flow in networks of clinical care and/or research services. Identifying how to utilize/allocate
resources to achieve a care institution’s goals is a difficult task due to the heterogeneity, and
urgency levels of the patients requiring service as well as the nature of the service processes.
1.1 Current challenges
Based on several collaborations developed with healthcare providers over the course of the
last five years, this work targets some key challenges that most large health care institutions
with significant research activities are faced with on a daily basis. To appreciate the need for
the methods and tools developed in this work, we consider this illustrative example. After
repeated visits to the primary care physician, and initial diagnostic tests, there is no clear
1
2diagnosis available to Chris. The doctor suspects that the condition might be serious. Chris
and the primary care doctor agree that it is wise to be referred to a specialty care provider
with the expertise and resources to obtain a diagnosis and treatment plan. Consider some
of the questions relevant to the medical center that Chris might be asking:
(Q1) How long will it take me to get an appointment? We will refer to this as the root
appointment. Medically, Chris will worry that irreversible damage may be sustained during
this wait. The first/root visit is especially important in our methodology. The wait from the
time of the visit request until the time of that appointment is referred to as access delay.
(Q2) Chris considers that it will take some random number of visits/consultations and tests
in different departments to get a clear diagnosis and treatment, and we refer to this as an
itinerary of care. Chris may wonder how long it will take to reach the end of that care
itinerary, which we call itinerary flow time. Reaching a diagnostic quickly is important
to start appropriate treatments as soon as possible if necessary, or relieve the patient’s mind
if not.
After the results of the diagnostic tests, a research coordinator may contact the specialty
physician and try to recruit Chris to be a participant in a clinical research trial. Research
trials are multi-visit protocols that are resource and time sensitive. Another question will
enter Chris’ mind:
(Q3) If I were to enroll in this clinical research trial, how long will it take? Clinical trials
have rigid protocol requirements that provide an accurate estimation of their durations (from
start to the end of the trial). Hence, Chris will be interested to know the Time to First
Available Visit (TFAV) in the clinical trial. Longer waits to start the trial will affect
Chris’ incentive to accept being part of it.
The medical center needs to be able to answer the above questions. Currently, experi-
enced guesses based on what happened in the past is the only way for medical centers to
3Figure 1.1: Patient flow through clinical care and research appointments under shared re-
sources
estimate Chris’ access to the many possible segments of his care/research itineraries. Lever-
aging forecasting methods to predict patients’ resource requirements, this research is able
to inform the institution of its predicted utilization levels, and how long patients like Chris
would likely have to wait.
Consider the questions that the health care institution might have:
(Q4) How can we achieve differentiated access delays to care and itinerary flow times based
on the patient’s urgency level or condition? For example, patients with severe spine pain
or an urgent problem will need fast diagnosis and access to surgery/treatment. The same
resources, however, are used to serve patients with less severe and non-urgent back pain
that do not require such fast access to all services. As another example, urology patients
that present with a suspicion of cancer need to go through diagnostic testing and surgeon
consultation. Those who need surgery are often urgent. These cancer patients will be much
more time sensitive compared to patients having non-malignant cysts.
4(Q5) When should the specialty physician schedule the follow-up visit? This follow-up visit
can only happen once all the diagnostic tests have been performed, in order to provide the
patient with a diagnosis. In common practice, it is difficult to predict at the time of the
initial/root appointment how long it will take Chris to go through all the required diagnostic
services. This length of time will be called the diagnostic flow time .
(Q6) How much capacity should we allocate to clinical care visits vs. clinical research tasks?
A tradeoff needs to be considered between the level of service provided to care for patients,
and the amount of resources allocated to add research value to the community.
(Q7) Given a commitment to the ongoing care needs of the patient panel/population, which
clinical research trials can/should be conducted within the limited resources of our services?
Having a larger portfolio of research trials than capacity can handle will create congestion
which will affect clinical care patients, and/or create very long access to clinical trial pro-
tocols. Hence, it is important to understand how much workload can be handled without
hurting clinical care and how this translates to service levels for the trial participants.
(Q8) How should we schedule our human resources performing research tasks to provide
efficient coordination between the logistical flows of the research participants and the time
and skills required on their visits. Clinical trials usually require specialized skills on each
appointment of a multi-visit protocol, and not all the resources have the skill set to perform
those visits. To maximize throughput and reduce wait, one does not want physicians/nurses
that possess many skills (for care and research) having to allocate their time on relatively
simple tasks that physician assistants or technicians could do. Resource coordination based
on matching a provider to an appropriate skill set to each participant’s visit can be a complex,
yet crucial element to delivering efficient clinical trials.
While the methods in this work can optimize which mix of clinical care offerings should be
offered, we have chosen to focus on treating patient care as obligate and optimizing the mix
5of clinical research that can be added to it. The proposed capacity planning and scheduling
methodology can serve a role as an integrating mechanism for accomplishing both the care
and research dimensions of treatment in a manner that maximizes the value to patients and
to research communities while managing costs and improving service by optimizing efficiency.
1.2 Capacity allocation and access management in other applica-
tion fields
Capacity allocation of resources has also been studied in other areas. Manufacturing is
one of them, but it is widely recognized that manufacturing models rarely transfer directly
to service operations problems. Airline transportation is an area with a rich literature and
history of industrial research focused on the operations of servicing transportation needs. As
we will see, the problems confronted by airlines are significantly more complex than those
in the healthcare operational problems we are targeting. To use differentiated terms for the
people served in each systems, let us reserve customers for the airlines and patients for the
healthcare application.
Airlines commonly structure the services/seats into differing levels of service (e.g., first
class with the most amenities, business class, and economy) with higher fees for the higher
levels of service. Contrary to the urgency classes we wish to treat in this dissertation, our
urgency classes are not tied to amenities and perks, but focus on how quickly a common
service (across patient classes) can be accessed. Of course, even in healthcare, there can be
some providers that seek to attract higher paying patients through the promise of boutique
services, but that is not the dominant practice.
This relates to the general observation that revenue management is a primary concern
in the airlines, which leads to elaborate and complex dynamically changing prices that seek
to extract the maximum profit from the customers and even to drive them away from one
6flight that may be highly utilized to one that may be harder to fill. While there is some
movement toward revenue management, attitudes and social values indicate that a revenue
management focus with dynamic pricing is inappropriate for the foreseeable future. It is the
case that many healthcare institutions struggle to provide sufficient access. New patients
tend to bring in significantly more revenue that existing/established ones. In this sense, by
creating specific patient classes for new patients, our work does incorporate a dimension of
revenue management.
The revenue management approach is motivated by and complicated by the fact that
airlines serve in batches, with strong incentives to fly full flights. Of course, utilization is still
important in healthcare, and our models include the metrics of utilization (or overutilization)
and staff overtime. Clearly, healthcare operations are highly provider-centric, in contrast to
major airline considerations such as geography, time zones, various classes of planes, and
critical maintenance tasks.
Seat reservations for each patient class (usually determined by the ticket fare, and
the patient status with the airline) are made for each aircraft in order to maximize rev-
enue/utilization. However, the concept of customer waiting time (from request to occurrence)
does not apply to airlines in the same way that it does for healthcare. Airline customers need
to get to their destination on a specific date (or a short time window around it): they either
travel for business (need to get someplace at a specific time), or during their vacation time.
But ultimately, most customers have a date set in mind, and will choose itineraries/airlines
based on pricing options. Hence, a customer usually won’t delay her flight date when a flight
is sold out; rather, they will pay extra for a higher fare class, choose a different airline/flight,
choose a different mode of transportation, or cancel the trip. In healthcare, patients usually
try to go through diagnosis and treatment as soon as possible. The demand is carried over
until a date with sufficient capacity is available to treat them (acknowledging that patient
7preference for date and time may play a role, especially for less serious issues).
Interestingly, a good fraction of healthcare practice has patients coming to see a particular
clinician/physician; however, in air transport customers seek only the particular geographical
itinerary and the date/time. The plane’s crew is irrelevant. This is a profound difference.
Similarly, many healthcare visits are viewed as an unwelcome and relatively brief intrusion
into one’s daily schedule. While the particulars of date and time matter, the more brief
the disruption of the office visit is, the less concerned the patient is with the date and time
of the appointment. This is in marked contrast to the complexities of scheduling airline
travel, which can be quite time consuming as a decision process. Most flights require a
major commitment of time, money, and effort. Frequently, there are multiple time and date
options available from various providers. In a sense, airlines create “booking reservation
plans” that they provide for viewing to prospective customers. Thus, customers can see
the seats in each class that are available and the pricing. Clearly, a visit to one’s primary
care provider implies a loyalty to a specific service provider. In some contexts, patients do
shop various providers to find the one they like the best (e.g., a knee replacement); however,
unlike air travel, healthcare provision attains greater value through the establishment of
a relationship with the provider and the development of deeper insights over time. Our
models can be employed at the level of an individual physician, or they can be applied to
an entire department/service. While few healthcare providers would see a need to post their
calendar online, certainly the availability of appointment dates is expected to be part of the
conversation as patients set up an appointment. The intended use of our planning models
is that the times available to a given type of patient will be limited so as to provide a better
experience for the entire set of patients served.
Moreover, in healthcare, patients need various resources in their “itinerary of care”, and
those needs are stochastic and uncontrollable (they will depend on their condition and its
8severity, which may be learned over time). In airlines, the “itinerary” of customers going from
point A to point B, then B to C, and so forth, usually with C = A is relatively deterministic
once the customer buys the ticket. Of course, the vast majority of control over which services
to pick lies with the customer (e.g. to get to Boston, I have a choice between a direct flight
at some price, or a layover in New York City for another price). Even if we control the
pricing to direct the customers to choose specific layovers, or build itineraries that would
maximize the effective profit to the airline, this form of control is usually not appropriate in
healthcare. Also, healthcare is often more stochastic, particularly in terms of the itinerary
of visits that will be generated based on the outcome of a root visit.
After searching the airline literature, we could not find any airline studies that consider
details at the passenger level for scheduling purposes. Our belief is that it is too difficult to
optimize the system as a whole while considering each passenger individually. In fact, airline
transportation problems have developed an elaborate system of decompositions and sub-
problems to allow solutions that avoid the intractability of treating everything in one model.
Note that the airline transportation problem must consider the time of day of each flight,
geography and network effects, the pilots, flight attendants, elaborate work rules, training
time, rigorous processes of test and maintenance, food services, limited gate capacity, etc.
Because health services rarely have tight restrictions on the time of day that particular
services are offered and because they do not require batches of people to be served at the
same time, we are able to take a planning approach that models each day in aggregate.
We leave time of day scheduling as a complementary piece that others have researched, and
we can revisit in the future to take advantage of the daily level planning models we are
developing.
It is worth noting the connections to queueing theory. Queueing methods can be used for
revenue management (and capacity reservations). Past work in this vein does not directly
9translate to our healthcare research focusing on access management. However, we have
taken the foundations of queueing and built them into MIPs that simultaneously optimize
the system while approximating the queueing dynamics.
1.3 Structure of the research
This research seeks to provide differentiated and controlled access to care/research ap-
pointments in healthcare networks under shared resources by optimizing capacity alloca-
tion/reservation schemes for different patient/appointment types (e.g., care vs. research,
urgent vs. less urgent). We are dealing with a large stochastic queueing network with
dependencies/precedence between patients and appointments, which makes it difficult to
answer the above eight questions in an integrated manner. Chapter II focuses on answering
(Q3), (Q7) and (Q8) assuming the set of resources available are devoted only to clinical re-
search visits. Such infrastructures are called “Clinical Research Units” (such as the Michigan
Clinical Research Unit (MCRU), where no clinical care visits are performed). Chapter III
focuses on (Q1) and (Q4), and Chapter IV will focus on (Q2), (Q4), and (Q5) in a hospital
setting where all resources are devoted to clinical care patients (all non-research medical
facilities). The conclusion chapter, Chapter V will address (Q6) and leverage the method-
ologies from the previous three chapters to summarize a high level procedure/algorithm that
would answer all questions in a multi-stage optimization approach.
Chapter II creates an operations engineering and management methodology to optimize
a complex operational planning and coordination challenge faced in healthcare. We moti-
vate and tailor the method to the needs of sites that perform clinical research trials. The
time-sensitive and resource-specific treatment sequences for each of the many trial proto-
cols conducted at a site make it very difficult to capture the dynamics of this unusually
complex system. Existing approaches for site planning and participant scheduling exhibit
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both excessively long and highly variable Time to First Available Visit (TFAV) metrics and
high staff overtime costs. We have created a new method, termed CApacity Planning Tool
And INformatics (CAPTAIN) that provides decision support to identify the most valuable
set of research trials to conduct within available resources and a plan for how to book their
participants while constraining (i) the staff overtime costs, and/or (ii) the TFAV by trial. To
estimate the site’s metrics via a Mixed Integer Program, CAPTAIN combines a participant
trajectory forecasting methodology with an efficient visit booking reservation plan to allocate
the date for the first visit of every participant’s treatment sequence. It also creates a daily
nursing staff schedule plan that is optimized together with the booking reservation plan to
optimize each nurse’s shift assignments efficiently to participants’ requirements/needs.
To better service patients, support providers, and obtain greater operational efficiency,
Chapter III develops operations models of direct impact to capacity planning and outpatient
appointment scheduling. With the increasing popularity of Accountable Care Organizations
(ACOs), destination medical programs, and other integrated care options, new challenges
have arisen in managing a larger suite of formerly independent/siloed services. In particular,
the capacity planning problem for medical services now becomes a coordinated network
problem rather than a department by department local optimization. Considering the suite
of services as a coordinated whole is critical because, in the integrated care model, patients
will often require a sequence of visits to satisfy their diagnosis and care needs for one itinerary
of care. Further, this sequence is often not known in advance, leading to decisions that are
made at one service having significant and complex impacts on other services in the network.
Within this framework, there are a number of different types of patients with different
urgency levels. At a destination hospital, for example, there are local patients versus regional
patients (who may travel up to 6 hours to the hospital), and even national/international
patients. We focus on managing the mix of patients to provide differentiated access to
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an initial/root appointment based on level of urgency. We manage this mix by reserving
appointment slots across the network for each level of patient urgency and patient specialty
type. For any given network capacity reservation scheme, we model the patient flow and
access metrics as a queueing network with patients arriving according to a non-homogeneous
Poisson process. After arrival, the patient seeks an appointment at the earliest possible
time slot. If capacity is available, the patient is scheduled into the slot and if not the patient
overflows and attempts to obtain an appointment on the next day. This process repeats until
the patient has been scheduled. From a modeling perspective we obtain distributions on the
amount of patients scheduled and amount overflowed through a set of recursive stochastic
equations. Various access delay metrics can then be calculated from the set of scheduled and
overflow random variables in combination with the arrival process.
Having developed results for the underlying stochastic network for a given capacity reser-
vation scheme, the next step is to optimize the scheme relative to the access delay metrics of
interest. To do so, we develop a suite of transformations to turn the stochastic metrics into
linear, deterministic ones as approximations capturing the essential stochastic and non-linear
properties of the system. This allows for the optimization to be solved as a Mixed Integer
Program with chance constraints. We parameterize this model with data from a partner
that operates a suite of outpatient services. We demonstrate through a case study that we
can improve access for urgent patients while still guaranteeing an appropriate service level
for other patients types.
In Chapter III, we construct new methodologies to control the access delay to the first ap-
pointment of an itinerary of care for each patient class. We are able to provide differentiated
access to a care episode based on patients’ urgency levels by allocating capacity across the
resources. We guarantee a certain service level (e.g., limiting the probability of the workload
exceeding capacity, performing limited workload in overtime) for downstream appointments
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of patient itineraries by assuming their resource needs followed historical patterns. There
are limitations to these modeling assumptions: (1) the historical resource requirement needs
of patients can be driven by historical blocking (e.g. a patient requires a downstream ap-
pointment tomorrow, but due to capacity, the patient had to wait three days historically),
(2) the itinerary flow times (from first visit to last visit of an itinerary) are assumed to be
fixed to the historical flow times, (3) the downstream demand that exceeds capacity on a
given day is assumed to be done in overtime; in practice, this demand may alternatively
be accommodated by delaying its service to a later day, and (4) itinerary flow times can
not be differentiated by patients’ urgency levels. In Chapter IV, we leverage the methods
developed in Chapter III to create a model capable of overcoming the limitations mentioned
above. Specifically, we will model and control how patients will flow (with delay) through
the resources of this capacitated stochastic queueing network. Our main contribution is to
provide expedited urgent patient types that flow through downstream itinerary resources by
reserving the right amount of capacity for urgent cases while assuring the less urgent patients
will not be delayed “too long”. By optimizing the tradeoffs between providing differentiated
access, itinerary flow times, and matching supply and demand, our Mixed Integer Program
provides a resource capacity allocation plan that meets the itinerary flow time targets of a
health care institution.
In Chapters II-IV, we assume that the set of resources for clinical care services have
no overlap with the set of resources for clinical research. Using clinical care resources to
perform clinical research trials can be quite challenging. The issue is really about running
two distinct businesses: a clinical care business and a clinical research business. Aside
from some operational differences (e.g., clinical research must follow a carefully prescribed
protocol and sometimes requires skills/experience and processes not available in clinical
care), the financial reality is complex and makes it undesirable to create a flexible operation.
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Because clinical care will always trump clinical research (by its very nature, clinical research
is a voluntary and elective intervention), dedicated clinical research chairs/beds, equipment,
and staff are created to maintain the quality of the research and the scale. Billing insurance
companies for clinical research is illegal and puts the business at risk for prosecution and
fines if there is a perception that research is being charged as care. If one is willing to take
the risk and mix the two businesses, then the back office administrative complexity increases
and effort must be expended (even at the provider/caregiver level in documenting their time
allocation) to sort out which specific activity can be billed to an insurance company and
which needs to be billed to the clinical research sponsor. Further, using care resources to
perform research is usually difficult due to the complexity of the research tasks: for example,
monitoring the impact of an infusion on the body or the collection, processing, and storage
of specimens. However, using clinical research resources for clinical care seems much more
feasible in practice, and the combination of methodologies developed in this dissertation
could be a first step towards that goal. In the conclusion chapter, Chapter V, we comment
on ideas for the integration of clinical care and clinical research under shared resources. We
present ideas for how to integrate the methodologies of the three previous chapters, and
directions for future research.
CHAPTER II
Access Planning and Resource Coordination for
Clinical Research Operations
2.1 Introduction
Clinical research trials are an essential part of discovering and testing new medical de-
vices, procedures and drugs. This paper develops a methodology for appointment visit
planning to improve clinical research trial delivery in dedicated performance sites is a gate-
way to better scientific knowledge, medical discoveries and effective new treatments for many
diseases. “These trials, research studies carried out with human volunteers to answer specific
questions concerning the effectiveness of a drug, device, treatment or diagnostic method, are
designed to advance scientific knowledge and promote discoveries to treat and cure illness
and disease, and increase longevity and the quality of life for countless people,” states [50].
While clinical trials are conducted in various settings, academic, medical, and industrial
institutions frequently choose to construct clinical research performance sites to provide a
shared infrastructure on which to perform them. We will use the term Clinical Research Unit
(CRU) to refer to such an organization/site. Operationally, a CRU has intuitive economies
of scale and scope by sharing resources across many trials. On the other hand, some clini-
cal trials have a complex operational structure that makes it difficult to plan and schedule
them at a shared CRU site. “The conduct of a clinical trial is a complex integration of many
14
15
activities requiring the coordination of a large number of individuals each with specific exper-
tise,” states [25]. This research develops a strategic decision support system called CApacity
Planning Tool And INformatics (CAPTAIN) for better resource planning and coordination,
faster access to treatment, efficient booking, and trial portfolio selection decision support in
CRUs (such as our partnering site, the Michigan Clinical Research Unit or MCRU).
2.1.1 The complexity of CRU operations and insights into their characteristics
To gain an understanding of a typical CRU, it is useful to consider the perspectives of
some key stakeholders, beginning with that of a participant. Participants (who may or may
not be accurately called patients) can have many motives to participate in a trial, including
the potential to receive a new treatment that is better than existing ones (although this
would be speculative). For a participant who is screened and found to be appropriate to
proceed in a trial, there will be a protocol specifying the details of how the trial must be
conducted. “Clinical trials are detailed plans for medical treatments, for instance a clinical
trial protocol can describe at which point of time, in which quantum, and how medications
or therapies have to be executed,” states [25].
The main operational features of a single clinical trial include: (i) each participant en-
rolling in a trial has a multi-visit treatment path (often between 1 and 10) with nearly
deterministic service times that are specified by the trial’s protocol, (ii) participant enroll-
ments are stochastic over time, (iii) the visits of the treatment path are time-sensitive and
can range from a few days up to a year (for example, visit 3 of a trial has to happen between
29 and 31 days after the first visit), and (iv) each trial visit requires a number of specific
resources (chairs, beds, specific rooms/equipment, and specific skills of the nursing staff).
We note that the determinism of service times in feature (i) mentioned above is not a strong
modeling assumption because of the detailed protocol instructions. The research trial must
have a predetermined number of participants to achieve statistical validity. Either missing
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a visit or experiencing excessive delay may invalidate that participant, so it is important
to ensure that the CRU’s care providers and physical resources are available to service the
scheduled participants.
Second, individual research investigators and their trial coordinators can be viewed as
customers who own the trials and work closely with CRU staff to administer the trials.
Trial coordinators will follow a participant recruitment plan (based on judgment and past
recruitment efforts for similar trials), possibly with nonstationary enrollment rates, from the
initiation of the trial until either a designated number of participants has been reached or,
in some cases, until a trial end date has been reached.
Third, operational planners for the CRU try to balance the competing needs for service of
the trials/protocols. One difficulty is that the scheduling of all of a participant’s visits needs
to be done at the enrollment date. There should also be a check that the trial protocol’s time
and resource requirements will be met for all future visits. Let us elaborate on the complexity
introduced by having nurses with varying skills. The left part of Fig. 2.1 provides an example
of the specific requirements of a given clinical trial. This trial has 5 visits, and we see that
visit 3 lasts 3 hours, needs to happen exactly 1 day after visit 2 (i.e., with a very tight time
window), needs skills 5, 8 and 9 from the nursing staff, and uses the DEXA scan room.
Based on the skills that each nurse possesses (see an example in the right part of Fig. 2.1),
we can see that only nurses 3 and 6 would be able to perform that visit.
Information systems help to track the clinical and operational data needed. However,
the complex resource and time coordination needs of the many trials of a CRU cannot be
managed well under current planning and scheduling methods. Much manual entry into
homegrown spreadsheets is typically required. A few CRUs have developed state of the art
systems that identify the key human and physical resources required to fulfill the visits that
are on the schedule, and they check for a resource conflict before allowing a centralized CRU
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Figure 2.1: Example of the time and resource requirements of a 5 visit clinical trial (left)
and the CRU nursing staff’s skill sets (right)
scheduler to make an appointment. The methodology of this paper was developed to meet
an unfilled need (i) to forecast and control key CRU performance metrics (e.g., avoiding
high overutilization costs), (ii) to perform the cost/benefit tradeoffs of accepting/starting
a particular new trial, and (iii) to generate a plan for how to keep participant access/wait
times to an acceptable limit.
2.1.2 High level insights into CRU functioning
When a new trial is proposed to the CRU, the managerial staff has to make the decision of
whether or not the scientific/financial value they will gain from it will outweigh the resources
it requires (human as well as room), or whether or not there are even enough resources to
accept it. Perhaps more importantly, there is currently no way to accurately determine
the negative impact of a new trial imposed on existing trials (i.e., externalities) due to the
increased congestion in the system.
CRU performance is dominated by the methods used to schedule the first visit of the
treatment sequence required by the trial protocol, because subsequent visit times are dictated
in the protocol from the time of the first visit. Failure to meet the required time window and
resource requirements for any visit after the first results in a protocol violation that devalues
research data and wastes resources. Furthermore, excessive violations will compromise the
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scientific integrity of the clinical trial if the target enrollment cannot be met. If all visits are
properly booked at the time the participant enrolls, we avoid double booked appointments
and congestion which may result in protocol violations or overutilization. As a rule, the
managerial staff of a CRU would rather delay the start date of a participant’s sequence of
visits (or perform some visits in overtime) than risk a protocol violation. In current practice
and in our planning model, the violation rate metric is approximately 0.
In Fig. 2.2 we illustrate an example of the current practice booking methodology, which
we call “First Available Slot” (FAS) dynamic scheduling. We suppose that on day t a trial
coordinator contacts the CRU to enroll a participant in a given trial. Suppose that this trial
requires 3 visits: the second visit has to be scheduled between 10 and 12 days after the first
visit, and the third visit has to be scheduled exactly 16 days after the first visit. The trial
coordinator will communicate with the CRU to schedule this participant as soon as possible
for his/her first visit. But this can only be done if there will be a nurse available with the
required skills (this includes not only the nurses’ nominal daily capacities but also the extra
capacity that the CRU is willing to spend on overutilization) for all visits of the trial (the
same goes for room/equipment availability). In Fig. 2.2, there are no nurses with the right
skills available to schedule this participant for his/her first visit on day t+ 1. On day t+ 2,
there is a nurse available with the required skills for visit 1 of such a trial. However, no nurse
with the right skills for visit 2 is available from day t+ 11 to day t+ 13 (10 to 12 days after
the first visit). There is no choice but to try to reschedule the participant’s first visit to day
t + 3. The same procedure is repeated (as seen in Fig. 2.2) until this participant is finally
able to be scheduled on day t+ 5 with a TFAV of 5 days.
Conceptually, it adds insight to consider the idea that a relatively more “complex” pro-
tocol contributes more to the Time to First Available Visit (TFAV) than does a simpler one.
Loosely speaking, they cause more congestion to the system, and they also suffer more from
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Figure 2.2: Example of the current practice booking methodology, the first available slot
congestion, experiencing relatively poorer access. Our intuition suggests that the complex-
ity of a protocol increases (ceteris paribus) with (i) a larger number of visits in the trial,
(ii) smaller visit time windows, (iii) shorter times between visits (i.e., the rate of resource
consumption increases) and (iv) larger workloads placed on the CRU. Such “higher density”
protocols tend to have a long and more variable TFAV. This effect has been observed in
many healthcare settings and is elucidated as follows: if poor capacity planning either uti-
lizes too little capacity (i.e., is inefficient) or permits too many protocols to be conducted
then the system will experience significant congestion, thereby delaying the starting times
of participants in every trial (increasing TFAV).
The more congested the system, the more difficult it is to schedule multi-visit participants,
especially for high density protocols. We use simulation to show this behavior. In the left
of Fig. 2.3, we observe the TFAV population average and population standard deviation of
16 trials with protocol characteristics populated by one problem instance of the randomized
test suite described in Section 4.1 (see Table 2.1 in Section 4.1). The estimates are good
enough to avoid the need for error bars. If we look at the TFAVs of trials in a congested
system, we will see highly variable TFAVs (average TFAV for a simple trial vs. a dense trial)
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as well as high variability in TFAV for participants within the same trial (especially in high
density protocols).
Figure 2.3: Impact of a trial’s protocol density on it’s own TFAV as well as the rest of the
portfolio of trials; Left: Population average and standard deviation of the TFAV
under the FAS policy for a given instance of the randomized test suite in Table
2.1; Right: TFAV mean and standard deviation of trial 3 and the same portfolio
instance averaged across all 15 other protocols as the mean workload rate of trial
3 varies
In the right of Fig. 2.3, we illustrate the effects on the population average TFAV when the
average workload per visit of trial number 3 increases (i.e., the trial’s density increases). We
used the same problem instance as in the left of Fig. 2.3 while varying the workload per visit
of trial 3. Trial 3’s enrollment rate constitutes roughly 8% of the total portfolio enrollment
rate in the left graph, and the point with a workload rate of 3.0 hours per visit in the right
graph corresponds to its value in the base case. First, as expected, the population average
TFAV of trial 3 will increase nonlinearly in the average workload per visit. Also, we see
not only a nonlinear increase in the population average TFAV over all trials in the portfolio
excluding trial 3, but the standard deviation bars on the means are convex increasing in
the variability around this TFAV. This shows how the density of one trial not only affects
the TFAV for its own participants, but greatly affects the TFAV of participants of all other
trials (since this portfolio is conducted under shared resources). This shows how selecting
new trials needs to be done carefully while understanding/forecasting the impact that this
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will have on other trials and the CRU resources.
In clinical research practice, the longer the TFAV, the greater the fraction of participants
who choose not to start the trial, thus increasing overall trial duration due to a lower en-
rollment rate. For example, high TFAV is also a problem for participants that need to start
the trial as soon as possible due to their clinical condition (e.g., advanced cancer). Further,
“each day it takes to bring [drug] products to the market is revenue lost: therefore, planning
is critical to the entire drug development process, including clinical trial operations,” [49].
Trial duration is a major problem in current practice.
The above concepts motivate our planning approach to provide improved and controlled
access (relative to FAS) for participants overall and especially in high density trials. Under
the current booking methodology, the participants enrolled in low density trials will have
very good access to care at the expense of the participants enrolled in high density trials.
The reason is that under this booking policy, the first available slot is always given to the
current enrolling participant even if he/she is enrolled in a low density trial that is easy
to book with low access (e.g., a short one visit trial) thus taking critical resource capacity
away from the future participants in trial protocols that may be harder to schedule. This
motivates our decision to reserve time slots (capacity) for first visits of each participant of
each trial (see Section 3.2), while assuring that enough capacity is available for subsequent
visits (with our participant flow forecasting methods in Section 3.4).
2.1.3 CRU needs for capacity planning and scheduling tools: A structured
survey
To clearly identify the status of common sense approaches in CRUs, MCRU conducted a
survey across 80 NIH-sponsored Cancer Centers, with 34 responses. The most difficult chal-
lenge was identified as knowing how to “Schedule the number/variety of protocols requested,”
with more than 95% selecting Strongly Agree or Agree. More than 80% of respondents agreed
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that a scheduling tool for predicting capacity and overutilization could help improve metrics.
CRUs agreed or strongly agreed that “In an effective Clinical Research Unit Planning Tool,
I would value the ability to: “predict the impact of a new trial (> 90%), reduce overuti-
lization expenses (80%), and reduce time-to-first-visit (80%). A real time scheduling tool
which confirms that the required resources are available for all visits at time of booking was
considered very valuable or valuable by 92% of the centers.
2.2 Literature survey
“Many clinical trials fail to deliver because of the lack of a structured, practical, busi-
nesslike approach to trial management,” observes [11] (see also [33] for further insight).
Rigorous research as well as the software vendor community have left the topic of CRU op-
erations almost untouched. Vendors have targeted the support of individual trials without
providing support for managing the CRU as a system of shared resources. Systems like
EPICTM (see [3]) provide basic scheduling and information management, but our research
seeks to harness mathematical system modeling and optimization to provide functionality
for planning, scheduling, and achievable trial performance. Survey results (provided in Sec-
tion 1.3) from many leading CRUs indicate that they are experiencing major difficulties and
are eager for science-based engineering systems for planning and scheduling. Most of the
literature in clinical trial management focuses on how to design trials that are successful and
efficient throughout the different stages that lead to drug development/commercialization
(see [54, 12]). Some literature treats the recruiting process of participants (see [39]). At
the same time, “patient recruitment should not start until the clinics and data center have
demonstrated that they are properly staffed and equipped to support this activity,” states
[41].
The research models and algorithmic solutions in the literature do not provide a method-
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ology that simultaneously accounts for the following elements that we integrate: (i) timeta-
bles for multi-visit care pathways of different durations and resource requirements with spec-
ified tolerances for their timing, (ii) a multi-month transient planning horizon, (iii) various
room resources, (iv) staff with specific skills/capabilities, (v) variable and uncertain partici-
pant enrollments, (vi) forecasting and controlling patient access by type, (vii) trial portfolio
selection, (viii) forecasting and controlling overutilization costs, (ix) efficient and practical
booking methodologies, and (x) coordinating the nursing staff and the physical resources
with participants’ treatment needs. Despite a large literature on scheduling and planning
(e.g., see [21]), there is little extant work to suit the problem at hand.
[21] uses the term indirect waiting to describe the wait to get an appointment which we
have captured at the daily level as TFAV. A prior model by [18] determines the best start
times of trials (within a day) and the allocation of individual personnel to clinical tasks
using a Mixed Integer Programming model. But this paper does not consider items (ii), (iii)
and (vi)-(x). Moreover, the trial protocols they considered do not require more than one
day to complete, whereas the sequence of visits to complete a trial can span many weeks
in our model. By using historical data to construct a matrix that assigns probabilities for
patients’ ward locations over time, [28] presents a new method to predict and optimize the
daily census at every ward in a hospital. By rearranging the elective/surgical schedules, they
can control the offered load on each hospital ward in an equilibrium model that is cyclo-
stationary. Our model differs from theirs in items (i), (ii), (iv), (vi), (vii), (viii), and (x).
Relevant literature includes scheduling outpatients to reduce waiting times ([7]), and many
others such as [46, 47] and [4]). [45] used approximate dynamic programming (ADP) to
consider different patient types that require different levels of access to a single appointment
for a diagnostic resource. This ADP approach was extended by [15] who allowed an interval
to be specified (earliest date and latest date) for the appointment. Our system differs from
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the prior two in items (i)-(iv), (vii), and (x).
2.3 The CAPTAIN methodology
CAPTAIN solves three interrelated problems: (i) selection of the portfolio of candidate
clinical trials that can and should be added to maximize the scientific/financial value ex-
tracted, (ii) creation of the daily Booking Reservation Plan (BRPlan), which is a capacity
allocation plan that reserves slots for trial visits, and (iii) construction of a daily nurse
schedule (NSPlan) that accounts for every planning visit’s requirements for nurse skills.
A key objective of a CRU is to extract the most value from the resources available, so to
facilitate item (i), we will use a scalar metric of total value gained and incorporate it as one
component in the decision of which trials to conduct. Our goal is to construct an optimized
transient/non-homogeneous BRPlan and NSPlan that will estimate and control the critical
CRU metrics defined earlier. We use a transient model since the portfolio of active trials
in a CRU tend to vary with time: some new trials can be added, while some will end or
be interrupted. The length of this planning horizon will be D business days of participant
enrollments (e.g., 60 days).
To support implementation, it is important that we be realistic in modeling the way that
CRUs would transition from any prior method for scheduling patients to our methodology.
We allow for the current portfolio in the CRU (before the incorporation of the CAPTAIN
tool), P0, to have been actively populated with appointments for T days (e.g., 720 business
days). This initial condition induces a certain “committed” workload/capacity for each
resource (skills and rooms) on each day of our planning horizon. This is generated by the
FAS scheduling of patients that enrolled prior to CAPTAIN’s period of planning. Those
initial workload conditions will be taken as inputs to our math program. Our question is:
how should the resource capacity still available be allocated to schedule our new participant
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enrollments from P0 and an optimized set of candidate trials while forecasting and controlling
the concerned metrics? More information about the transient and implementation aspects
of CAPTAIN can be found in Appendix C in Section 2.7.3. Note that all mathematical
notations are also described in Appendix A in Section 2.7.1.
2.3.1 Scientific value and the objective function
To help evaluate potential trials to be added, the model accepts an input scientific value
rating Mk for every candidate clinical trial k ∈ Pcand. This is an obvious mechanism to
obtain the greatest good from the CRU resources. Of course, setting Mk = 1 for all trials
k is still a very useful model, provided constraints are placed on TFAV to provide equal
access to all despite logistical differences between trials. In current practice, they schedule
any new participant enrollment to the next available slot such that all future visits can
adhere to the protocol requirements while also respecting capacity constraints. As a side
effect, this results in a system which offers the best access (low TFAV) to the participants
in the low density trials. Complex trial protocols suffer with long TFAV metrics which is
a barrier to enrollment, may undermine the participant’s health care, and lengthens the
duration of the trial. The scientific value input allows the optimization to combine all the
relevant metrics in allocating capacity while satisfying constraints on metrics that include
TFAV and overutilization limits. Scientific value can have different meanings for different
CRUs. While scoring Mk is a challenge outside the scope of this paper, one view is to rate
the trials based on the scientific/research knowledge that can be gained from them (this is
already done in practice). Scientific value could also incorporate the financial value gained
from a trial, especially for industry funded trials. It is not difficult to set up the scoring
system to ensure that the scientific goals take priority over finances by weighting the various
categories appropriately.
One possible objective of the Mixed Integer Program can be summarized neatly by max-
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imizing the following, but the deep computations all happen in the constraints, which are
provided later: ∑
k∈P
Mkhk, (2.1)
where the binary decision variable hk is set to 1 if and only if trial k ∈ Pcand will be activated,
and P = Pcand ∪ P0. Note that hk will be a parameter equal to 1 for trials k ∈ P0 that are
still ongoing at the beginning of our planning horizon. The following sections will introduce
and justify the modeling of our system’s constraints, and a complete version of the Mixed
Integer Program used in the numerical case studies can be found in Appendix D.
2.3.2 The Booking Reservation Plan (BRPlan)
The BRPlan is essentially a patient admission control mechanism that packs the partic-
ipants’ first visit requests into the planning space of physical, human, and time resources
via planned appointment time blocks for each type of first visit planned and accounting for
all follow-up visits. Our decision variables will set a maximum limit on the number of type
k participants that can start their treatment sequence on day d of our planning horizon,
thereby controlling the participant flow of enrollments. For each active and candidate trial
k ∈ P , our BRPlan decision variables, Θk,d, will take values in Z+, and be defined over the
set of days {1, ...,D + TFAV maxk }. The horizon extends TFAV maxk days beyond the end of
the planning horizon, D, because CAPTAIN schedules the enrolling participants (up to day
D) within the population maximum TFAV, TFAV
max
k , which is set by the decision maker.
To compute the TFAV access metric and to optimize the BRPlan, a given type k partici-
pant enrolling will always be given the first available type k reserved capacity slot within
the BRPlan. After the first visit, we account for participant’s preference within the time
windows of subsequent visits. The first visit for type k is booked to the first available day
with sufficient reserved capacity by the BRPlan, so that we can emphasize the effectiveness
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of the capacity management method of a CRU to guarantee a level of access to the most
urgent patients and to do so without dependence on the participants’ personal preferences.
The BRPlan differs from the current first available slot methodology, because it selects the
first available slot reserved for type k participants (which was determined by an informed
decision of all protocols’ needs derived via optimization).
To quantify the stochastic booking process, we assume that a type k participant enrolling
on day t can be scheduled for her first visit no earlier than day t+1. We provide the following
key definition:
Definition II.1. Let αk,d,t denote the nonnegative integer valued random number of type
k first visit participants booked under the BRPlan on day d ∈ {1, ...,D + TFAV maxk } and
enrolled on day t ∈ {0, ...,D}, where t < d.
One can compute αk,d,t recursively while considering the type k daily demand/enrollment
random variables denoted by Ak,t, t ∈ {0, ...,D} taking values in Z+, and the previously
defined BRPlan type k admission limit decision variables, Θk,d, as:
αk,d,t = min
{(
Θk,d −
t−1∑
l=0
αk,d,l
)
,
(
Ak,t −
d−1∑
l=t+1
αk,l,t
)}
, (2.2)
where (i) the left hand side of the minimum is the integer number of type k reservations/slots
remaining on day d for first visits after all participants who enrolled before day t have been
scheduled, and (ii) the right hand side of the minimum is the random number of type k
participants who enrolled on day t and who are not booked for their first visit appointment
before day d (or later).
Our goal is to translate this set of stochastic non-linear equations into a set of determin-
istic linear constraints subject to Θ that can capture the mean of the αk,d,t random variables.
This information is needed to accurately estimate (i) how demand will be fulfilled according
to a given BRPlan Θ, (ii) the delay to obtain a first visit, and (iii) how the CRU’s resources
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will be utilized. The dynamics of our system are conceptually similar to the idea of blocking
in queueing networks, which is difficult to compute except in special cases, and is non-linear
in our main decision variable Θ. To overcome this, we consider approximation techniques
that can tractably capture the key system dynamics linearly in order to forecast and control
our desired metrics in a deterministic Mixed Integer Programming (MIP) optimization.
Although keeping a full information state of prior enrollments allows us to estimate our
metrics exactly and linearly in our decision variables, an important mechanism to keep our
optimization tractable is to approximate the information state by aggregating the enrollment
information for the m or more days prior to current day t, with m ≥ 1. The random variables
Ak,t take values in the set I = {0, 1, ..., I}, with I being the maximum number of type k
enrollments on a given day.
Definition II.2. For all k ∈ P , t ∈ {1, ...,D}, d ∈ {t + 1, ...,D + TFAV maxk }, m ≥ 1, and
j∗(t) = max{t −m + 1, 1} we define the set Ak,d,t(m) with elements αat,at−1,...,aj∗(t),ak,d,t ∈ R+,
a ∈ {0, 1, ..., j∗(t) · I}, and the vector (aj)j∈{j∗(t),...,t} ∈ I that represents the conditional
expectation of the number of patients that enrolled on day t and are scheduled on day d given
a partial history of prior enrollments (Ak,t, ...,Ak,j∗(t),
∑j∗(t)−1
i=0 Ak,i) = (at, at−1, ..., aj∗(t), a),
where the oldest history, days {0, 1, ..., j∗(t)− 1} are aggregated as a sum.
As a first example, let’s assume that t is day 15 and m = 5. Then we notice that
j∗(15) = 11 and that our set Ak,d,15(5) will contain the conditional expectations αa15,a14,...,a11,ak,d,15
of the number of participants enrolled on day 15 and scheduled on day d > 15 given the
following partial history of enrollment: (a) the aggregated information of total enrollments
from days 0 to 10 (
∑10
i=0 Ak,i = a,∀a ∈ {0, ..., 11I}), and (b) the daily enrollment information
from days 11 to 15 (Ak,i = ai, ∀ai ∈ I,∀i ∈ {11, ..., 15}). Now, in the case when m > t (say
m = 20), we will have j∗(15) = 1, and we notice that our set Ak,d,15(20) will contain the
conditional expectations αa15,a14,...,a1,ak,d,15 of the number of participants enrolled on day 15 and
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scheduled on day d > 15 given a full daily history of enrollment from days 0 to 15 (where
day 0’s enrollment realization will be characterized by a).
Remark II.3. In Definition II.2, we omitted the first day where t = 0 due to notational
complexity. To address this issue, we will assume j∗(0) = 0 and use the convention αa0k,d,0 :=
α
a0,aj∗(0),a
k,d,0 to define the elements of the set Ak,d,0(m) similarly to Definition II.2. Hence, in
the case t = 0, αa0k,d,0 will represent the conditional expectation of the number of patients
that enrolled on day 0 and are scheduled on day d given that there were Ak,0 = a0 type k
enrollments on day 0.
In Lemma II.4 and Theorem II.5, we show that a linear MIP can be formulated in our
decision variables when we keep a full information state of prior enrollments: m =∞.
Lemma II.4. For all k ∈ P , t ∈ {0, ...,D}, d ∈ {t + 1, ...,D + TFAV maxk }, the elements
α
at,at−1,...,a0
k,d,t ∈ Ak,d,t(∞) can be expressed in a MIP as a set of linear constraints subject to
our decision variables Θ.
To prove Lemma II.4 and all the following lemmas and theorems, see Appendix B in
Section 2.7.2. We allow general (and time dependent) distributions for type k demand, so
the model can use historical/empirical distributions from the given (or from a similar) trial’s
enrollment processes or use expert opinion to account for different rates of enrollments with
time, which may be useful during periods of trial advertisement. With a finite I, we let
Pk,t(al), al ∈ I with I = {0, 1, ..., I} ⊂ Z+ be the probability that there are a enrollments of
type k on day t (which can be drawn from historical and protocol data). Finally, we make
the assumption that Ak,t1 is independent of Ak,t2 for all t1 6= t2 ∈ {0, ...,D} (which is a
good assumption in practice even when the arrival process is nonstationary over time due to
promotions).
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Theorem II.5. Given any BRPlan matrix Θ, and as I → +∞ in the case of unbounded
support for the enrollment distribution, αk,d,t, the expected value of αk,d,t, can be computed
linearly in our decision variables Θ as:
αk,d,t =
∑
α
at,at−1,...,a0
k,d,t ∈Ak,d,t(∞)
α
at,at−1,...,a0
k,d,t ·
t∏
l=0
Pk,l(al). (2.3)
For every k ∈ P , t ∈ {0, 1, ...,D}, and d such that t < d ≤ D + TFAV maxk , the set
Ak,d,t(∞) will be composed of (I¯ + 1)t+1 elements. In our setting, clinical trial daily enroll-
ment/demand rates are rather low (generally less than 1 enrollment per day), which allows
us to choose a small I¯ while not losing much accuracy. We run into dimensionality issues as
the length of our planning horizon gets large (e.g., t is 60 for a 12 business week planning
horizon). For tractability, we approximate our booking methodology by reducing the cardi-
nality of the set Ak,d,t(∞). In all that follows, we use the set defined as Ak,d,t(m) in Definition
II.2, with a partial aggregation of the enrollment information from days 0 to j∗(t)− 1. The
goal is to express α
at,at−1,...,aj∗(t),a
k,d,t ∈ Ak,d,t(m) linearly in our decision variables, but Eq. 2.2
requires taking the conditional expectation of the minimum of two random variables. In the
case m = ∞ (see Lemma II.4), conditioning on the complete history of enrollments allows
the two elements of the minimum of Eq. 2.2 to be deterministic, so the expected value of
the minimum will be the minimum of the expected values of each term. In the case m < t,
this won’t hold, and we rely on the following approximation. We define αˆ
at,at−1,...,aj∗(t),a
k,d,t as an
element of the set Aˆk,d,t(m) which approximates Ak,d,t(m), and so we define αˆat,at−1,...,aj∗(t),ak,d,t
to be:
min
{
E
Ak,t − d−1∑
l=t+1
αk,l,t|(Ak,t,Ak,t−1, ...,Ak,j∗(t),
j∗(t)−1∑
i=0
Ak,i) = (at, at−1, ..., aj∗(t), a)
 ,
E
Θk,d − t−1∑
l=0
αk,d,l|(Ak,t,Ak,t−1, ...,Ak,j∗(t),
j∗(t)−1∑
i=0
Ak,i) = (at, at−1, ..., aj∗(t), a)
}.
(2.4)
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We will assume that the elements α
at,at−1,...,aj∗(t),a
k,d,t of Ak,d,t(m) are close to αˆ
at,at−1,...,aj∗(t),a
k,d,t ∈
Aˆk,d,t(m) for all k ∈ P ,∀t ∈ 0, ...,D,∀d ∈ t + 1, ...,D + TFAV maxk . In other words, we
assume equality in the well known Jensen’s inequality (i.e. we assume E [min{X,Y }|Z] =
min{E [X|Z] ,E [Y |Z]} for the random variables X, Y and Z). The less variability there
is in the random variables E [X|Z] and E [Y |Z], the more accuracy we will have in our
approximation. Hence, the more enrollment information we condition αk,d,t on (i.e. the
larger m is), the closer αˆ
at,at−1,...,aj∗(t),a
k,d,t will be to α
at,at−1,...,aj∗(t),a
k,d,t .
Proposition II.6. Given αˆ
at,at−1,...,aj∗(t),a
k,d,t ∈ Aˆk,d,t(m) defined in Eq. 2.4, and any BRPlan
matrix Θ, as I → +∞, αk,d,t, the expected value of αk,d,t, can be approximated linearly in
our decision variables Θ as:
αk,d,t ≈
∑
αˆ
at,at−1,...,aj∗(t),a
k,d,t ∈Aˆk,d,t(m)
αˆ
at,at−1,...,aj∗(t),a
k,d,t ·
 t∏
l=j∗(t)
Pk,l(al)
 · P k,j∗(t)(a). (2.5)
where P k,j∗(t)(a) =
∑
a0+a1+...+aj∗(t)−1=a
∏j∗(t)−1
l=0 Pk,l(al) is the probability of having exactly a
type k enrollments in the first j∗(t) days (from day 0 to j∗(t)− 1) of our planning horizon.
Note that as m decreases, |Aˆk,d,t(m)| decreases while trading off some accuracy when
computing αk,d,t (since we aggregated information on past enrollment realizations). If we let
µk,d be the random variable designating the number of type k participants scheduled on day
d of our planning horizon under the BRPlan policy, we can compute its mean as:
µk,d = E [µk,d] =
d−1∑
t=0
αk,d,t. (2.6)
2.3.3 Formulation and control of the Time to First Available Visit
In this subsection, we want to control participants’ access to trials. We formulate three
TFAV metrics for a given trial k: (i) the average TFAV, denoted TFAV avgk , which is the
mean TFAV averaged over all participants of type k that enrolled within our time horizon,
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(ii) the TFAV-exception rate, TFAV exceptk,t (ω) is the expected value of the percentage of
type k participants that enrolled on day t and that had to wait strictly longer than ω days
before their initial visit, and (iii) the population maximum TFAV, denoted TFAV
max
k , which
captures the maximum expected number of days that a type k participant had to wait within
our time horizon. In (ii), the TFAV-exception rate will be defined for each day t ∈ {0, ...,D}
by a type k sequence
(
TFAV exceptk,t (ω)
)
ω∈T , T ⊂ {0, 1, 2, ...,TFAV
max
k }, where each element
is the expected fraction of type k participants enrolling on day t which will exceed ω days of
waiting for their first visit (i.e., won’t be scheduled before t+ ω + 1). By allowing the CRU
administrator to control (i)-(iii), we will be able to reduce the access variability between
participants of a given trial and shape the access delays across trials. The elements and the
cardinality of the set T are to be custom selected to meet the relative trial priorities and
participant treatment needs.
Theorem II.7. The average type k TFAV can be expressed linearly in our BRPlan variables
Θ as follows:
TFAV avgk =
D∑
t=0
D+TFAV
max
k∑
d=t+1
∑
α
at,at−1,...,a0
k,d,t ∈Ak,d,t(∞)
(d− t) · αat,at−1,...,a0k,d,t
·
∑
(aD,aD−1,...,at+1)∈ID−t
∏D
l=0 Pk,l(al)∑D
i=0 ai
(2.7)
Next, the customer-average type k TFAV exception rate on day t for a chosen delay ω is
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computed linearly in Θ as follows:
TFAV exceptk,t (ω) = E
D+TFAVmaxk∑
d=t+ω+1
αk,d,t
Ak,t
 (2.8)
=
∑
(at,...,a0)∈It+1
D+TFAV
max
k∑
d=t+ω+1
E
[
αk,d,t
Ak,t
|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)
]
·
t∏
l=0
Pk,l(al) (2.9)
=
D+TFAV
max
k∑
d=t+ω+1
∑
α
at,at−1,...,a0
k,d,t ∈Ak,d,t(∞)
α
at,at−1,...,a0
k,d,t
at
·
t∏
l=0
Pk,l(al). (2.10)
Eq. 2.9 can be derived by conditioning Eq. 2.8’s expectation with respect to (At, ...,A0) =
(at, ..., a0). Assuming a finite set I (which is a good assumption in practice), we can change
the order of summation, and by using the definition of set Ak,d,t(∞) and its elements
α
at,at−1,...,a0
k,d,t , we can derive Eq. 2.10. It will be linear in our decision variables thanks to
our result in Lemma 3.1.
Remark II.8. Note that when solving this problem for long planning horizons, we can approx-
imate the average TFAV (resp., TFAV exception rate) formulation in Theorem II.7 (resp. Eq.
2.10) by computing TFAV avgk (resp., TFAV
except
k,t ) as a linear combination of αˆ
at,at−1,...,aj∗(t),a
k,d,t
terms (see Section 2.3.2 for more details), as follows:
TFAV avgk ≈
D∑
t=0
D+TFAV
max
k∑
d=t+1
∑
αˆ
at,at−1,aj∗(t),a
k,d,t ∈Aˆk,d,t(m)
(d− t) · αˆat,at−1,aj∗(t),ak,d,t
·
∑
(aD,aD−1,...,at+1)∈ID−t
P k,j∗(t)(a) ·
∏D
l=j∗(t) Pk,l(al)
a+
∑D
i=j∗(t) ai
, (2.11)
TFAV exceptk,t (ω) ≈
D+TFAV
max
k∑
d=t+ω+1
∑
αˆ
at,at−1,aj∗(t),a
k,d,t ∈Aˆk,d,t(m)
αˆ
at,at−1,aj∗(t),a
k,d,t
at
· P k,j∗(t)(a) ·
t∏
l=j∗(t)
Pk,l(al).
(2.12)
We can limit TFAV avgk by constraining it by a specified upper bound on average access
wait, denoted TFAV
avg
k . Also, we let pk,t(ω), with ω ∈ T be the limit placed on the
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expected percentage of type k participants that enrolled on day t that are permitted to ω
days of waiting for their first visit. Note that setting pk,t(TFAV
max
k ) = 0 for all t ∈ {0, ...,D}
is equivalent to setting a population maximum TFAV limit of TFAV
max
k on trial k. This
assures that type k enrollments on any given day t will be booked for their first visit on a
day d ≤ t+ TFAV maxk .
2.3.4 The stochastic Participant Resource Requirement Model
The Participant Resource Requirement Model (PRRM) is a stochastic location process
model (a particular random field) we developed to tractably capture randomness in partici-
pant resource needs over time, and it was inspired by [28]. Let the set of all possible physical
locations/resources be R and the set of all skills of the personnel be S. Then the entire set
of resources is indexed by r in R ∪ S. Note that specific skills are required on each visit of
a trial (as opposed to specific nurses). Each skill is mapped via the nurse skill sets to one
or more staff possessing that skill. This captures the unique skills of each individual staff
member. First, we focus on the workloads induced on skills, and we will later assign those
workloads to specific nurses.
The protocol information for any trial k includes (i) the number of visits Vk in the trial,
(ii) the time window requirements on each visit v, Ωk,v, which represents a finite set of
days that visit v can be scheduled after the first visit without provoking a deviation from
protocol (patient preference is exercised only within those time windows), (iii) the set of
clinical resources needed (for example it could be skill 1, skill 5, and the Procedure Room)
needed for each visit v, and (iv) the deterministic workload, w¯k,v,r, induced by a visit v on
resource r. As an example of item (ii), if Ωk,v = {10, 11, 12} then a type k participant will
require resources on a given day between 10 and 12 days after his/her first visit. There may
exist some protocols where visit v has no time window requirement, and in this case we let
Ωk,v = {1, 2, ...,Lmax}, where Lmax is the maximum length (in days) of the longest protocol
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(for a single participant). For first visits, there are no time windows since the participant can
start on any day with available capacity, so by convention, we let Ωk,1 = {0},∀k ∈ P . We use
the protocol information in items (i)-(iv) to create a participant flow model that forecasts
the required workload of participants of type k, on and after their first visit. The vector
PRRMk,d1(d) determines, for a randomly sampled participant starting protocol k on day d1,
the number of hours he or she will need each resource r ∈ R∪S∪H on day d, where H is the
“home” resource (i.e., the participant has no appointment in the CRU). Letting er be the
unit vector with a 1 in the rth column, our goal is to compute P (PRRMk,d1(d) · er = w), the
probability that a participant starting protocol k on day d1 will require w hours of resource
r on day d. Because participants enrolling in an active trial k on day d1 have a uniform
distribution of preferred days within their visits’ time windows, this generates the following
probability distribution of the workload induced on resource r (skills and rooms) on day d:
P (PRRMk,d1(d) · er = w) =
Vk∑
v=1
1w=wk,v,r
1 {(d−d1)∈Ωk,v}
|Ωk,v| . (2.13)
Remark II.9. From Eq. 2.13, we can compute the expected value of the PRRM, denoted
PRRMk,d1,r(d), for all trials k:
PRRMk,d1,r(d) := E (PRRMk,d1(d) · er) =
Vk∑
v=1
1 {(d−d1)∈Ωk,v}
|Ωk,v| w¯k,v,r. (2.14)
In this paper, we assume a uniform distribution within the days of the visit time windows
to model patient preferences. Note that in practice, we can generalize this by using patient
preference estimated from historical distributions. Also, the required time window of visit
v of a protocol is only dictated by the timing of the first visit. A trivial extension of our
PRRM formulation would be to consider the time dependence between two subsequent visits
(e.g. visit 3 has to occur between 10 and 12 days after visit 1, but also exactly one day after
visit 2).
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2.3.5 Formulation of the offered daily workload
As is common in queueing problems, computing the workloads in the system is funda-
mental. The daily offered workload for our planning horizon will depend on (i) W initr (d), the
existing workload on resource r and day d induced by participants that enrolled prior to the
start of our horizon, (ii) the portfolio of the selected candidate trials chosen at the beginning
of our planning horizon, (iii) the number of daily participant bookings for their first visit by
trial, to be optimized by the reserved resource capacity plan, BRPlan, and (iv) the PRRM
model of patient flow through subsequent visits. Since we are considering enrollments from
days 0 to D, and we limit the trial k population maximum TFAV level to TFAV maxk , we
need to predict the offered workloads up to day D+Lmax + maxk{TFAV maxk } (where Lmax
is the duration in days from the first visit to the last visit of the longest protocol). The
following theorem shows how to compute the offered workload on any day d and resource
r ∈ R ∪ S.
Theorem II.10. Given µ¯k,d1, the mean offered workload for resource r (r ∈ R∪ S) on day
d of our planning horizon, with d = {1, 2, ...,D+Lmax + maxk TFAV maxk }, can be expressed
linearly as follows:
W¯r(d) = W
init
r (d) +
∑
k∈P
min{d,D+TFAVmaxk }∑
d1=1
µ¯k,d1 · PRRMk,d1,r(d). (2.15)
While Theorem II.10 applies to both the rooms and skills of the personnel, we now focus
on the human resources, which we refer to as nurse resources (as non-nursing staff can be
treated similarly). Below, index n denotes the nth nurse in set N of all nurses working in
the CRU. In order to achieve the desired targets on the overutilization and TFAV metrics,
CAPTAIN has the ability to provide a Nurse Schedule Plan (NSPlan) that (i) plans for each
day d, the number of hours Kn(d) each nurse n should work on day d given the clinic’s
constraints on shift assignments, and (ii) coordinates participants’ needs (skills required on
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each visit) with nurses’ skill sets and availability. Feature (i) permits the model to generate
a nursing shift assignment plan that takes into account the possible shift lengths of a CRU
(for examples, see Case Studies A and B in Section 2.5.2) as well as the CRU’s rules on
shift assignments (an example is provided when the test suite is described in Section 2.4.1).
In the MIP formulation in Appendix D (Section 2.7.4), we omit the nurse staff workload
planning constraints, since these must be coded into the MIP in a manner unique to the
case study (i.e. rules on shift assignments and shift lengths). Conceptually, the idea is
to ensure that {(Kn(1), ...,Kn(D + Lmax + maxk TFAV maxk ) : n ∈ N} ∈ ∆, with the set
∆ assuring that all staffing rules are obeyed. The modeling of skill sets allows for the
consideration of training/cross-training in addition to hiring/expansion. In (ii), we need to
compute decision variables xs,n(d) that determine the number of hours nurse n should be
assigned to participants that require skill s on day d of the planning horizon while respecting
the allowable shift lengths. Continuity of care is not a concern for the multiple visits of a
trial, hence we do not need to assign the same nurse to all the visits of a participant. Note
that Theorem II.10 determines the mean workload induced on the nursing skills, but not the
nurses themselves (because protocols do not specify which nurse needs to be present for a
visit, but rather the skills).
The decision variables xs,n(d) need to ensure that the offered workload on any skill on
any day d (expressed in Theorem II.10) has to be assigned only to a nurse n that can perform
that skill s, where N (s) denotes the set of nurses that possess skill s. Observe that such a
decision not only affects the workload induced on the skill required by this visit, but also on
all other skills that this nurse possesses due to shared capacity. Eq. 2.16 and 2.17 assure
that the set of nurses that possess skill s can serve the anticipated workload, and that no
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nurse n will be assigned workload not in his/her skill set. Let
W s(d) =
∑
n∈N (s)
xs,n(d),∀s ∈ S, ∀d ∈ {1, 2, ...,D + Lmax + max
k
TFAV
max
k }. (2.16)
From Eq. 2.16, we can now compute the mean daily workload induced on each nurse:
W (n, d) =
∑
s∈S
xs,n(d),∀n ∈ N ,∀d ∈ {1, 2, ...,D + Lmax + max
k
TFAV
max
k }. (2.17)
We allow the system administrator to impose a constraint on the maximum allowable,
planned mean overutilization for nurse n on day d, denoted O¯n(d):
W (n, d) ≤ Kn(d) +On(d),∀n ∈ N ,∀d ∈ {1, 2, ...,D + Lmax + max
k
TFAV
max
k }. (2.18)
For room resources (e.g., bed, chair, procedure room, exercise room, DEXA scan, etc.),
the model is a degenerate case of nurse resources, because there is no need for “room flex-
ibility” or a room “staffing plan.” We model a fixed daily available capacity (of 12 hours
in MCRU’s case). From Theorem II.10, the expression for the mean overutilization hours
induced each day on any room resource can simply be formulated in Eq. 2.59 (Appendix D
in Section 2.7.4).
2.4 Validation approach
Having defined our decision support optimization model, we now validate our computa-
tions and approximations. To validate the concept of the BRPlan and our main performance
metrics, we begin by assuming that there is no selection of additional trials and that the
NSPlan is not optimized (i.e., we continue booking the participants of P0 in our planning
horizon with the same nurse schedule as current practice, but now by following the BRPlan).
Section 2.5.1 will test the portfolio selection feature of our problem while Section 2.5.2 will
test the improvements made by the BRPlan and NSPlan (which will then be optimized)
methodologies over the FAS policy. The validation in this section aims to test the accu-
racy of our BRPlan approximation and how this affects the forecasting of our metrics: the
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portfolio selection and nurse daily capacity decisions are not correlated to accuracy, but we
do still validate our approach for many portfolio instances and nurse schedules of our ran-
domized test suite (each instance having a fixed portfolio and nurse schedule). Therefore, in
this section, our objective is to maximize the mean resource utilization/workload (which is
equivalent to minimizing the overall mean TFAV of participants) subject to constraints on
our other metrics. For all our following numerical results (validation and sensitivity/tradeoff
analyses), we conservatively employ the m = 1 approximation, which highlights a worst case
scenario for the approximation. Specifically, in the case where m = 1, we lose accuracy in
computing the mean number of enrolled participants that will be booked on a given day,
because we consider the number of enrollments on the current day, and aggregate all the
enrollment information of previous days.
2.4.1 Test Suite
Our objective is to perform a performance evaluation that is more scientific than a case
study of a specific CRU. Drawing from protocol characteristics from MCRU that are believed
to be representative of many sites, we constructed a randomized test suite of protocols, CRU
features, and CRU constraints on key metrics, that have characteristics spanning those in
practice. We randomized (with uniform distributions) the number of active trials modeled
as well as the protocol characteristics of all active and candidate trials. The ranges on the
uniformly distributed parameters of our randomized test suite are provided in Table 2.1. In
the following experimental studies, we also use a fixed number of rules on shift scheduling: it
is required that a given nurse (1) cannot have two 12 hour shifts (the longest possible shift)
two days in a row, (2) cannot be on call (a nonzero capacity) more than three days in a row,
and (3) is assigned a total planned capacity of 40 hours in a week. Each performance site
will have its own set of rules/preferences, and our methods are flexible enough to incorporate
such specific requirements (see e.g., [34]).
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Parameter Range
Workload induced on a resource for a given visit (in hours) 1 - 6
Time between successive visits (in business days) 1 - 15
Visit time windows ( in ± days) 0 - 10
Number of visits 1 - 10
Enrollment rates (in participants/day) 0.1 - 1
Number of active trials 6 - 16
Number of candidate trials to consider accepting 0 - 8
Number of nurses 6
Number of nurse skill sets 10
Possible shift lengths (in hours/day) 0, 4, 8 or 12
Number of room types 6
Room capacity (in number of hours per day for each type) 12 - 48
Daily overutilization target over all resources (in hours) 0 - 6
Population Average TFAV target TFAV avgk (in business days) 10 - 25
Mean percentage of participants exceeding a given TFAV target (in %) 0 - 50
Population Maximum TFAV target (in business days) TFAV avgk - 40
Table 2.1: Test suite defined by trial protocol features (upper part of the table), CRU features
(middle part of the table), and targets/bounds set on the main metrics (lower part
of the table)
Note that in practice, candidate trials proposed to the CRU have a fully defined protocol,
so the protocol parameters needed for the model will be known prior to the activation of the
trial (including the desired number of participants). Estimating enrollments for candidate
trials is challenging, but our experience and that of MCRU staff indicates that it can help to
use historical enrollment data from trials with similar features. We randomized each nurse
skill set as follows. Referring to the table on the right of Fig. 2.1, we use a probability of 0.5
in placing a check mark in each cell to denote that nurse n has skill s, with cells being i.i.d.
2.4.2 Simulation of the BRPlan for validation purposes
For purposes of validation, we wrote a custom C++ simulation and employed the test
suite to see how an optimized BRPlan, Θk,d, would behave in practice. The enrollment rates
for all trials are modeled as Poisson processes for simplicity of exposition. The simulation
takes in two of the main outputs from CAPTAIN: the BRPlan and the NSPlan. Also, it
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considers the committed workload (i.e., already scheduled visits) at the beginning of the
planning horizon (based on a simulation of the prior history of the system to generate the
irrevocable workload from participants that enrolled prior to our planning horizon). After
an enrollment of a given type in our planning horizon, the simulation checks for capacity
availability to schedule the participant based on the optimized BRPlan, Θk,d, and the previ-
ous enrollments that already occupy some of the slots of the BRPlan. The simulation books
each new participant for a first visit on the earliest future day when there is enough resource
capacity reserved by the BRPlan for that type of trial. Once this day is identified, the
participant is scheduled for the first visit, and all the downstream visits of the protocol are
generated according to the PRRM (see Section 2.3.4) and the distributions associated with it
(e.g., uniform distributions on the participant preference within the required time windows).
The simulation then uses the optimized NSPlan to assign the visit (and workload) to a given
nurse with the required skill such that all nurse work rules of the prior subsection are obeyed.
This process is repeated on each day of our planning horizon. We run 1,000 sample path
realizations of our planning horizon in order to get accurate metric estimates. The presented
simulations are accurate to within 1% or better with a 95% confidence interval.
2.4.3 Validation of the BRPlan
Because we approximated the dynamic BRPlan scheduling methodology via a determin-
istic set of linear equations to be used as constraints in the optimization (see Section 2.3.2),
we want to estimate the accuracy of our forecast of the mean daily number of type k partic-
ipants scheduled under a given BRPlan (µk,d). This section validates our BRPlan approach
by comparing these approximations to the sample mean of the simulated model µ¯simk,d , (which
mimics exactly how the BRPlan could be implemented very simply in practice). We will use
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the Absolute Percentage Error (APE) metric defined as follows:
APEBRPlank,d = |
µk,d − µ¯simk,d
µ¯simk,d
| · 100%. (2.19)
By investigating many problem instances/realizations of the test suite described in Table
2.1, we confirmed the intuition that the accuracy of our approximated analytical BRPlan
approach varied from one trial to another within a single simulated CRU instance. The
BRPlan reserves capacity for each trial, hence the booking process of each trial is independent
of another trial’s booking once the Θk,d decision variables are all fixed. We found that the
APE was most sensitive to two characteristics: (i) the bound we set on the trial’s TFAV
(mean, max and/or TFAV exception), and (ii) the “density” - a concept hard to quantify
but increasing in higher enrollment rates, greater workload induced, shorter time windows,
shorter time between visits, and a greater number of visits per participant. In Fig. 2.4, we
investigated the sensitivity of the BRPlan APE to the enrollment rate of the trial (Fig. 2.4
left) and the maximum bound set on TFAV for the given trial (Fig. 2.4 right). Note that
all other parameters were fixed and were set to a given realization of the randomized test
suite of Table 2.1. We averaged our daily APEs over all days of our planning horizon to aid
presentation.
Figure 2.4: BRPlan APE of the number of patients scheduled (as defined in Eq. 2.19) for a
given trial as a function of (i) Left: its enrollment rate and (ii) Right: the bound
we set on maximum TFAV
While we do not have space to present examples for every conjectured component of
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trial “density” (see the discussion in Section 2.1.2) our results suggest that our approach
works best either for (i) high density trials or for (ii) trials that can tolerate longer waiting
times. These two factors are generally related, because higher density trials required longer
waits to first visit. Considering the practical desire for high throughput, our BRPlan will
usually reflect high utilization which by experimentation we found to correspond to close
gaps between the number of patients scheduled and the reserved capacity Θk,d. In cases
approaching heavy traffic, CRUs and/or specific trials will tend to have high enrollment
rates and long waits, and in these situations our approximations work very well. For (ii),
as the waiting time target gets larger for a trial, the number of days between two successive
non zero Θk,d values gets larger (ceteris paribus). Hence, the number of participants that
enrolled but still haven’t gone through their first visit will also grow larger. By accumulating
this unfulfilled demand for first visit (with a fixed arrival rate), the variability around the
number of patients that will be scheduled in the reserved capacity will be reduced. Note that
when the enrollment interarrival times are deterministic, the APEs are 0 and our analytical
approach is exact. In conclusion, our approximated BRPlan methodology tends to work best
in high utilization situations and low variability settings such as those with relatively longer
TFAV times and more predictable enrollment times.
2.4.4 Validation of the average TFAV
To illustrate the accuracy of the average TFAV estimation method, we will illustrate one
problem instance of our randomized test suite from Table 2.1 so we can describe the details
driving accuracy. We considered 16 trials that varied a lot based on their characteristics
including density. In Fig. 2.5, we compare the analytical average TFAV optimized via the
linearization in Eq. 2.45 to the average TFAV computed via the simulation (by computing
the TFAV APE value similarly to Eq. 2.19). The APE accuracy of our estimations for each
trial is shown in Table 2.2. Just as we suggested in Section 4.3, we see that the accuracy
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(APE) varies across trials with different characteristics. As we see later in a test case (see
Fig. 2.7 in Section 5.2), the bounds on population average TFAV reveal that the trials with
higher waiting time bounds achieved smaller APEs. This aligns with our statement that our
methods work best in a high utilization setting.
Figure 2.5: Validation of period 1 trials’ population average TFAV
Trial: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
APE 7.8 8.3 8.8 8.9 7.4 5.0 5.6 5.8 5.5 3.2 1.7 2.0 1.4 7.1 8.6 5.6
Table 2.2: Absolute Percentage Errors (APEs) in % of the population average TFAV by trial
over one instance/realization of the randomized test suite in Table 2.1
2.4.5 Validation of the mean offered workload
We provide validation of our analytical workloads by calculating the daily average APE
for each nurse skill (Si, i = 1, ..., 10) and each of the 30 instances of the randomized test
suite of Table 2.1 considered. In Table 3, we then provide an average and standard deviation
(STD) over those 30 instances of the daily APEs. We note that the forecasting of the total
aggregate workload induced on the entire CRU (denoted “Ag. Skills” in Table 2.3) is very
accurate with only a 1.5% error on average. Similarly, the error for room resources can be
found, but we omit them because rooms are not the capacity constraint and represent a
special case of human skills (since rooms have fixed daily capacities).
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Workload induced on: S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 Ag. Skills
Average APE (%) 2.4 2.5 2.3 2.5 2.8 2.5 2.3 3.4 2.5 3.5 1.5
STD APE (%) 4.6 3.9 2.8 3.3 3.6 3.6 4.0 4.2 4.0 4.7 2.3
Table 2.3: Daily average Absolute Percentage Errors (APEs) (average and standard devia-
tion over 30 instances of the randomized test suite of Table 2.1) of the offered
workload forecasts by skill Si.
2.5 Optimization results
Having formulated our performance metrics linearly in our decision variables, we can
constrain them based on managerial inputs: (i) O¯r(d), the maximum allowable number of
overutilization hours for resource r (for nurses and/or rooms) and each day d, (ii) TFAV
avg
k ,
the upper limit of the population average TFAV for each trial, (iii) TFAV exceptk,t (ω), the
TFAV exception limiting the percentage of type k participants enrolling on day t that will
exceed ω days TFAV, and (iv) TFAV
max
k , the population maximum TFAV for each trial
k. The optimization functionality of CAPTAIN was implemented using Visual Studio 2010
with an integrated IBM CPLEX solver. The computer used was a 2007 Intel Xeon CPU
with 8GB of RAM. For a 60 business day (12 weeks) planning horizon, this program was
solved up to a 1% optimality gap in 1 to 6 hours depending on the protocol complexities. As
the planning horizon gets larger, the computing time increases exponentially. However, 12
weeks is already considered as a very long planning horizon for our application, since CRUs
tend to update their portfolios more frequently.
2.5.1 Tradeoff Analysis and Portfolio Selection
We studied the optimal objective values and the associated portfolio selections under
various constraints set on daily overutilization and on average TFAV for the candidate trials.
We considered 8 candidate trials that could be added to the current portfolio in our planning
horizon. The candidate trials also have randomly generated parameters according to Table
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2.1. The goal of this section is (i) to provide high level validation that the optimization’s
objective behaves as expected when the constraints on TFAV and overutilization are altered,
and (ii) to show that the selection of a portfolio is not a simple, intuitive process (because of
the complex interactions between protocols). This motivates the critical need for a decision
support system to manage a CRU.
A rough, high level validation of our method is seen in the left part of Fig. 2.6. A CRU
can extract greater scientific value from an optimized portfolio when the bound set on the
population average TFAV for all candidate trials is increased by the CRU. By having the
ability to delay the access of less delay-sensitive participants, the method is able to integrate
more trials in our planning horizon’s updated portfolio. Moreover, as seen on the left for a
fixed population average TFAV for all candidate trials, the four experiments that increase the
overutilization bound show that the CRU can extract more scientific value from the portfolio
chosen. For example, by allowing more overutilization hours/expenses, high density trials
that were difficult to schedule because of the protocol requirements (e.g., those with very
long service times, short time windows for subsequent visits to happen, etc.) may become
feasible to offer.
In the right part of Fig. 2.6, we represent the optimal portfolio selections of the candidate
set of trials {C1, ...,C8} each having given bounds on daily overutilization and TFAV. We
see that this decision is neither trivial nor intuitive. By increasing the population average
TFAV bound for all candidate trials as indicated in the rows (respectively the overutilization
bounds per day, identified for each table), we see that the optimal portfolio selection is not
always just monotonically adding new trials to the optimal portfolio selection with lower
TFAV bounds (resp. overutilization bounds). For example, with an overutilization bound of
4 hours per day, we would only choose candidate trial C2 when the TFAV bound is 5 days.
But when the TFAV bound is increased to 15 days, trial C2 is replaced by C1, C3 and C4
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Figure 2.6: Left: Tradeoff Analyses of the Scientific Value Gained vs. the bound set on
population mean TFAV (in days) for all candidate trials and the overutilization
bound in hours per day over all nurses; Right: Optimal portfolio selection with
respect to population mean TFAV for all trials when the overutilization bound
is 2, 4 and 6 hours per day over all nurses
(and we see similar complex behavior when the constraint on overutilization varies). This
motivates the utility of the CAPTAIN methodology, since the managerial staff is not able
to accurately predict how a given portfolio would impact the site’s performance metrics.
2.5.2 Improvements
To assess the benefits of CAPTAIN, we again assumed that no trials would be added at
the beginning of our planning horizon, because this allows us to compare the difference be-
tween an optimized BRPlan and the current practice of FAS scheduling for a given portfolio
generated by the randomized test suite (Table 2.1). To illustrate how using CAPTAIN as a
booking/planning tool to schedule participants (ignoring the portfolio selection component)
is itself very helpful to control and improve the CRU metrics. This is done by maximizing ag-
gregated resource utilization/workloads over all days of our planning horizon, and letting the
solver find an optimized BRPlan that will satisfy the constraints set on mean overutilization,
population mean TFAV, TFAV-exception, and population maximum TFAV for each trial.
Note that the objective could also be to minimize on of our TFAV metrics (mean, maximum
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and/or, TFAV-exception) weighted across all active trials.
Fig. 2.7 presents a visual illustration of the capabilities and potential of CAPTAIN for one
representative problem instance (portfolio of trials) from our randomized test suite in Table
2.1. The upper left of Fig. 2.7 shows the population average TFAV, the population standard
deviation TFAV, and the population maximum TFAV for each trial in a CRU that operates
under the current FAS daily level booking policy with a total overutilization limit of 4 hours
per day (over all human resources). This was illustrated in the example of Fig. 2.3 - left,
but we added the population maximum TFAV for each trial on the graph. In this problem
instance, the FAS policy resulted in a total of 1.4 overutilization hours per day on average
over all resources (given an overutilization limit of 4 hours per day over all resources). The
capability of CAPTAIN allows the user to input any desired target on mean overutilization
(per resource and per day), but in order to show in a fair way the improvements made
by CAPTAIN, we kept the mean overutilization to the same level as the FAS policy in
Fig. 2.7. The upper right of Fig. 2.7 shows the population average TFAV, the population
standard deviation TFAV (from simulation after the BRPlan has been optimized), and the
population maximum TFAV for each trial in a CRU that operates under CAPTAIN’s daily
level BRPlan methodology and achieves on average the same overutilization than the FAS
policy while also meeting certain targets on population average TFAV for each trial. The
horizontal dashed lines show the population average TFAV targets we set on each trial in
our optimization. Although we are able to achieve such targets (which gives us the control
to prioritize needier participants and/or high-valued trials), we realize that the population
standard deviation TFAV for trials with “poor” access (e.g., trials 8-13) tends to be larger
than those under FAS policy. In contrast, trials with “good” access (e.g., trials 1-5) will
have lower TFAV variability than under the FAS policy. The explanation is that trials with
higher population average TFAV targets will have a larger number of successive days with
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no BRPlan reservations (since they are not prioritized) which significantly increases TFAV
variability between participants. Decision makers may want to avoid such scenarios. For
example, it is likely that guaranteeing 25 days access on average to their participants will
result in a high number of them waiting longer than that due to variability.
One will often want to reduce the TFAV-exception rate for each trial to guarantee
that no more than a certain percentage of type k participants will exceed a given target.
We added those constraints to the optimization (while keeping the previous overutiliza-
tion and population average TFAV constraints) by selecting a TFAV-exception target of⌈
TFAV
avg
k +
√
TFAV
avg
k
⌉
and a TFAV-exception rate of 10% for each trial k. The results
are illustrated in the lower left of Fig. 2.7. Although we see a slight increase in the population
standard deviation of trials with high access, we were able to decrease the access variability
for participants in trials that have a larger average TFAV target. However, the population
maximum TFAV of those trials has increased compared to the population maximum TFAV
of the upper right of Fig. 2.7, even though we have decreased the population standard devi-
ation of those trials. Notice that by definition, the TFAV-exception controls the percentage
(or number) of participants exceeding a TFAV target, but not the number of days that those
participants will exceed the target. Hence, in the lower left of Fig. 2.7, we may have a small
number of participants from trials 8-13 that exceed the
⌈
TFAV
avg
k +
√
TFAV
avg
k
⌉
target.
However the few that do are likely to exceed it by a lot, thereby increasing in the population
maximum TFAV. Again, decision makers may want to avoid such situations and also be able
to control the population maximum TFAV such that there isn’t even a single patient that is
predicted to wait extremely long for first visit.
In the lower right of Fig. 2.7, we see the portfolio TFAV results of a BRPlan that assures
(i) population average TFAV targets per trial, (ii) TFAV-exception targets for each trial,
and (iii) population maximum TFAV targets per trial (indicated by solid horizontal lines).
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Of course, reducing the population maximum TFAV while keeping the TFAV-exception %
the same will result in a decrease in the population standard deviation.
Figure 2.7: Simulation and optimization analysis of CAPTAIN’s improvements and controls
over TFAV variability compared to current practice under the same overutiliza-
tion level of 1.4 hours per day over all resources. Upper left - FAS scheduling;
Upper right - BRPlan with average TFAV constraints indicated by dashed lines;
Lower left - BRPlan with constraints of upper right graph and a TFAV-exception
of 10%; Lower right - BRPlan with constraints of lower left graph and a TFAV
maximum as indicated by solid lines
We observe significant benefits from using the BRPlan booking methodology rather than
the FAS policy. With a mean overutilization limit of 1.4 hours, the BRPlan was able to
reduce the population maximum TFAV (the longest time any participant will have to wait)
from over 55 days (using the FAS policy, upper left of Fig. 2.7) down to 40 days (lower
right of Fig. 2.7). Also, we see that we were able to limit the population average TFAV
for each trial to the desired limit, therefore significantly increasing access to care for more
urgent participants. By adding constraints on the TFAV-exception rate, we are able not
only to reduce TFAV variability between participants of the same trials, but we are also able
to give the managerial staff some valuable information: they will then be able to advertise
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that a given trial guarantees y % (e.g., 90 %) of its participants will have access within
x days (e.g., 15 business days) after enrollment. Having this information may increase
enrollment (by increasing the perceived value/service), increase participant satisfaction, and
decrease overall trial duration. We notice that under both scheduling methodologies (FAS
and BRPlan), we have the same amount of daily capacity at our disposition, but we are able
to limit average waiting times to significantly shorter amounts while also reducing access
variability for each trial. This happens because the BRPlan is able to reduce the workload
predictable and unpredictable variability by packing participant visits more efficiently while
the FAS rule generates big “holes” (and workload variability) in the schedule. The BRPlan
levels the daily workload (and reduces its variability) while also providing overall better
access, which results in an increase in resource utilization for a transient planning horizon
(see also the FAS and CAPTAIN-Base Case rows in Table 2.4).
Table 2.4. Calculations of (i) the mean total resource utilization (averaged over all days of
our planning horizon), (ii) the standard deviation of the total resource utilization (averaged
over all days of our planning horizon), (iii) the mean TFAV in days averaged over all 16
active trials, (iv) the standard deviation of the TFAV averaged over all 16 active trials, and
(v) the maximum TFAV averaged over all 16 active trials, for the following cases: (a) the
FAS policy, (b) CAPTAIN’s Base Case (BRPlan optimization with a fixed NSPlan), (c)
CAPTAIN’s Case Study A (BRPlan and NSPlan optimization with 0, 4, 8, 12 hours shift
options) and (d) CAPTAIN’s Case Study B (BRPlan and NSPlan optimization with 0, 4,
6, 8, 10, 12 hours shift options). Note that the constraints specified by the lower right part
of Fig. 2.7 were enforced for the CAPTAIN results.
Taking this one step further, we now allow the MIP to also optimize the NSPlan. The
number of hours that each nurse will work on each day will now be optimized (under the
same parameters and constraints in the lower right part of Fig. 2.7) while obeying a certain
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set of rules (defined generally as ∆ in Section 2.3.5). In the following case studies, we use
the same set of rules reported in the description of our test suite (Section 2.4.1). In case
study A, we consider three types of shifts (not including the 0-hour shift): 4, 8, or 12 hour
shifts. In case study B, we have more shift options/flexibility: 4, 6, 8, 10, 12 hour shifts.
Our FAS case study and CAPTAIN Base Case consider a fixed (suboptimal) NSPlan (the
same one used in our calculations in the upper left of Fig. 2.7 for FAS, and lower right of
Fig. 2.7 for the CAPTAIN Base Case). Note again that in all of our 4 cases (rows in Table
2.4), we are considering the same volume of arrivals and the same nurse total capacity over
all days of our transient planning horizon. We see that the largest marginal improvement
from the FAS policy (in terms of the average and standard deviation of the utilization and
TFAV metrics) is the optimization of a BRPlan while keeping the nurse schedules the same
(see the first two rows of Table 2.4).
But we can provide even more improvements by also creating an NSPlan (that obeys the
same set of nurse scheduling rules) that is more flexible and appropriate for the optimized
BRPlan. Our forecasting methodologies create the relation between fulfilled demand and
offered workloads on skills, and the NSPlan links the right amount of nurse capacity based on
the skill sets needed on each day. Although it creates only small improvements on our metrics,
it is worth noting that having more shift options (therefore flexibility in scheduling nurse
capacity with our NSPlan) provides an increase in utilization (and workload smoothing),
while increasing access for patients (see Case Study A and Case Study B in Table 2.4).
In equilibrium, higher utilization generates longer waiting times for a fixed throughput;
however, in our transient case, we are able to increase throughput (throughout our planning
horizon) by providing shorter waiting times which translates into higher utilization within
our transient planning horizon.
We have explained the use of CAPTAIN for CRUs which are faced with the decision
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of which portfolio mix of candidate trials should be performed (in addition to the current
portfolio), given a fixed infrastructure and set of nurses with specific skills. Because we
validated the ability of CAPTAIN to accurately optimize the transition from a prior set
of appointments on the books (i.e. under FAS), this also assures us that CAPTAIN can
handle transitions caused by future periods (see Appendix C in Section 2.7.3 for further
details). This decision support tool could also be used for physical capacity expansions and
hiring purposes. It can answer the question: to what level of capacity should we expand
our resources in order to meet our objectives for scientific value, service/access levels for
participants, and staff overutilization? In other words, given any portfolio of trials and
service level constraints, CAPTAIN could determine the minimum staff and room capacities
required to conduct this portfolio.
2.6 Conclusion
In contrast to current practice in CRUs, which is often based on common sense and
experience, this new planning model, CAPTAIN, increases operational efficiency (and thus
cost effectiveness), increases the ability to extract scientific value by thoughtfully selecting
the clinical trials performed, and provides a high level of access with limited waiting times
that are planned to match the participants’ needs. This planning system coordinates care
resources and participant visits via novel forecasting and optimization algorithms. This
paper provides a proof of concept for a general decision support tool that can enable a CRU
to gain control over key performance metrics. Based on a planning horizon, CAPTAIN (i)
determines the optimal mix of protocols to perform, (ii) forecasts and controls the workloads
that will be placed on resources (staff and rooms), (iii) forecasts and controls overutilization
in part by creating efficient nurse schedules and participant/staff coordination, (iv) provides
a “system optimal” daily level scheduling plan via the Booking Reservation Plan (BRPlan),
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(v) optimizes the allocation of resource capacity, (vi) forecasts and controls the participants’
waiting times to first visit, and (vii) answers “what if” questions. As a non-stationary
model, CAPTAIN can begin with a base case representing the current conditions and all
the existing appointments made to then select the potential clinical research trials that
should be conducted without generating excessively long access delays (to first visit) and
high overutilization costs. It generates a BRPlan to guide appointment scheduling. The
plan is time-varying, maintaining effective operations from one planning period to the next.
Whereas this preliminary work targets strategic planning, future research can focus on
appointment scheduling at the time of day level. Therefore, as future research, the method-
ology will benefit from another layer of modeling and resource allocation to bridge from the
planning level to the execution level to schedule time of day appointments.
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2.7 Appendix
2.7.1 Appendix A: Notations
Symbol Description
D Length (in days) of the CAPTAIN planning horizon
P Set of active trials in our planning horizon
Pcand Set of candidate trials that can be activated in our planning horizon
P0 Set of trials that have been active before our planning horizon
T Time horizon (in days) of current practice booking for the
current portfolio P0
Mk Research/scientific (or financial) value of conducting trial k
hk Binary variable equal to 1 if candidate trial k is activated,
and 0 otherwise
Θk,d Integer number of slots reserved for type k 1
st visits on day d
TFAV
max
k bound set on the population maximum TFAV (in days) for type
k participants
αk,d,t Random number of type k participants enrolled on day t
and booked for 1st visit on day d (under the BRPlan)
Ak,t Random number of type k participants enrolling on day t
I Sample space of the daily number of enrollments random
variable of a given type
I¯ Maximum number of daily enrollments for a given trial
Pk,t(a) Probability of having a enrollments of type k on day t
P k,t(a) Probability of having a total of a enrollments of type k on the days
in {0, 1, ..., t− 1}
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Symbol Description
αk,d,t Mean number of type k participants enrolled on day t and booked
for 1st visit on day d (under the BRPlan)
µk,d Random number of type k participants booked for 1
st visit on day d
µk,d Mean number of type k participants booked for 1
st visit on day d
TFAV avgk Expected TFAV under the BRPlan averaged over all type
k participants
TFAV
avg
k Input bound set on the population average TFAV (in days)
for type k participants
TFAV exceptk,t (ω) Input bound on the type k ratio of participants enrolling on day t
that exceed ω days TFAV
pexceptk,t (ω) Input bound set on the mean percentage of type k participants
exceeding ω days TFAV
R Set of all physical resources (rooms, beds, chairs,...)
S Set of all skills that the nursing staff can perform
N Set of all nurses
Vk Number of visits required for trial k
Ωk,v Time window set of days where a type k visit v can be scheduled
after type k visit v′ < v without provoking a protocol violation
wk,v,r Hours of workload induced on resource r by a type k participant
on visit v
Lmax Duration (in days) from the first visit to the last visit of the
longest trial
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Symbol Description
PRRMk,d1(d) Vector determining the number of hours a randomly sampled type k
participant starting visit 1 on day d1 will impose on a given
resource on day d
PRRMk,d1,r(d) Mean number of hours required on day d and resource r by a type k
participant starting visit 1 on day d1
W initr (d) Initial workload on resource r and day d induced by participants
enrolled prior to the start of our planning horizon l
W r(d) Workload induced (in hours) on resource r (room, nurse or skill)
on day d
Kr(d) Capacity (in hours) of resource r (room or nurse) on day d
∆ Set specifying the clinic’s rules on nurse planning and scheduling
xs,n(d) Mean number of hours assigned to nurse n in order to perform
skill s on day d
N (s) Set of nurses that can perform skill s
O
l
r(d) Bound set on overutilization (in hours) of resource r
(room or nurse) on day d
TFAV lk Time to First Available Visit for participants in trial k in
planning horizon l
µsimk,d Simulated mean number of type k participants booked for
1st visit on day d
2.7.2 Appendix B: Proof of selected results
Proof of Lemma II.4
We will show this result by induction over the 2 dimensional space {(d, t) : d ∈ {1, ...,D+
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TFAV
max
k }, t ∈ {0, ...,D}, t < d}. Assume that Lemma 3.1 holds for all (d1, t1) with t1 < d1,
t1 < t, and d1 < d.
To show it is true for (d, t) with t < d, we start by using the definition of the random vari-
able αk,d,t (see Eq. 2.2). Eq. 2.20 simply uses the definition of the elements in set Ak,d,t(∞).
In Eq. 2.21, we realize that the random variables (i) αk,d,l, with 0 ≤ l ≤ t−1, (ii) αk,d,l, with
t+1 ≤ l ≤ d−1, and (iii) Ak,t, are all deterministic when conditioned on (Ak,t,Ak,t−1, ...,Ak,0),
which allows us to take the expected value inside the minimum in Eq. 2.22. By noticing that
the random variables in item (i) are independent of (Ak,t,Ak,t−1, ...,Ak,l+1) and by using the
definition of the elements in set Ak,d,t(∞), we get Eq. 2.23.
α
at,at−1,...,a0
k,d,t = E [αk,d,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)] (2.20)
= E
[
min{Θk,d −
t−1∑
l=0
αk,d,l,Ak,t −
d−1∑
l=t+1
αk,l,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)
]
(2.21)
= min
{
Θk,d −
t−1∑
l=0
E [αk,d,l|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)] ,
E
[
Ak,t −
d−1∑
l=t+1
αk,l,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)
]}
(2.22)
= min
{
Θk,d −
t−1∑
l=0
α
al,al−1,...,a0
k,d,l , at −
d−1∑
l=t+1
α
at,at−1,...,a0
k,l,t
}
(2.23)
Eq. 2.23 implies that constraints 2.24 and 2.25 hold. However they are not equivalent
since we require at least one of those two constraints to be binding. The BRPlan has to
book every enrolling participant to the first available reserved slot, which would not be
true if both constraints on α
at,at−1,...,a0
k,d,t were unbinding. To assess this issue, we create a
binary helper variable, b
at,at−1,...,a0
k,d,t , with d > t, such that it is equal to 1 if there is enough
reserved capacity of type k remaining on day d to schedule the participants that enrolled
on day t and still haven’t been scheduled up to d; b
at,at−1,...,a0
k,d,t is equal to 0 otherwise (i.e.,
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1{Θk,d −
∑t−1
l=0 α
al,at−1,...,a0
k,d,l ≥ at −
∑d−1
l=t+1 α
at,at−1,...,a0
k,l,t }).
α
at,at−1,...,a0
k,d,t ≤ Θk,d −
t−1∑
l=0
α
al,al−1,...,a0
k,d,l (2.24)
α
at,at−1,...,a0
k,d,t ≤ at −
d−1∑
l=t+1
α
at,at−1,...,a0
k,l,t (2.25)
Θk,d −
t−1∑
l=0
α
al,al−1,...,a0
k,d,l −
(
at −
d−1∑
l=t+1
α
at,at−1,...,a0
k,l,t
)
≤ B · bat,at−1,...,a0k,d,t , (2.26)
at −
d−1∑
l=t+1
α
at,at−1,...,a0
k,l,t −
(
Θk,d −
t−1∑
l=0
α
al,al−1,...,a0
k,d,l
)
≤ B · (1− bat,at−1,...,a0k,d,t ) (2.27)
α
at,at−1,...,a0
k,d,t ≥ Θk,d −
t−1∑
l=0
α
al,al−1,...,a0
k,d,l −B · bat,at−1,...,a0k,d,t (2.28)
α
at,at−1,...,a0
k,d,t ≥ at −
d−1∑
l=t+1
α
at,at−1,...,a0
k,l,t −B ·
(
1− bat,at−1,...,a0k,d,t
)
(2.29)
Given a large enough B (e.g., 20), constraints 2.26 and 2.27 assure that b
at,at−1,...,a0
k,d,t takes the
values specified by the definition we just provided. Based on this definition, constraint 2.28
(resp. constraint 2.29) will now make sure that constraint 2.24 (resp. 2.25) will be binding
when b
at,at−1,...,a0
k,d,t = 0 (resp. b
at,at−1,...,a0
k,d,t = 1), hence when the available capacity remaining
is smaller than the demand still needed to be scheduled (resp. more available capacity than
remaining demand) defined in constraint 2.26 (resp. 2.27). Because of our induction hypoth-
esis on α
at,at−1,...,a0
k,d1,t1
for t1 < d1, t1 < t, and d1 < d being linear in our decision variables Θ, the
system of constraints 2.24-2.29 linearizes Eq. 2.23 which can be integrated in a deterministic
MIP. The basis of induction requires us to show that α
at,at−1,...,a0
k,1,0 = min{Θk,1, a0} can be
expressed by a set of linear constraints in Θk,1. By using the same methods used for (d, t)
above, the basis of induction follows immediately. By induction, we have showed that this
is true for all (d, t) with t < d, and proved Lemma II.4.
Proof of Theorem II.5
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Given any BRPlan schedule, we must estimate αk,d,t, the mean number of type k par-
ticipants that enrolled on day t and are booked for their first visit on day d. In Eq. 2.30,
we condition αk,d,t subject to al, l = 0, ..., t, the number of type k enrollments that occurred
on day l from the beginning of our planning horizon up to day t. In Eq. 2.31, we use the
assumption that the number of enrollments on a given day is independent of anything else
in our system model (specifically, the number of enrollments on other days), and we also
partition (Z+)t+1 into the sets I t+1 and (Z+ \ I)t+1 in our sum over all (at, ..., a0) ∈ (Z+)t+1.
αk,d,t =
∑
(at,at−1,...,a0)∈(Z+)t+1
E [αk,d,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)]
· P ((Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)) (2.30)
=
∑
(at,at−1,...,a0)∈It+1
E [αk,d,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)] ·
t∏
l=0
Pk,l(al)
+
∑
(at,at−1,...,a0)∈(Z+\I)t+1
E [αk,d,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)] ·
t∏
l=0
Pk,l(al)
(2.31)
The second sum in Eq. 2.31 will converge to 0 as I goes to infinity. Moreover, by using the
definition of the set Ak,d,t(∞) (see Definition 3.2), we can express the mean number of type
k participants that enrolled on day t and are booked for first visit on day d, as I →∞:
αk,d,t =
∑
α
at,at−1,...,a0
k,d,t ∈Ak,d,t(∞)
α
at,at−1,...,a0
k,d,t ·
t∏
l=0
Pk,l(al) (2.32)
Finally, by using the result from Lemma II.4, and noticing that Pk,l(al) is independent of Θ,
for all k ∈ P , al ∈ I, and l ∈ {0, ..., t}, we have shown that αk,d,t can be expressed linearly
in our decision variables Θ.
Proof of Proposition II.6
To compute αk,d,t, we condition αk,d,t in terms of (Ak,t,Ak,t−1, ...,Ak,j∗(t),
∑j∗(t)−1
i=0 Ak,i) in
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Eq. 2.33. As I¯ →∞, and by the definition of Ak,d,t(m), Eq. 2.34 follows. That is, αk,d,t =
∑
(at,...,aj∗(t),a)∈Zt−j∗(t)+2
E
αk,d,t|(Ak,t,Ak,t−1, ...,Ak,j∗(t), j∗(t)−1∑
i=0
Ak,i) = (at, at−1, ..., aj∗(t), a)

·
 t∏
l=j∗(t)
Pk,l(al)
 · P k,j∗(t)(a) (2.33)
=
∑
α
at,at−1,...,aj∗(t),a
k,d,t ∈Ak,d,t(m)
α
at,at−1,...,aj∗(t),a
k,d,t ·
 t∏
l=j∗(t)
Pk,l(al)
 · P k,j∗(t)(a) (2.34)
≈
∑
αˆ
at,at−1,...,aj∗(t),a
k,d,t ∈Aˆk,d,t(m)
αˆ
at,at−1,...,aj∗(t),a
k,d,t ·
 t∏
l=j∗(t)
Pk,l(al)
 · P k,j∗(t)(a). (2.35)
Finally, we can use our approximation αˆ
at,at−1,...,aj∗(t),a
k,d,t ∈ Aˆk,d,t(m) for the elements
α
at,at−1,...,aj∗(t),a
k,d,t ∈ Ak,d,t(m) in Eq. 2.35. What remains to be shown is that αˆ
at,at−1,...,aj∗(t),a
k,d,t
can be expressed in a MIP linearly in the decision variables Θ. Rewriting Eq. 2.4, we get:
αˆ
at,at−1,...,aj∗(t),a
k,d,t = min
{ Uat,at−1,...,aj∗(t),ak,d,t︷ ︸︸ ︷
at −
d−1∑
l=t+1
αˆ
at,at−1,...,aj∗(t),a
k,l,t ,
Θk,d −
t−1∑
l=0
∑
(aj∗(t)−1,...,aj∗(l))∈Ij∗(t)−j∗(l)
αˆ
al,al−1,...,aj∗(l),a−
∑j∗(t)−1
i=j∗(l) ai
k,d,l
j∗(t)−1∏
n=j∗(l)
Pk,n(an)
P k,j∗(l)(a)
︸ ︷︷ ︸
V
at,at−1,...,aj∗(t),a
k,d,t
}
,
(2.36)
and αˆ
at,at−1,...,aj∗(t),a
k,d,t can now be expressed linearly in Θ in constraints 2.37-2.42.
αˆ
at,at−1,...,aj∗(t),a
k,d,t ≤ V
at,at−1,...,aj∗(t),a
k,d,t (2.37)
αˆ
at,at−1,...,aj∗(t),a
k,d,t ≤ U
at,at−1,...,aj∗(t),a
k,d,t (2.38)
V
at,at−1,...,aj∗(t),a
k,d,t − U
at,at−1,...,aj∗(t),a
k,d,t ≤ B · b
at,at−1,...,aj∗(t),a
k,d,t , (2.39)
U
at,at−1,...,aj∗(t),a
k,d,t − V
at,at−1,...,aj∗(t),a
k,d,t ≤ B ·
(
1− bat,at−1,...,aj∗(t),ak,d,t
)
(2.40)
62
αˆ
at,at−1,...,aj∗(t),a
k,d,t ≥ V
at,at−1,...,aj∗(t),a
k,d,t −B · b
at,at−1,...,aj∗(t),a
k,d,t (2.41)
αˆ
at,at−1,...,aj∗(t),a
k,d,t ≥ U
at,at−1,...,aj∗(t),a
k,d,t −B ·
(
1− bat,at−1,...,aj∗(t),ak,d,t
)
(2.42)
Eq. 2.36 implies that constraints 2.37 and 2.38 hold, but they are not equivalent. We
require at least one of those two constraints to be binding, because the BRPlan has to book
every enrolling participant to the first available reserved slot. We created the parameter B
and the binary helper variable, b
at,at−1,...,aj∗(t),a
k,d,t = 1{U
at,at−1,...,aj∗(t),a
k,d,t ≤ V
at,at−1,...,aj∗(t),a
k,d,t }, with
d > t, such that it is equal to 1 if there is enough reserved type k capacity remaining on
day d to schedule the participants that enrolled on day t and still haven’t been scheduled
up to d; b
at,at−1,...,aj∗(t),a
k,d,t is equal to 0 otherwise. This is defined in constraint 2.39 and 2.40.
Given a large enough B (e.g., 20), constraints 2.39 and 2.40 assure that b
at,at−1,...,aj∗(t),a
k,d,t
takes the required values. Based on this definition, constraint 2.41 (resp. constraint 2.42)
ensures that constraint 2.37 (resp. 2.38) will be binding when b
at,at−1,...,aj∗(t),a
k,d,t = 0 (resp.
b
at,at−1,...,aj∗(t),a
k,d,t = 1). That is, constraint 2.37 (resp. 2.38) will be binding when the available
capacity remaining is smaller than the demand to be scheduled (resp., more available capacity
than remaining demand).
Proof of Theorem II.7
In this result, we want to show that the mean type k TFAV (averaged over all participants
of a given trial) can be expressed linearly in our BRPlan decision variables Θ. First, in
Eq. 2.43, we take the expectation of the ratio of the total number of days that type k
participants wait for their first visit during our planning horizon (numerator), and the total
number of enrollments that occurred from days 0 to D (denominator). Eq. 2.44 follows after
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conditioning this expression subject to the daily enrollments from days 0 to D.
TFAV avgk = E
[∑D
t=0
∑D+TFAVmaxk
d=t+1 (d− t) · αk,d,t∑D
i=0Ak,i
]
(2.43)
=
D∑
t=0
D+TFAV
max
k∑
d=t+1
∑
(aD,aD−1,...,a0)∈ID+1
D∏
l=0
Pk,l(al)
· (d− t) · E
[
αk,d,t∑D
i=0Ak,i
|(Ak,D,Ak,D−1, ...,Ak,0) = (aD, aD−1, ..., a0)
]
(2.44)
=
D∑
t=0
D+TFAV
max
k∑
d=t+1
∑
(aD,aD−1,...,a0)∈ID+1
1∑D
i=0 ai
·
D∏
l=0
Pk,l(al)
· (d− t) · E [αk,d,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)] (2.45)
=
D∑
t=0
D+TFAV
max
k∑
d=t+1
∑
(at,at−1,...,a0)∈It+1
(d− t) · E [αk,d,t|(Ak,t,Ak,t−1, ...,Ak,0) = (at, at−1, ..., a0)]
·
∑
(aD,aD−1,...,at+1)∈ID−t
∏D
l=0 Pk,l(al)∑D
i=0 ai
(2.46)
=
D∑
t=0
D+TFAV
max
k∑
d=t+1
∑
α
at,at−1,...,a0
k,d,t ∈Ak,d,t(∞)
(d− t) · αat,at−1,...,a0k,d,t ·
∑
(aD,aD−1,...,at+1)∈ID−t
∏D
l=0 Pk,l(al)∑D
i=0 ai
.
(2.47)
In Eq. 2.44, the denominator inside our conditional expectation becomes deterministic since
it is conditioned on all the daily enrollments in our planning horizon, hence we can express it
outside the expectation in Eq. 2.45. Note now that the conditional expectation of the random
variable αk,d,t is independent on future enrollment realizations (Ak,D,Ak,D−1, ...,Ak,t+1) =
(aD, aD−1, ..., at+1): we can now ignore those realizations in the conditional expectation,
which gives us Eq. 2.45. In Eq. 2.46, the sum over the set ID+1 is separated into two sums:
one over the set I t+1, and the other over the set ID−t. Finally by using the definition of the
set Ak,d,t(∞) (see Definition II.2) and our result derived from Lemma II.4, we have proved
Theorem II.7.
Proof of Theorem II.10
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We consider the workloads induced on resource r and day d of our planning horizon by
(i) participants enrolled prior to our horizon (the parameter W initr (d)), and (ii) participants
that will eventually enroll in our planning horizon. To capture the workloads induced by
participants who haven’t enrolled yet, consider that scheduling under the BRPlan generates
a random integer number of type k participants booked for a first visit on each day d1
denoted µk,d1 . We must check if each participant i that will be booked for a first visit on
each day d1 prior to day d will induce a stochastic workload on resource r, d− d1 days after
their first visit, based on PRRM realizations. For example, if µk,d1 = 3, we will sum three
independent realizations of the type k PRRM to determine the number of hours of resource
r needed for future days (e.g., d− d1 days after the first visit). Hence, we can compute the
offered workload for each skill or room resource r, d days after the beginning of period l,
where d ∈ {1, 2, ...,D + Lmax + maxk TFAV maxk } as:
Wr(d) = W
init
r (d) +
∑
k∈P
min{d,D+TFAVmaxk }∑
d1=1
µk,d1∑
i=1
PRRM ik,d1(d) · er, (2.48)
where PRRM ik,d1(d) · er is the ith realization of the random variable PRRMk,d1(d) · er. By
linearity of the expectation we get:
W¯r(d) = W
init
r (d) +
∑
k∈P
min{d,D+TFAVmaxk }∑
d1=1
E
[µk,d1∑
i=1
PRRM ik,d1(d) · er
]
(2.49)
since E [W initr (d)] = W initr (d). Those quantities are deterministic since all visits of a trial are
scheduled at the enrollment date (prior to our planning horizon). We note that (i) µ¯k,d1 =
E [µk,d1 ] <∞,∀k ∈ P ,∀d1 = 1, ...,D + TFAV maxk since the number of enrolling participants
(and therefore, scheduled participants) on any day is finite; (ii){PRRM ik,d1(d) · er}i=1,2,...
all have the same expectation for a fixed patient type k ∈ P , d1 ∈ {1, ...,D + TFAV maxk },
d ∈ {1, ...,D + Lmax + maxk TFAV maxk } and r ∈ R ∪ S; and (iii) the PRRM random
variables that we defined are drawn from protocol data and do not depend on µk,d,∀k ∈
65
P ,∀d = 1, ...,D + TFAV maxk . Hence, by these three facts and Wald’s equation, we get Eq.
2.48 and prove Theorem II.10.
2.7.3 Appendix C: Practical implementation and transience
In this paper, we studied the effects of our planning tool over a finite planning horizon
by considering the initial transition from the current FAS scheduling policy to the BRPlan.
Thus, the portfolio selection and capacity planning decisions in our planning horizon are
dependent on an initial state of the system determined by the existing appointments (booked
via the FAS policy) of participants that enrolled prior to CAPTAIN’s period of planning.
Possible questions are: how is the transition between planning periods handled? How would
CAPTAIN deal with unplanned portfolio updates within a planning horizon?
We define period l as the interval of time between the lth and (l + 1)th trial portfolio
update (or equivalently, CAPTAIN run). A portfolio update should be performed when the
CRU wants to add a portfolio of candidate trials to their workload, or when at least one
current trial ends. CAPTAIN is able to construct an optimal transient/non-homogeneous
BRPlan and NSPlan that takes into account those portfolio updates. The maximum length
of any period will be D days. We define P l−1 as the current portfolio (or set) of active trials
in the CRU during period l − 1, P lcand as the portfolio of candidate trials that are to be
considered for addition at the beginning of period l, and P l−1out as the portfolio of trials that
ended during period l − 1.
The inputs for the lth run (period 1) of CAPTAIN will be defined by the set Γl: (i)
P l−1, the portfolio of active trials in period l − 1 (possibly using an aggregate model of low
enrollment trials for computational simplicity); (ii) P0out, the set of trials that ended before
the lth run but might still have participants receiving service in period l; (iii) P lcand, the
candidate portfolio of trials that the CRU wishes to consider at the beginning of period
l; (iv) W l,initr (d), the committed resource r (nurses and rooms) workload on each day d of
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Figure 2.8: CAPTAIN’s functionality with information inputs on the left and CAPTAIN
forecasting and optimization on the right
the lth period/planning horizon (i.e., day T + d) induced by the participant bookings that
were made in the past (i.e., from previous periods); and (v) the CRU’s desired constraints
on resource overutilization and/or TFAV target (mean, maximum, and/or TFAV exception)
per trial. Conceptually, CAPTAIN combines optimization with an online metrics forecasting
capability to achieve the targets requested by the managerial staff. D days (or sooner) after
the start of period l, the CRU will update the inputs of CAPTAIN, restart planning for the
next D days, and construct the information set Γl+1.
As illustrated in Fig. 2.8, at the beginning of period l, we use the information set Γl as an
input to CAPTAIN. The modeled metrics are (i) the offered workload on each (physical or
human) resource for every day of period l, (ii) the resource utilization (and overutilization)
for every day of period l, and (iii) the population average, the mean percentage of patients
exceeding a TFAV limit and/or, the population maximum TFAV for each trial in period l.
The forecasting methods combine (i) the participant first visit bookings (see Section 2.3.2)
generated by reserving resource capacity with our Booking Reservation Plan methodology
(the BRPlan), (ii) the Participant Resource Requirements Model (the PRRM), which cap-
tures the participants’ trajectory for each trial in portfolio P l that will be conducted in
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period l (see Section 2.3.4), and (iii) the nursing staff’s daily staffing levels and planned
allocations (the NSPlan, see Section 2.3.5).
2.7.4 Appendix D: Mixed Integer Program
max
∑
k∈P
Mkhk, (2.50)
αk,d,t =
∑
αˆ
at,a
k,d,t∈Aˆk,d,t(1)
αˆat,ak,d,t · Pk,t(at) · P k,t(a), (2.51)
∀t ∈ {0, ...,D}, ∀d ∈ {t+ 1, ...,D + TFAV maxk },∀k ∈ P ,
αˆat,ak,d,t ≤ at −
d−1∑
l=t+1
αˆat,ak,l,t, (2.52)
αˆat,ak,d,t ≤ Θk,d −
t−1∑
l=0
∑
(at−1,at−2,...,al)∈I(t−l)
αˆ
al,a−
∑t−1
i=l ai
k,d,l ·
(
t−1∏
n=l
Pk,n(an)
)
· P k,l(a), (2.53)
Θk,d −
t−1∑
l=0
∑
(at−1,at−2,...,al)∈I(t−l)
αˆ
al,a−
∑t−1
i=l ai
k,d,l ·
(
t−1∏
n=l
Pk,n(an)
)
· P k,l(a)−
(
at −
d−1∑
l=t+1
αˆat,ak,l,t
)
≤ B · bat,ak,d,t, (2.54)
at −
d−1∑
l=t+1
αˆat,ak,l,t −
Θk,d − t−1∑
l=0
∑
(at−1,at−2,...,al)∈I(t−l)
αˆ
al,a−
∑t−1
i=l ai
k,d,l ·
(
t−1∏
n=l
Pk,n(an)
)
· P k,l(a)

≤ B · (1− bat,ak,d,t) , (2.55)
αˆat,ak,d,t ≥ Θk,d −
t−1∑
l=0
∑
(at−1,at−2,...,al)∈I(t−l)
αˆ
al,a−
∑t−1
i=l ai
k,d,l ·
(
t−1∏
n=l
Pk,n(an)
)
· P k,l(a)−B · bat,ak,d,t
(2.56)
αˆat,ak,d,t ≥ at −
d−1∑
l=t+1
αˆat,ak,l,t −B ·
(
1− bat,ak,d,t
)
(2.57)
∀t ∈ {0, ...,D},∀d ∈ {t+ 1, ...,D + TFAV maxk }, at ∈ I, a ∈ {0, ..., tI¯},∀k ∈ P ,
µk,d =
d−1∑
t=0
αk,d,t,∀k ∈ P ,∀d ∈ {1, ...,D + TFAV maxk }. (2.58)
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W¯r(d) = W
init
r (d) +
∑
k∈P
min{d,D+TFAVmaxk }∑
d1=1
µ¯k,d1 ·
Vk∑
v=1
1 {(d−d1)∈Ωk,v}
|Ωk,v| w¯k,v,r, (2.59)
∀r ∈ S ∪R,∀d ∈ {1, 2, ...,D + Lmax + max
k
TFAV
max
k },
W¯r(d) ≤ Kr(d) + O¯r(d),∀r ∈ R,∀d ∈ {1, 2, ...,D + Lmax + max
k
TFAV
max
k }, (2.60)
W¯s(d) =
∑
n∈N (s)
xs,n(d),∀s ∈ S,∀d ∈ {1, 2, ...,D + Lmax + max
k
TFAV maxk }, (2.61)
W¯ (n, d) =
∑
s∈S
xs,n(d), W¯ (n, d) ≤ Kn(d) + O¯n(d), (2.62)
∀n ∈ N ,∀d ∈ {1, 2, ...,D + Lmax + max
k
TFAV
max
k },
D∑
t=0
D+TFAV
max
k∑
d=t+1
∑
αˆ
at,a
k,d,t∈Aˆk,d,t(1)
(d− t) · αˆat,ak,d,t ·
∑
(aD,aD−1,...,at+1)∈ID−t
P k,t(a) ·
∏D
l=t Pk,l(al)
a+
∑D
i=t ai
≤ TFAV avgk ,∀k ∈ P (2.63)
D+TFAV
max
k∑
d=t+ω+1
∑
αˆ
at,a
k,d,t∈Aˆk,d,t(1)
αˆat,ak,d,t
at
· Pk,t(at) · P k,t(a) ≤ pk,t(ω),∀k ∈ P , ∀t ∈ {0, ...,D},∀ω ∈ T
(2.64)
hk ∈ {0, 1}, ∀k ∈ P , (2.65)
Θk,d ∈ Z+,∀d ∈ {1, ...,D + TFAV maxk },∀k ∈ P , (2.66)
{(Kn(1), ...,Kn(D + Lmax + max
k
TFAV maxk ) : n ∈ N} ∈ ∆ (2.67)
CHAPTER III
An Outpatient Planning Optimization Model for
Integrated Care and Access Management
3.1 Introduction
For scheduled healthcare delivery environments, the prevailing first come first served
approach to appointment scheduling does not support that relative urgency varies across
types or classes of patient visits. This research contributes a method toward a more ra-
tional and planned approach to healthcare delivery. Access delay, or the length of time
required to get an initial appointment, is a key performance metric that characterizes how
a care delivery system manages its resources and its workload. While emergency care has
developed elaborate methods to differentiate the access delay based on patient acuity (i.e.,
degree of urgency with which they need care, roughly speaking), only simple and relatively
crude methods have been developed for appointment-based service operations. For example,
primary care providers will reserve some appointment slots during the flu and cold season
for urgent sick visits, whereas annual physical exams are scheduled months in advance and
are sometimes steered into summertime visits. To account for the complexity of many out-
patient care networks, this intuition must be extended, deepened, and ultimately integrated
into a sophisticated decision support method to reduce waste and enhance patient access.
In particular, our work is applied to outpatient services with different patient classes, each
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of which may be offered different levels of access. We will refer to this methodology and a
research software instantiation as OPT for “Outpatient Planning Technology.”
To appreciate the need for a system such as OPT, consider this illustrative example.
Chris happens to live more than 100 miles away from a major medical center. After repeated
visits to his primary care physician, referral to several specialists, and many diagnostic tests,
there is still no clear diagnosis available to Chris. The doctors suspect that the condition
is serious. Chris and the primary care doctor agree that it is wise to travel to a medical
center with the expertise and resources to obtain a diagnosis and treatment plan. Chris
might be asking himself: how long will it take to get an appointment? Medically, Chris
will worry what irreversible damage he may sustain during this wait. The first visit is
important in our methodology, and the wait from request until the time of that appointment
is referred to as access delay. Chris also realizes that it will take some random number of
visits/consultations and tests to get a diagnosis and treatment, which we refer to this as
an itinerary of care. A complicating factor is that Chris’s full treatment needs (quantity,
timing, and services required) are not known at the time of the initial appointment request,
which may result in downstream appointment demand exceeding the capacity available at the
institution. This leads to a stochastic network patient flow problem complicated by the need
to exert admission control to optimize the patient flows (aggregated by patient type). A key
motivation to control access delay becomes clear by realizing that while some patient types
do not require short waits, urgent cases (e.g., an episode of care to follow up on an indication
of advanced breast cancer) will benefit medically from quick diagnosis and treatment. For
example, the Mayo Clinic, Rochester, serves a diverse patient population both in terms of
conditions treated but also geography and urgency. New patients that travel from across
the nation or around the world might require more resources at a higher level of urgency as
compared to local established patients. As is often the case in healthcare, the same set of
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resources serves patients with varying access delay sensitivities/requirements. Patients with
severe conditions will come to Rochester for fast diagnosis and access to surgery. The same
resources, however, will be used to serve patients with the same condition that can easily
travel back and forth to the clinic and do not require fast access to all services. On the other
hand, patients who present a suspicion of cancer will need to gain rapid access to diagnostic
testing, surgeon consultation and, if necessary, surgery.
Access delay is a key performance metric that characterizes how a care delivery system
manages its resources and its workload. The itinerary of care is from the time a patient
requests service to the last care visit that ends an itinerary (care pathway). Optimizing
this access delay metric with different targets for different patient types presents important
research challenges that have received little attention for outpatient care networks (e.g., see
for single-unit works [45], [44], [51], [15]). From the perspective of the healthcare organiza-
tion, additional critical metrics must be considered such as (1) medical service (or clinician)
utilization, (2) what case mix by patient type can/should be serviced, (3) the daily workload
hours that exceed resource capacity (i.e. either delayed to the next day, or performed in
overtime), and (4) the probability that the workload induced on medical services will exceed
the capacity of key resources. To the best of our knowledge, no methodology yet exists to
address these critical issues of access to patients such as Chris while considering the complex
and type-dependent tradeoffs among the metrics that the provider must manage.
3.2 Motivation
As the complexity and interconnectivity of systems increases, proper planning and flow
management to coordinate a network of resources is becoming increasingly important. This
endeavor is complicated by the fact that requests for appointments and patient itineraries
are stochastic in many such real-world networks. Additionally, entities that enter the system
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may have different completion deadlines and different priorities or service level targets for
meeting those deadlines. This type of system is particularly well-represented in healthcare,
where the paradigm of integrated care delivery is gaining importance.
Due to increasing cost pressure, there are considerable financial incentives to transition
to larger, more coordinated network care models such as those found at the Mayo Clinic, the
Cleveland Clinic, and Kaiser Permanente. With Accountable Care Organizations expected
to play an increasingly important role in health care, effective coordination across health
services will only grow in importance as providers try to improve their health outcomes (see
[52]). As health care moves toward consolidation, the resulting healthcare networks will
serve a diverse patient population both in terms of conditions treated but also geography
and urgency. This leads to the same set of resources serving patients with varying time
sensitivity to completing their treatment. An example of this is Mayo Clinic’s Spine Care
Midwest initiative. Patients with severe pain will come to Rochester for fast diagnosis and
access to surgery. The same resources, however, will be used to serve patients with chronic
back pain that can easily travel back and forth to the clinic and do not require fast access
to all services. Another example is surgical patients with cancer. These patients often have
higher priority over surgical patients that do not have cancer. In urology, patients may
present with a suspicion of cancer and they need to gain rapid access to diagnostic testing,
surgeon consultation and, if necessary, surgery.
3.2.1 Current approach and implications
A simple First-Come-First-Served (FCFS) approach to care dominates current practice,
causing patients with more urgent care needs to be treated the same as those who can wait
longer for an appointment without a negative health impact. However, in some medical
specialties at a partner healthcare provider, physicians will assign slots in their schedule to
reserve capacity for specific types of patients. This is done for a few of reasons: (1) some
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physicians specialize and need to reserve capacity for patients who might materialize and
require a given subspecialty; (2) our partnering hospital is a top research clinic, and doctors
want to see patients who fit the requirements of ongoing medical studies; (3) physicians
generally prefer seeing patients they already had contact with (established) rather than going
through the diagnosis of a new patient. When those patients don’t materialize, however, the
slots go unused, and the impact can be large in terms of utilization and capacity going to
waste. Patients may have their appointments delayed because they don’t meet the criteria
specified for a given slot. Having designated slots is a reflection of the desire of the practice
to manage patient mix, but this approach to the problem may not be efficient.
Based on roughly one year of data from our partnering hospital for a subset of the medical
departments, it was possible to observe a posteriori the performance of the current scheduling
approach. In Fig. 3.1, we observe the tail distribution of the access delay to a root appoint-
ment of an itinerary of care in three medical departments based on patient urgency. More
specifically the graph in Fig. 3.1 shows the probability of exceeding n weeks of access delay
(n = 1, .., 6) based on (1) the patient type (urgency level) and (2) the medical department
required for the first visit appointment in the itinerary. In Fig. 3.2, for each department
d ∈ {GIM ,GI,Neurology}, we observe (1) the daily resource capacity of the department
(in hours), (2) the daily average total workload (in hours) induced on the department based
on current practice scheduling, and (3) the daily mean and standard deviation of the internal
referral workload (i.e., workload induced by patients that started their itinerary in another
department d1 6= d but were referred to department d for a downstream appointment in their
itinerary).
Here, we can see that urgent vs. non-urgent access delays vary significantly by medical
department. This is not surprising since demand for specific services will vary across the
different patient classes considered here. Heterogeneous demand distributions will generate
74
Figure 3.1: Access delay (in weeks) tail distribution to the first visit of an itinerary for
different patient types in GI and GIM based on historical data
uncontrolled and/or undesirable differences in access delay across the patient classes if ca-
pacity is not properly allocated and access delays are not properly forecasted. Based on
historical data, new patients tend to have many more resource requirements (e.g., number
of appointments, referrals to other departments, etc.) than non-urgent cases because physi-
cians will need to obtain more information for diagnosis and/or treatment. In the cases of
Neurology and GIM, we see that this heavier load on resources tends to have a negative
impact on access delay. This is undesirable because a delayed diagnosis for urgent patients
can be very harmful. Neurology as a medical service tends to admit patients with much
more serious conditions (compared to GIM) and we can see that the tail distribution on
access delay tends to be lighter than GIM, which shows that this service do take urgency
into account when scheduling (as opposed to just using a FCFS rule). For example, the GI
department has recently followed an initiative to prioritize urgent patients, which explains
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their significantly shorter access delays. However, the consequences weren’t properly fore-
casted, and resulted in much higher access delays for non-urgent patients (compared to GIM
and Neurology). This motivates the need for an integrated approach in capacity planning to
understand the tradeoffs between the competing access delay metrics by patient class and
medical specialty.
Figure 3.2: Current practice internal referral workload and total workload in 3 medical de-
partments
In GIM, we notice that roughly 40% of the total workload comes from internal referrals
from other departments (i.e., downstream appointments in a patient’s itinerary) and that
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the standard deviation of that referred workload is much larger than other departments.
This variability of internal referral demand/workload makes it difficult to predict how many
initial appointments (urgent/non-urgent visits) to schedule, and how many slots to reserve
for internally referred demand. Most of this referred demand is usually generated a day
before or the day of the appointment since referrals usually occur based on results from an
earlier visit or test, while first visit demand (new or established) occurs at least a week before
the appointment. Hence, it is important not to over commit to initial appointments early on
since a significant (and variable) amount of referred workload will be required in GIM shortly
thereafter: in current practice, that would result in excessive downstream appointments being
performed in overtime (since appointment commitments are non revocable). Moreover, it
highlights the fact that admission decisions in other departments can have drastic effects
on a department like GIM because, with a decentralized approach to scheduling, admission
decisions in GI or Neurology are made independently of the load it could impose on GIM. In
Fig. 3.2, we see that GI has very low utilization which is probably due to an improper use of
resources (e.g. physicians having inefficient slot reservation templates, or poor downstream
resource requirement forecasting). For the neurology department, we observe a roughly
constant workload throughout the week but with variable resource capacity: this creates
variable utilization, large amounts of overtime on Fridays, and poor patient access.
This high level historical analysis aligns with our intuition about the dynamics of this
large stochastic queueing network control problem: (1) each combination of patient class and
specialty/department has their own issues to improve upon because of different demand pat-
terns and scheduling policies, and (2) a single scheduling/capacity planning decision for each
specialty and patient class affects (a) other patient classes, (b) other departments/specialties,
and (c) multiple competing critical metrics/objectives in such a system.
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3.2.2 Controlling Access via the Template Process
The above motivates the need for a capacity plan that can provide improved access for a
heterogeneous group of patients, each with different levels of urgency and different resources
needs along their itinerary through the care network. One can describe the system as a multi-
class queueing network with blocking. Each group has a different sensitivity to the time to
initial appointment. Our approach is to create a plan for capacity allocation so that each
patient type must wait for an available appointment permitted for their type (maintaining
FCFS within type), enabling the organization to reliably achieve patient class-dependent
delay targets.
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Figure 3.3: One week of a scheduling template for a given medical department/specialty.
OPT’s main output to an outpatient practice is a template for planned capacity (see
example in Fig. 3.3) at the daily level that meets all of the requirements of the prac-
tices/services modeled (e.g. GI, GIM, and Neurology). The template can be thought of as a
booking plan for how many patients of each type should be scheduled at maximum based on
each day of a planning horizon. Fig. 3.3 illustrates one week of a template for the General
Internal Medicine (GIM) department at our partnering hospital. Our partnering outpatient
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institution uses them to capture care provider schedules. These templates can be used at the
individual provider level, however, they always exist at the department/medical service level
and that is our focus here. OPT will optimize schedule templates of outpatient practices by
service to control the tradeoff between achieving (1) a high utilization of clinicians’ time, (2)
short access delays to an initial appointment, (3) a low probability of downstream workload
exceeding capacity, and (4) a low number of downstream appointments being performed in
overtime.
The templates are populated by the main decision variables of our optimization formu-
lation, a multi-dimensional array Θ =
(
Θk,τt
)
, where τ ∈ C represents the patient class (e.g.
urgency level, geozone, etc.), k ∈ K represents the department/specialty (or even the sub-
specialty) required during the root appointment of an itinerary, and t ∈ T is the day in our
planning horizon. The template Θ contains the main decision variables of our optimization
formulation, which sets the capacity for initial/root appointments of a care itinerary. The
capacity not consumed by the root visits will be used to satisfy subsequent visits (2nd, 3rd,
etc.) of each patient’s itinerary This output template corresponds to existing templates often
used in practice by schedulers. For example, the scheduler may be given an upper bound in
the number of initial appointments of a given type (by department, subspecialty, urgency,
and geozone) to allow on any given day. This upper bound may not always be achieved
due to variability in demand, and our models account for this. It allows us to bridge the
gap between high level capacity planning, and actual day to day scheduling, while providing
accurate forecasts of the most important metrics for decision makers in outpatient practices.
EMR systems may implement more sophisticated decision support using the template.
3.2.3 Competing Key Performance Metrics
As mentioned in previous sections, scheduling according to a given template will affect
numerous critical performance metrics. Our model incorporates the following competing
79
metrics for each medical department k ∈ K:
1. (M1) Access delay by patient class τ ∈ C; specifically, we will optimize/control the
percentage of type τ patients that exceed n weeks of waiting for a root appointment.
2. (M2-M3) Mean and variance, respectively, of the resource utilization.
3. (M4) Number of planned working hours that exceed resource capacity (or equivalently,
mean number of overtime hours).
4. (M5) Probability that the offered workload will exceed resource capacity.
Rather than solving a multi-objective optimization program (which has been shown to be
difficult to implement in practice), we will use one metric in our objective with constraints
on the others. Scheduling according to the template generated by a given objective (e.g.
minimize urgent patient access delay) and constraints (target value for utilization, non-
urgent access delay, overtime hours, etc...) will assure that the optimal objective will be
achieved while satisfying the targets set on the other metrics. For example, we may want
to minimize the access delay metric M1 with τ = Urgent and n = 2 weeks, in department
k = Neurology. At the same time, the access delay of non-urgent patients in Neurology
and any GI or GIM patient should not be negatively affected. Consider that the more root
appointments there are for any type of patient, the more workload that it will generate due
to downstream resource requirements (especially by increasing access for urgent patients).
This will affect M2 and M3 and could lead to the deterioration of metrics M4 and M5. In
other words, we are dealing with competing objectives and, in this example, we will make
sure to (1) provide an upper bound constraint M1 for all other patient types and medical
services, and (2) an upper bound constraint on M2-M5 to make sure we do not over commit
our resources to root appointments without proper forecasts of downstream requirements in
patients’ itineraries.
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3.2.4 Differentiation from past research and practice
To the best of our knowledge, the objectives of this research are beyond the capabilities of
published research or available commercial products. Our approach differs significantly from
the appointment-based scheduling literature (and other areas such as capacity planning, lead
time quoting, and revenue management) because it contains multiple technically difficult
characteristics such as (1) scope (network vs. single clinic), (2) planning horizon (many
day and permitting non-stationarity vs. single day), (3) wait in days for an appointment
(explicitly considering working hours by provider by date) rather than minutes of waiting in
continuous time after arriving for a visit, (4) incorporation of multiple complex metrics, and
(5) service itineraries vs. a single appointment.
This work departs from all commercial software with which we are familiar. Moreover,
it differs significantly from the classical outpatient scheduling literature in terms of scope
(network vs single clinic) and timing (multiple day planning horizon vs single day). Much
of the outpatient scheduling literature focuses on the scheduling of a single clinic, which is
often modeled as a queueing system (see the survey paper [7]), and scheduling patients to
time slots within a day considering no-shows, doctor availability etc. See these key survey
papers [7, 19, 32]). The concept of capacity reservation/allocation is present in some revenue
management research (e.g., [2]), but those models lack the features and complexity proposed
(see [53, 30, 42]). There has been work in this general area (e.g., [20, 31, 32]) including
integrated care in the context of a network of outpatient care services (e.g., [36]).
Recent works for single-unit (non-network) systems have considered priority scheduling
and dynamic capacity allocation problems solved via approximate dynamic programming,
[29]. Some papers consider multi-priority jobs arriving dynamically that must be scheduled
on some future date (or rejected) with holding costs for delays or overtime (see [45, 10,
14]). Other papers consider the fact that each patient (job) may initiate a time series of
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appointments over multiple days with deadlines/time windows for subsequent appointments
(see [15, 31, 51]).
In this research, we rather propose to examine the tactical perspective by allocating ca-
pacity for different priority patients on clinicians’ schedules in advance of observing requests
from individual patients. This is important in outpatient environments, because clinicians
typically work according to static calendars as that help them plan their patient care and
other activities such as research and administration. Finally, we consider multiple objectives
and the percent of patients that meet predetermined, class-specific deadlines for time to ini-
tial and subsequent diagnosis and treatment visits. This involves capturing the propagation
of workload overflowing from one day to the next as well as downstream visits. Linearizing
these processes is another contribution.
Integrated outpatient care also has commonalities with hospital inpatient scheduling
problems. Early stochastic models of hospital census includes simulation (see [24, 38, 17, 23]),
and probabilistic approaches (see [9]), but capacity optimization was heuristic or intractable.
Recent elective patient admission scheduling research has treated the optimization of elective
admission schedules for stochastic flows through a network of inpatient hospital resources
(e.g. wards) (see [8, 1, 5, 27]). These works, however, consider elective scheduling rather
than capacity reservation as is more appropriate for outpatient networks. In this research,
we consider how stochastic arrivals fill appointment slots reserved in advance. Further,
this research captures delays throughout care episodes, a feature not found in the elective
literature.
3.3 “Demand in Progress”
In practice, the provider organization first determines a capacity reservation plan (the
template in our terminology) and reserves capacity in each medical specialty for each patient
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class (which can include urgency level/priority) over a finite planning horizon. Then, patients
call in to schedule an initial/root appointment according to a random and time-dependent
arrival process. The distribution on the daily number of arrivals (i.e., demand for a root ap-
pointment) can be general and captured by an empirical distribution based on historical data.
Patients will be booked into the earliest reserved slot according to the current availability
of the template. Patient demand exceeding the available capacity on a certain day becomes
carryover demand that the model attempts to book into the following day and so forth until
available capacity is found. To capture these dynamics, let τ ∈ C represent the patient type,
where patient type determines both the resources needed to complete a patient’s stochastic
itinerary as well as the patient’s urgency/priority. For example, patient type includes the
status of the patient (urgent vs. non-urgent - important for urgency/priority and stochastic
itinerary), the geozone of the patient (national/international vs. local/regional - important
for urgency/priority and stochastic itinerary), and the specialty the patient requires in a
given service/department k ∈ K (important for stochastic itinerary). The decision variables
Θk,τt for planning horizon t ∈ {1, ...,T} are the clinic’s capacity allocation plan for patient
type τ in service k. Schedulers commonly tend to schedule the root appointment without
regard to downstream requirements that may be needed at the time. This is because (1)
the root appointment is usually a diagnosis, and access to this visit may be urgent, and
(2) very little (if any) information is known about the downstream requirements (referrals,
follow-ups) at the time the patient schedules her root/diagnostic appointment. Hence, in
this section, we do not consider the modeling of downstream appointments, but this will be
analyzed in Section 5.
In our system, demand is either met immediately (scheduled into the current day under
consideration if capacity is available) or carryovers to the following day. Each time that
a given patient type demand cannot be met on a given day (because previous bookings
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already filled up the reserved capacity), this demand will be “pushed back” to the next
day. We will call this carryover demand. To link this to an outpatient practice’s actual
process, a scheduler will receive a patient request to start a new itinerary and will consult
the scheduling template on each future day to check availability for that patient type based
on the capacity plan designed by our methods. We will model this process as the demand
will carryover from day to day until there is an availability in the template Θ. The patient
will finally be booked by the scheduler on the first day in the future where there is enough
available capacity according to the template, so we model this as having her demand carried
over from day to day until she is booked. This of course does not make the assumption
that the patient will have to wait to know about her appointment until the first day with
availability. Our model employing carryover demand simply recreates the booking process
of the scheduler in practice. A scheduler will know in real time by consulting the current
state of the scheduling template the first day that the patient can be scheduled (according
to the template).
On a given day t of our planning horizon, the type τ demand in service k can be split
into: (i) the exogenous demand represented by the patient requests for a root appointment
that were received on the current day t, and (ii) the carryover demand that represents all
previously made requests that were not scheduled up to day t due to capacity/template
restrictions. We refer to the combination of (i) and (ii) as the Demand In Progress (or DIP)
random variable, similar to the concept of the commonly known Work In Progress (WIP)
in queueing networks. To maintain realism, we also assume that a patient that requested
an appointment in service k earlier than another patient of the same type will have their
root appointment happen earlier, since the scheduler will book patients in a first come first
served manner based on the limits on available time set by the template. We can think of
this booking process as a FIFO queue for each patient class and medical service within the
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reserved capacity of our template.
Let DIP k,τt,w , t ∈ {1, ...,T} be the random variable which represents the amount of type
τ DIP demand seeking admission in service k on a given day t in planning horizon (e.g.
week) number w (see Eq. 3.1), βk,τt+1,w, t ∈ {1, ...,T − 1} as the type τ carryover demand
random variable in service k from day t to day t + 1 in planning horizon w (Eq. 3.3), and
βk,τ1,w as the type τ carryover demand random variable in service k from day T of the prior
planning horizon, w − 1, to day 1 in the current planning horizon w (Eq. 3.2). In this
paper, the dynamics of our system will be analyzed over an equilibrium cyclo-stationarity
planning horizon of T days, so the template does not depend on w. These random variables
will satisfy the following set of equations for any patient type τ and planning horizon w:
DIP k,τt,w = D
k,τ
t + β
k,τ
t,w ,∀t ∈ {1, ...,T}, (3.1)
βk,τ1,w =
(
DIP k,τT ,w−1 −Θk,τT
)+
, (3.2)
βk,τt+1,w =
(
DIP k,τt,w −Θk,τt
)+
,∀t ∈ {1, ...,T − 1}, (3.3)
where Dk,τt represents the type τ exogenous demand random variable in service k on day
t of our planning horizon (that can be captured by historical data). The DIP on a given
week/day, DIP k,τt,w , is the sum of the exogenous demand, D
k,τ
t,w , and the carryover demand
from the previous day, βk,τt,w . To capture the carryover demand from day t to t + 1, we take
the positive difference of the day t DIP and the amount of carryover demand on that same
day.
Given we have a stable system, as w → +∞, our random variables DIP k,τt,w , βk,τt,w , and
will converge in distribution to the random variables DIP k,τt and β
k,τ
t respectively. Hence,
in equilibrium, Eqs. 3.1-3.3 can be rewritten as:
DIP k,τt = D
k,τ
t + β
k,τ
t ,∀t ∈ {1, ...,T} (3.4)
βk,τt⊕1 =
(
DIP k,τt −Θk,τt
)+
, ∀t ∈ {1, ...,T} (3.5)
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where the operator ⊕ is the modulo T operator defined for convenience to assure that all
our variables will have their subscripts in {1, ...,T} in our rolling planning horizon (e.g. if
t = T then t⊕ 1 = 1).
For ease of exposition, let us also define αk,τt to be the amount of DIP
k,τ
t that is scheduled
on day t:
αk,τt = min{DIP k,τt , Θk,τt } = DIP k,τt − βk,τt⊕1. (3.6)
Then,
DIP k,τt = α
k,τ
t + β
k,τ
t⊕1. (3.7)
Our goal is to translate this set of stochastic non-linear equations (3.4-3.7) into a set of
deterministic linear constraints subject to Θ that can capture the probability distributions
of the DIP k,τt and β
k,τ
t random variables. This information is needed to accurately estimate
(based on a given template, Θ) (1) the DIP levels in the planning horizon, (2) the delay to
obtain a first visit (which can be calculated by how many times demand carries over), (3) how
demand will be fulfilled and scheduled, (4) how capacity decisions will impact demand and
workload for downstream visits, and (5) how the institution’s resources will be utilized. The
dynamics of our system are conceptually similar to the idea of blocking in queueing networks,
which is difficult to compute except in special cases, and is non-linear in our main decision
variable Θ (i.e., allocated capacity). To overcome this, we propose to develop approximation
techniques (see Sections 6.1 and 6.2) that can capture the key system dynamics linearly in
order to forecast and control our desired metrics (see Sections 4 and 5) in a deterministic
Mixed Integer Programming optimization.
3.4 Access delay
Access delay is a crucial metric for healthcare organizations, as most recently and vividly
demonstrated by the public firestorm surrounding long wait lists at Veteran’s Administration
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(VA) hospitals. To quantify and reduce access delay, this section describes the mathematical
approach and challenges at the root of this problem.
Each specialty/service may have different targets/bounds on the waiting time for a first
visit appointment to respond appropriately to the urgency of each patient type. This problem
induces multi-dimensional tradeoffs, as increasing access for one type of patient necessarily
means reserving more capacity for that patient and thereby reduces access for other patient
types. Note that our methodology clarifies what is possible and what is not.
We constrain user-selected quantiles of the access delay distribution. This sets a service
level bound on the expected fraction of patients of type τ in service k to exceed a desired
target (set by the healthcare organization) on access delay. To do so, let pk,τn be the bound
we set on the percentage of type τ patients in service k that will exceed TFAV k,τn days of
waiting for an initial/root appointment, with TFAV standing for “time to first available
visit.” The subscript n allows us to set multiple bounds for each patient type. For example,
we may want (for n = 1) 20% (pk,τ1 = 0.2) of type τ patients to get an appointment within
4 days in service k (TFAV k,τ1 = 4), (for n = 2) 50% (p
k,τ
2 = 0.5) of type τ patients to get
an appointment within 7 days in service k (TFAV k,τ2 = 7), and similarly for other desired
performance constraints. Note that the number of those constraints, which corresponds to
the control we set on the access delay, can vary based on the case and the decision maker’s
needs. Note that if TFAV k,τn is increasing in n, we will want p
s,d,z
n to be decreasing in n.
Otherwise, some constraints will have no effect.
To capture these service level metrics, we begin by defining δk,τt,n as the number of open
slots left in our template from day t up to day t+ TFAV k,τn after all demand prior to day t
has been scheduled:
δk,τt,n =
TFAV k,τn∑
l=0
Θk,τt⊕l
− βk,τt
+ .
This is the positive difference of (a) the total number of type k, τ slots in an empty template
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from day t to day t+TFAV k,τn and (b) the number of type k, τ carryovers to day t. We will
consider the expected fraction of type τ patients requesting an appointment in service k on
day t that exceed TFAV k,τn days of waiting for a root appointment, denoted as G
k,τ
t,n :
Gk,τt,n = E

(
Dk,τt − δk,τt,n
)+
Dk,τt
 ,
which we will linearize in Section 3.7.2. This quantity could be used in multiple ways. For
example, we may want to minimize this quantity for urgent patient types. Alternatively, for
other patient types we may constrain Gk,τt,n to be smaller than a percent (service level p
k,τ
n )
of the total demand on day t:
Gk,τt,n ≤ pk,τn . (3.8)
3.5 Workload
We develop a computationally efficient offered load approach to forecast downstream
demand during a patient’s itinerary based on a stochastic location process parameterized
with historical patient flows that are a good representation of the actual visit precedence
relationships for a patient’s care path (e.g. a general surgery consult must occur at least
one day after the CT scan visit to allow ample time to read the CT image). Based on our
experience working with data with our partnering hospital, this is a good assumption for some
specialties and patient types. On the other hand, it is less realistic for some other services
and patient types because the historical time series data is contaminated with endogenous
downstream delays inherent in the system that obscure the true itinerary. We propose to use
the stochastic location process in an offered load model with infinite capacity, yet historical
patient flow data are clearly capacitated. To eliminate this endogeneity, we take advantage
of the fact that demand for healthcare services typically follows a seasonal pattern, which is
confirmed by the data from the partnering hospital. Thus to approximate the true stochastic
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location process probabilities, we use data from low utilization months during which time
patients rarely have difficulty getting an appointment. This approximates uncapacitated
flow because we are trying to capture the itinerary, not the volume of flow.
We construct a model for workload (utilization) at each specialty within the care network
based on the capacity reservation plan, Θ. This quantity is needed to assure that we respect
daily capacity constraints while estimating/controlling two critical metrics: (1) the proba-
bility that the offered workload will exceed capacity, and (2) the expected daily workload
overflow, which can be seen as the daily number of overtime hours that have to be spent on
downstream appointments (see Section 6.4).
3.5.1 Downstream Demand distributions
Based on historical data, we construct a downstream resource requirement (or “location”)
probability function capturing the timing (precedence) and type of all subsequent appoint-
ments across the network of clinical specialties after a patient’s first visit; tailored to each
patient type.
We consider K to be the set of medical specialty services at the care provider institution.
Since a patient could have appointments at multiple medical specialties on a single day, we
need to consider a vector state space for the stochastic location process. Let this vector state
space be S0 = {[a1, a2, . . . , a1, . . . , a|K|] : ak ∈ Z+,∀k ∈ K}. We let the full state space be
S = S0⋃{∆}, where ∆ represents that the patient has no appointments (e.g. has returned
home, has not yet become a downstream patient, or has no visits on a given day within
his/her itinerary). We allow each ak to take values in Z
+ since in the outpatient setting, a
patient can have more than one appointment in a medical specialty on a given day.
Let Lk1,τt1 (t) be the S-valued function that represents the unhindered (no delays) ap-
pointment(s) needed at time t during a care episode for a patient of type τ that started
her itinerary in service k1, where t1 is the day that the patient started her itinerary. For
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notational convenience we let
P(Lk1,τt1 (t) · ek = m) = rk1,τ ,kt1 (m, t− t1), (3.9)
where rk1,τ ,kt1 (·, ·) is calculated based on historical data, and ek is a column vector with all
0’s and a 1 in the kth row.
3.5.2 Offered workload formulation
Based on the formulations in this past section, we can now express the steady state mean
offered workload on day t of our planning horizon in each medical department. First, let Mk
be the maximum number of time slots a patient can require within a day in specialty k.
Theorem III.1. The steady state mean offered workload in service k on day t (under the
capacity reservation plan Θ) can be computed as:
W
k
t =
∑
τ∈C
∑
k1∈K
T∑
t1=1
E[αk1,τt1 ] ·
∞∑
j=0
Mk∑
m=1
m · rk1,τ ,kt1 (m, t− t1 + jT ) · ek · Sk (3.10)
Proof. By combining Lk1,τt1+jT (t) with α
k1,τ
t1,j
, the number of type τ initial appointments in
specialty k1 on day t1 ∈ {1, ...,T} of planning horizon j, we can determine the demand stream
(and also workload by multiplying by the appointment length required) for downstream
appointments at each specialty t days later.
Therefore, for medical specialty k, the offered workload random variable (which includes
initial and subsequent appointments for each patient type) on day t of planning horizon (e.g.
week) w under the booking reservation scheme Θ can be expressed as:
W kt,w =
∑
τ∈C
∑
k1∈K
w∑
j=0
T∑
t1=1
α
k1,τ
t1,j∑
i=1
Lk1,τt1+jT ,i(t+ wT − (t1 + jT )) · ek · Sk, (3.11)
where Sk is the length of a slot in specialty k, and L
k1,τ
t1+jT ,i
(t + wT − (t1 + jT )) is the ith
i.i.d instance of the Lk1,τt1+jT (t+ wT − (t1 + jT )) random variable. Notice that the first inner
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sum in Eq. 3.11 considers αk1,τt1,j , all type (k1, τ) patients that were scheduled for their root
appointment on day t1 of week j ≤ w. For each one of those patients, we will multiply a
given realization of Lk1,τt1+jT (t+wT −(t1 +jT )) with ek ·Sk, which will determine the workload
each one of those patients will impose in specialty k, t + wT − (t1 + jT ) days later (hence,
on day t of week w). For notational convenience, if t + wT − (t1 + jT ) is negative then
Lk1,τt1+jT (t+wT −(t1 +jT )) will be 0. The second and third inner sums are over all days weeks
w from 0 to w, and all days t1 in weeks j = 0, ...,w. Therefore, this captures all type (k1, τ)
patients that were scheduled for a root appointment earlier than day t of planning horizon
w, and the sum of their resource requirements in specialty k on day t of week w. The last
two outer sums consider all patient types τ ∈ C, k1 ∈ K.
As w → ∞, Eq. 3.11 the steady state mean workload on day t of our planning horizon
can be computed as follows:
W
k
t =
∑
τ∈C
∑
k1∈K
T∑
t1=1
∞∑
j=0
E
α
k1,τ
t1,j∑
i=1
Lk1,τt1+jT ,i(t+ wT − (t1 + jT )) · ek · Sk (3.12)
=
∑
τ∈C
∑
k1∈K
T∑
t1=1
E[αk1,τt1 ] ·
∞∑
j=0
Mk∑
m=1
m · rk1,τ ,kt1 (m, t− t1 + jT ) · ek · Sk (3.13)
Eq. 3.12 calculates the limit of Eq. 3.11 as w → ∞ and takes the expectation of this
expression. Then, using Wald’s equation, the expected value of a random sum, will be equal
to the expected value of αk1,τt1,j multiplied by the expected value of the L
k1,τ
t1+jT ,i
(t+wT − (t1 +
jT )) · ek random variable. Using Eq. 3.9, and using the fact that our calculations are made
in equilibrium, Eq. 3.13 follows, and we proved Theorem III.1.
To calculate the variance in the number of appointment slots requested for service k on
day t of our planning horizon, we will need to compute the variance of the number of type
τ patients scheduled in service k on day t according to our template Θ.
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Theorem III.2. The steady state variance of the offered workload in specialty k on day t of
our steady state planning horizon is given by
W˜ kt =
T∑
t1=1
∑
τ
∑
k1∈K
∞∑
j=0
[
Var
[
αk1,τt1
]( Mk∑
m=0
m · rk1,τ ,kt1 (m, t− t1 + jT ) · ek · Sk
)2
+ E
[
αk1,τt1
]
·
Mk∑
m=0
(
m2 · S2k · rk1,τ ,kt1 (m, t− t1 + jT ) · ek
(
1− rk1,τ ,kt1 (m, t− t1 + jT ) · ek
)
−
∑
m<q≤Mk
2mq · S2k · rk1,τ ,kt1 (m, t− t1 + jT ) · ek · rk1,τ ,kt1 (q, t− t1 + jT ) · ek
)]
(3.14)
Proof. Following the general idea of the proof in Theorem III.1, we can formulate the steady
state variance of the specialty k workload random variable on day t of our planning horizon
as:
W˜ kt =
∑
τ∈C
∑
k1∈K
T∑
t1=1
∞∑
j=0
V ar
[ αk1,τt1,j∑
i=1
Lk1,τt1+jT ,i(t+ wT − (t1 + jT )) · ek · Sk
]
(3.15)
Notice that (Lk1,τt1+jT ,i(t+wT − (t1 + jT )) ·ek)i is a sequence of independent random variables
which are also independent of αk1,τt1,j , the number of patients scheduled. Moreover, the variance
of Lk1,τt1+jT ,i(t+wT − (t1 + jT )) · ek is the same for every i. Then, the variance of this random
sum can be expressed as follows:
V ar
[ αk1,τt1,j∑
i=1
Lk1,τt1+jT ,i(t+ wT − (t1 + jT )) · ek · Sk
]
= E[αk1,τt1,j ] · V ar[Lk1,τt1+jT ,i(t+ wT − (t1 + jT )) · ek · Sk]
+ E[Lk1,τt1+jT ,i(t+ wT − (t1 + jT )) · ek · Sk]2 · V ar[αk1,τt1,j ] (3.16)
By using the same arguments as the proof of the previous theorem, Eq. 3.14 follows.
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3.6 DIP distribution adjustment combining optimization and sim-
ulation
3.6.1 Discrete Event Simulation
In order to validate the approximations used in our template optimization approach, we
constructed a high-fidelity discrete event simulation in Visual C++. The simulation inputs
include: (1) an optimized weekly template in equilibrium, (2) the daily resource capacity,
(3) the stochastic location functions for downstream appointments based on historical data,
(4) the empirical demand distribution for each patient type τ based on historical data, and
(5) the historical internal referral workload mean and variance from patients starting their
itineraries outside of the three departments we consider (GI, GIM and Neurology). We
will consider a 500 day warm-up period to reach equilibrium. The metrics considered in
this simulation will be: (1) the expected percentage of type τ patients exceeding ω days of
waiting, (2) the mean and variance of the number of type τ patients scheduled by day of
week (as well as the carryover patients), (3) the mean and variance of the offered workload
by day of week, (4) the expected number of overtime hours by day of week, and (5) the
probability of exceeding the daily resource capacity. The metrics we wish to validate will
be computed over an evaluation horizon/period that reached equilibrium by using the batch
mean method. In addition, the simulation considers a large number of replications (of the
warm-up and the evaluation period) for the evaluation of the mean and variance of our
metrics, which we shown to be enough to have our sample means and variances converge to
the true means and variances. The number of replications, the number of batches, and their
sizes in the evaluation period, have been selected to guarantee a 95% confidence interval on
our sample metrics (for their means and variances/standard deviations).
At the end of the day, we consider all arrivals of all types that occurred within the day, and
the template scheduling function determines the first available reserved slots in our schedule
93
by keeping track of the number of remaining open reserved slots for each patient type. Once
all patients that requested their initial appointment on that day have been scheduled (on
a future day), we update our metrics. We will use realizations of the stochastic location
distributions to determine the workload they will impose on days following the first visit,
due to their downstream appointments. Note that if any of the appointments scheduled
(initial or downstream) generate a workload that makes the aggregate offered load go over
the daily capacity, then the appointment will be treated as “overtime” workload. Once
the simulation reaches the end of its horizon, and has gone through all its replications, we
can then compare our simulated metrics to the results we got from the optimization, and
compute the percentage errors.
3.6.2 Simulated DIP distributions
On any day t, we are adding a large number of random variables (each determining
the amount of carry over demand from previous days l to t with l < t) to the exogenous
demand on day t. But we should note that those random variables that we are summing are
not i.i.d, therefore using the Central Limit Theorem to assume the DIP random variables
follow a Normal distribution has its limitations. In some situations e.g., in heavy traffic,
the skew of the distribution tends to increase: this leads to an inexact characterization of
the DIP distributions if we assumed normality, therefore errors in our metrics’ forecasting
(especially for the second moment terms) and a suboptimal template. We conducted some
statistical analysis on DIP distributions given a wide range of templates Θ. We considered
historical demand patterns, and first simulated the booking process in a low traffic setting
(for a template that would generate low utilization/waiting times). Then, we simulated the
booking process assuming a historical template, which is a representation of a heavy traffic
scenario. We estimated the DIP distributions under those capacity planning scenarios and
compared it to Normal distributions (or log-normal) with same means and variances. In Fig.
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3.4 we represent the low traffic scenario while the heavy traffic case can be found in Fig. 3.5.
Figure 3.4: Simulated Monday DIP distribution with mean of 26.36 and standard deviation
of 9.16 approximated by a Normal distribution (26.36, 9.16) and its effects on
the Tuesday carryover demand relative to the truncation factor Θ
Θt,τ1 = 15 DIP Simulated Dist. Normal Dist. APE AE
P(DIP t,τ1 > Θ
t,τ
1 ) 0.86 0.86 0.06 0.00
E(βt,τ2 ) 11.68 11.83 1.27 0.15√
V ar(βt,τ2 ) 8.65 8.33 3.72 0.32
Table 3.1: Absolute Percentage Error (APE) and Absolute Error (AE) of the probability of
exceeding Θ = 15, the mean Tuesday carryover demand, and Tuesday carryover
demand standard deviation when we approximate the Monday DIP distribution
by a Normal
In Table 3.1 we compared three metrics that would be impacted by a Normal approxi-
mation to the DIP: the probability of exceeding the number of reservations Θt,τ1 , the mean
carryover demand and the carryover demand standard deviation. The accuracy of those
metrics will vary based on Θ’s relative value to the distribution of the DIP. In the first
two cases (Θ = 15, 25), when our template is below the mean or equal to the mean of our
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DIP distribution, we observe high accuracy in our metrics. When looking at the Absolute
Percentage Error (APE) and Absolute Error (AE) of those three metrics, we can see that
the Normal approximation to the DIP distribution behaves quite well. But if we now look
at the heavy traffic case (Fig. 3.5 and Tables 3.2 and 3.3), which is a much more realistic
representation of reality, we can see that the Normal approximation generates large APEs
for the three metrics we care about. This is mainly due to the increase in skewness of the
true DIP distribution, which now behaves closer to a log-normal distribution.
Figure 3.5: Simulated Monday DIP distribution with mean of 91.91 and standard deviation
of 73.91 approximated by a Normal distribution (91.91, 73.91) and a log-normal
distribution (91.91, 73.91) and its effects on the Tuesday carryover demand rel-
ative to the truncation factor Θ
Θt,τ1 = 16 DIP Simulated Dist. Normal Dist. log-normal Dist.
P(DIP t,τ1 > Θ
t,τ
1 ) 0.964 0.846 0.978
E(βt,τ2 ) 76.037 81.756 74.143√
V ar(βt,τ2 ) 73.771 67.454 64.443
Table 3.2: Probability of exceeding Θ = 16, the mean Tuesday carryover demand, and Tues-
day carryover demand standard deviation for the Monday DIP distribution when
(1) it has been simulated (i.e., the true distribution), (2) approximated by a
Normal, and (3) approximated by a log-normal distribution. (1) and (2) both
generated with mean and standard deviation equal to the simulated DIP
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Θt,τ1 = 16 Normal APE log-normal APE
P(DIP t,τ1 > Θ
t,τ
1 ) 12.261 1.427
E(βt,τ2 ) 7.522 2.490√
V ar(βt,τ2 ) 12.642 8.725
Table 3.3: Absolute Percentage Error (APE) of the probability of exceeding Θ = 16, the
mean Tuesday carryover demand, and Tuesday carryover demand standard de-
viation when we approximate the Monday DIP distribution by a Normal and
a log-normal distribution, both with mean and standard deviation equal to the
simulated DIP
Our model will adjust the DIP distributions in a recursive manner via simulation to
determine a truly optimal template with low metrics’ forecasting errors. The first step
of our methodology and algorithm will be to solve the optimization program assuming a
historical distribution on the DIP random variables (e.g. see the simulated bars in Fig.
3.5), and the following steps of the algorithm will use simulation to determine the correct
distribution associated with the optimized template (of a given algorithm iteration). In
most of our case studies occurring in clinical practice, an adjustment in the probability mass
function of the DIP random variables needs to occur for accurate forecasts of our metrics,
especially for the variance/standard deviation estimates (since it relates to the tail behavior
of the distribution).
3.6.3 Discretization of the DIP distributions
The type τ DIP random variable in service k on a given day t of the planning horizon,
DIP k,τt has mean DIP
k,τ
t and variance ˜DIP
k,τ
t satisfying the following: DIP
k,τ
t = D
k,τ
t +
B
k,τ
t , D˜
k,τ
t = D˜
k,τ
t + B˜
k,τ
t , where D
k,τ
t = E
[
Dk,τt
]
, B
k,τ
t = E
[
βk,τt
]
, D˜k,τt = V ar
[
Dk,τt
]
, and
B˜k,τt = V ar
[
βk,τt
]
. First, by the linearity of the expected value function, the mean of the DIP
random variable will clearly be the sum of the mean exogenous and carryover demands (See
Eq. 3.4). Moreover, note that the exogenous demand Dk,τt is independent to the carryover
demand βk,τt on a given day t, since the number of patient requests for an appointment on
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day t is independent of anything else in our system (including the carryover demand). This
allows us to sum up the variance of those two random variables to get the variance of the
DIP. Hence, we only need to express the expected value (B
k,τ
t ) and variance (B˜
k,τ
t ) of the
βk,τt random variables in order to get an estimate on the DIP distributions. However, the
expectation and variance of the carryover demand (as well as the probability of carrying
over) for a generally distributed DIP random variable is non-linear in the admission schedule
Θ for most distributions.
We propose an approximation based on Riemann integration. Let I = {1, 2, . . . , I} be
an index that creates a discrete grid with I sections. The grid need not (and in application
is not chosen to be) linear. Thus we have a one-to-one mapping function m(i) : I →M that
maps the integer values of I to the grid values M (see a grid example in Table 3.4).
i ∈ I 1 2 3 4 5 6 7 8 9 10 11 12 13
m(i) ∈M -3.1 -1.8 -1.2 -0.6 -0.2 -0.1 0.0 0.1 0.2 0.6 1.2 1.8 3.1
Table 3.4: Sample grid mapping from the set I to the grid M
Definition III.3. For a given grid m(i), i ∈ I, and any feasible template Θ, let Ψk,τt (i) be
a data input to the optimization determining the probability of having the random variable
DIP k,τt be in the interval
[
DIP
k,τ
t +m(i) ·
√
˜DIP
k,τ
t ,DIP
k,τ
t +m(i+ 1) ·
√
˜DIP
k,τ
t
]
.
Ψk,τt (i) will be calculated before an optimization run either by using historical data or
by using discrete event simulation (See Section 3.6.4 for more explanations). We justify
the assumption that Ψk,τt (i) does not vary regardless of which feasible template the Mixed
Integer Program converges to with:
1. the changes in DIP means and variances (when the template is optimized) are calcu-
lated linearly online (see Section 3.7.1) and are incorporated in the grid design (See
Definition 6.1). Hence, assuming invariance in Ψk,τt (i) does not mean we assume that
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our optimized template will have the same DIP distributions as historically, but rather,
it will belong to the same distribution family with different means and variances.
2. as we go through iterations of the DIP distribution adjustment algorithm (Section
3.6.4), our input Ψk,τt (i) to the MIP will get closer to the true DIP distribution associ-
ated with the optimized template. This is due mainly to the fact that as we go through
the iterations of our algorithm, the variations in the “optimal” template will decrease.
One grid design that has nice intuition and behaves well in practice is to make the grid
such that each interval contains an equal amount of probability density on a partition of the
interval [0, +∞) of our DIP distribution. An example of such a discretization is shown in Fig.
3.6 with the grid values of Table 3.4, where our decision variables are represented in bold.
Given a linear approximation of the square root function (since mean and variance can be
calculated linearly, see Section 3.7.1), those approximations allow us to estimate linearly the
discretized distributions of DIP k,τt (i). In the limit, as I →∞ and m(i+1)−m(i)→ 0, ∀i ∈ I,
this approximation will converge to the exact DIP distribution because it is equivalent to
Riemann integration.
We propose a linearizing approximation for the square root function. Let ˜DIP
k,τ
t be
the quantity that we want to take the square root of (e.g., type τ variance of the DIP
on day t). Let ˆDIP
k,τ
t be an initial guess of
√
˜DIP
k,τ
t (e.g., standard deviation). We
approximate the true
√
˜DIP
k,τ
t by applying one step of the Newton’s method:
√
˜DIP
k,τ
t ≈
0.5 · ( ˜DIP τt / ˆDIP
τ
t + ˆDIP
τ
t )). In previous work, [27] showed that this approximation is
highly effective in modeling healthcare workloads when ˆDIP
k,τ
t is chosen to be the historical
workload standard deviation.
Now, we can define a separate variable, DIP k,τt (i) ≥ 0, for the realization of DIP k,τt at
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Figure 3.6: Applying the grid approximation to a DIP Normal distribution
each grid level i based on the grid discretization and Newton approximations made above:
DIP k,τt (i) := DIP
k,τ
t +
1
2
m(i) ·
(
˜DIP
k,τ
t
ˆDIP
k,τ
t
+ ˆDIP
k,τ
t
)
+ k,τt (i), (3.17)
where
k,τt (i) ≤ −
(
DIP
k,τ
t +
1
2
m(i) ·
(
˜DIP
k,τ
t
ˆDIP
k,τ
t
+ ˆDIP
k,τ
t
))
+M · bk,τt (i), (3.18)
k,τt (i) ≤M · (1− bk,τt (i)), (3.19)
and
−M ·
(
1− bk,τt (i)
)
≤ DIP k,τt +
1
2
m(i) ·
(
˜DIP
k,τ
t
ˆDIP
k,τ
t
+ ˆDIP
k,τ
t
)
(3.20)
DIP
k,τ
t +
1
2
m(i) ·
(
˜DIP
k,τ
t
ˆDIP
k,τ
t
+ ˆDIP
k,τ
t
)
≤M · bk,τt (i). (3.21)
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Notice that in Eq. 3.17, we also add a term k,τt (i) ≥ 0 which will assure that DIP k,τt (i) ≥
0,∀i ∈ I since the DIP random variable cannot take negative values. We choose M to be
a large enough integer, and create a binary variable bk,τt (i) where constraints 3.20 and 3.21
assure that bk,τt (i) = 1 if DIP
k,τ
t +
1
2
m(i) ·
(
˜DIP
k,τ
t
ˆDIP
k,τ
t
+ ˆDIP
k,τ
t
)
≥ 0 and 0 otherwise. Hence
k,τt (i) will either take the value 0 or −DIP k,τt − 12m(i) ·
(
˜DIP
k,τ
t
ˆDIP
k,τ
t
+ ˆDIP
k,τ
t
)
≥ 0 thanks to
constraints 3.18 and 3.19 based on the binary variable bk,τt (i).
3.6.4 The DIP distribution adjustment algorithm
We will employ the following algorithm to capture the true discretized DIP distributions
of a given optimized BRPlan.
1. Input an objective and constraints on the other metrics into the Mixed Integer Program
(see Section 3.7).
2. Solve the optimization program described in Section 3.7 associating the historical den-
sities Ψk,τ (i)[0] to grid points DIP k,τt (i)[0] (see Section 3.6.3) and get the optimal
template Θ∗[0], and the resulting optimized/controlled metrics.
3. Set n = 1.
4. Input the iteration n−1 template Θ∗[n−1] into the discrete event simulation described
in Section 6.1 and compute the simulated density Ψk,τt (i)[n] at grid point DIP
k,τ
t (i)[n−
1].
5. If
∑
i∈I |Ψk,τt (i)[n]−Ψk,τt (i)[n− 1]| ≤ κ,∀k,∀τ then go to step 9.
6. Input Ψk,τt (i)[n] into the Mixed Integer Program with the same objective and con-
straints.
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7. Solve the optimization program now associating the iteration n simulated density
Ψk,τt (i)[n] to grid points DIP
k,τ
t [n].
8. Set n = n+ 1 and go to Step 4.
9. Compute the statistics of our simulated performance metrics and validate our analytical
model by calculating (1) the Absolute Percentage Error (APE), and (2) the Absolute
Error (AE) on the desired performance metrics.
10. End Algorithm
At iteration n = 0, CPLEX determines the optimal template (given an objective and
constraints on other metrics) assuming a historical discretized distribution Ψk,τ (i)[0], i ∈ I
on the DIP random variables. Note that this optimized template is not truly optimal since the
densities in between grid points are likely to change if our new template varies significantly
from the historical one. At iteration n = 1, we first use discrete event simulation to observe
how patient demand will fill the template slots and record the simulated true density in
between the n = 0 optimized grid points (i.e. in between m(i + 1) and m(i) DIP standard
deviations above/below the n = 0 DIP mean). If our historical distribution assumption is
“good enough”, we stop the algorithm and validate the statistics on our modeled performance
metrics. Otherwise, we input into the optimization program the adjusted densities (simulated
at n = 1) in between two grid points from iteration n = 0. When optimizing again at n = 1,
the DIP grid points will not be the same as the n = 0 DIP grid points since the mean and
standard deviation of our DIP will change with an updated optimized template. So our
adjusted densities will not be assigned to the exact same DIP values but will still reflect the
amount of density within a certain standard deviation factor above/below the mean. This
information is valuable to capture the correct shape of the distribution while still being able
to update its mean and variance when the optimized template changes. We then repeat the
102
same procedure until our optimized template stabilizes while now using the true distributions
of the DIP random variables.
3.7 Deterministic Linear Optimization
3.7.1 Linear parameterization the DIP distribution
Our goal is to compute the mean and variance of the DIP random variables for any day
t ≥ 0 (and, equivalently the mean and variance of the carryover random variables) linearly
in our decision variables Θ. We will show this by induction. If we can show that this is true
for all t ≥ 0, then this result will also apply to our equilibrium planning horizon with t ∈ T .
Initialization On day 1, we start with an empty system, meaning there is no carryover
demand. The DIP random variable will be equal to the exogenous demand on day 1 (see
Eq. 3.4) which can be expressed linearly in our decision variables Θ (since the exogenous
demand is independent of our template).
Induction hypothesis We assume that we can express the DIP mean and variance on
day t linearly in our decision variables Θ.
Induction step We would like to compute the distribution of the DIP random variable on
day t+ 1. To estimate the mean DIP
k,τ
t and variance ˜DIP
k,τ
t of the DIP random variables
linearly in Θ, it is sufficient to express linearly the mean B
k,τ
t+1 and variance B˜
k,τ
t+1 of the
carryover random variables on day t+ 1 (see Eq. 3.4).
βk,τt+1 will be a truncation of the DIP demand on day t, a distribution with mean DIP
k,τ
t
and variance ˜DIP
k,τ
t , with a lower-bound truncation at Θ
k,τ
t , which is then translated by
Θk,τt : this means that β
k,τ
t+1 will be a mixed random variable and have a mass point at 0
equal to the probability of the DIP demand on day t being below Θk,τt , and will have the
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same distribution as the tail distribution of the DIP when the DIP random variable is larger
than Θk,τt (i.e., for β
k,τ
t+1 > 0). An example of such a distribution can be seen in Fig. 3.7
with a truncation at 15 (Fig. 3.7 left) and a truncation at 25 (Fig. 3.7 right) of an assumed
normally distributed DIP.
Figure 3.7: Probability mass function of the carryover demand to the next day when the cur-
rent day DIP has a Normal distribution with mean 26.36 and standard deviation
9.16 with (left) a template Θ = 15 and (right) a template Θ = 25
DIP k,τt (i) (see Eq. 3.17) is linear in our decision variables Θ by the induction hypothesis:
DIP
k,τ
t and ˜DIP
k,τ
t can be estimated linearly in Θ. We can now express the carryover
demand level at grid level/realization i of the DIP based on Eq. 3.5 by:
βk,τt+1(i) =
(
DIP k,τt (i)−Θk,τt
)+
. (3.22)
To linearize βk,τt+1(i), we start by defining a binary decision variable y
k,τ
t (i, l) that equals 1
when DIP k,τt (i)−Θk,τt > l, and 0 otherwise. The following constraints on yk,τt (i, l) will assure
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that this definition is satisfied:
−M ·
(
1− yk,τt (i, l)
)
≤ DIP k,τt (i)−Θk,τt − l (3.23)
DIP k,τt (i)−Θk,τt − l ≤M · yk,τt (i, l). (3.24)
By noticing that yk,τt (i, 0) is expressed linearly in Θ in constraints 3.23 and 3.24, we can now
transform Eq. 3.22 into linear constraints with respect to our decision variables:
βk,τt+1(i) ≥ DIP k,τt (i)−Θk,τt (3.25)
βk,τt+1(i) ≤ DIP k,τt (i)−Θk,τt +M ·
(
1− yk,τt (i, 0)
)
(3.26)
As I → +∞ and m(i+1)−m(i)→ 0,∀i ∈ I, the following linear expression with respect
to our decision variables Θ, ∑
i∈I
βk,τt+1(i)Ψ(i), (3.27)
will converge to the daily mean carryover demand B¯k,τt+1. This uses the concept of Riemann
integration.
Theorem III.4. As I → +∞ and m(i+1)−m(i)→ 0,∀i ∈ I, the following linear expression
with respect to our decision variables Θ,
∞∑
l=0
[
2l ·
∑
i∈I
yk,τt (i, l) ·Ψ(i)
]
−
∑
(l1,l2)∈(Z+)2
∑
(i1,i2)∈I2
zk,τt (i1, i2, l1, l2) ·Ψ(i1) ·Ψ(i2),
will converge to the daily carryover demand variance B˜k,τt , where z
k,τ
t (i1, i2, l1, l2) satisfies
the following constraints:
zk,τt (i1, i2, l1, l2) ≤ yk,τt (i1, l1), (3.28)
zk,τt (i1, i2, l1, l2) ≤ yk,τt (i2, l2), (3.29)
zk,τt (i1, i2, l1, l2) ≥ yk,τt (i1, l1) + yk,τt (i2, l2)− 1. (3.30)
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Proof. We want to express the variance, B˜k,τt , of our carryover random variables linearly in
our decision variables. First, note that we can show by recurrence that:
E[(βk,τt )2] =
∞∑
l=0
2l · P
(
βk,τt > l
)
. (3.31)
Moreover, by using our previously defined binary variables yk,τt (i, l) (see constraints 3.20 and
3.21), Eq. 3.31 can be rewritten as:
E[(βk,τt )2] =
∞∑
l=0
[
2l ·
∑
i∈I
yk,τt (i, l) ·Ψ(i)
]
(3.32)
Next, we can also compute the mean of our carryover demand random variable as a linear
combination of the CDF (see Eq. 3.27 for the standard way of computing the mean):
E[βk,τt ] =
∞∑
l=0
P
(
βk,τt > l
)
=
∞∑
l=0
∑
i∈I
yk,τt (i, l) ·Ψ(i) (3.33)
The variance of B˜k,τt , of our overflow random variables can now be expressed as:
B˜k,τt =
∞∑
l=0
[
2l ·
∑
i∈I
yk,τt (i, l) ·Ψ(i)
]
−
[ ∞∑
l=0
∑
i∈I
yk,τt (i, l) ·Ψ(i)
]2
(3.34)
=
∞∑
l=0
[
2l ·
∑
i∈I
yk,τt (i, l) ·Ψ(i)
]
−
∑
(l1,l2)∈(Z+)2
∑
(i1,i2)∈I2
yk,τt (i1, l1) · yk,τt (i2, l2) ·Ψ(i1) ·Ψ(i2)
(3.35)
Finally, replacing the binary products yk,τt (i1, l1)·yk,τt (i2, l2) by a binary variable zk,τt (i1, i2, l1, l2)
satisfying Eqs. 3.28-3.30, we have expressed the variance of the carryover random variable
linearly in our decision variables (see Eqs. 3.23-3.26).
We have shown the ability to derive the mean B
k,τ
t+1 and variance B˜
k,τ
t+1 of the carryover
random variables on day t + 1 linearly in Θ. By induction, the DIP mean and variance
will be linear in the template Θ for any t ≥ 0. This result holds for any day t ∈ T in our
equilibrium planning horizon.
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Discussion: Although, we were able to calculate the variance B
k,τ
t+1 of our carryover
random variables linearly in our decision variables Θ, tractability issues arise when solving
this model with commercial solvers such as CPLEX. This is mostly due to the number of
binary variables zk,τt (i1, i2, l1, l2) that need to be optimized. For example, considering only
10 grid points (which is already a small sample size of possible DIP realizations), and the
possibility to have at maximum 500 patients carryover (which in practice, could go up to the
1,000) would lead to 102 × 5002 = 30, 000, 000 binary variables each each patient specialty
k, urgency level τ , and day of the week t.
Therefore, we rely on an approximation of the variance in order to make our problem
tractable. To approximate the variance of carryover and admitted/fulfilled demand, we
condition on each realization DIP k,τt (i) of our DIP random variable at grid level i and
divide the total DIP variance proportionally between the carryover and admissions. By
using our binary variable yk,τt (i, 0) that equals 1 if-f DIP
k,τ
t (i) ≥ Θk,τt , and defining A˜k,τt
as the variance of the number of type (k, τ) patients scheduled on day t, we can linearly
approximate our variances in a tractable way as follows:
B˜k,τt u
∑
i∈I
yk,τt (i, 0) ·Ψ(i) (3.36)
A˜k,τt u
∑
i∈I
(1− yk,τt (i, 0)) ·Ψ(i) (3.37)
We now leverage the dynamics developed in this section to measure the critical metrics
discussed in the introduction and previous sections, particularly (i) the access delay from
initial appointment request to the earliest time that appointment can be feasibly sched-
uled, (ii) the offered resource workload/utilization, and (iii) the downstream demand block-
ing/overtime.
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3.7.2 Access delay formulation
In this subsection, we linearly approximate Gk,τt,n with respect to our decision variables,
Θ. Recall that:
Gk,τt,n = E

(
Dk,τt − δk,τt,n
)+
Dk,τt

First observe that the numerator of inside this expression can be expressed as the positive
difference of two random variables: (i) the exogenous demand on day t, Dk,τt and (ii) the
number of remaining slots left in our template up to day t + TFAV k,τn after all demand
prior to day t has been scheduled, δk,τt,n . We can then divide this positive difference by
random variable (i) to get a ratio. Because the exogenous demand is independent of past
demand/decisions, these two random variables are independent. Hence, we are dealing with
two streams of random variables, that are independent. We can use our grid approximation
just as before, while making sure we capture the convolution of the two random variables.
We condition δk,τt,n on the event that the total demand is DIP
k,τ
t	1(i) on day t− 1 (see Eq.
3.17), then we get:
δk,τt,n (i) =
TFAV k,τn∑
l=0
Θk,τt⊕l
− βk,τt (i)
+ ,∀i ∈ I,∀n ∈ N , (3.38)
and define γk,τt,n (i, j) as the percentage of type τ patients requesting an appointment in service
k on day t that exceed TFAV k,τn days of waiting for their appointment given that (a) there
are j type τ requests in service k on day t, and (b) there are δk,τt (i) remaining type τ slots
in the template for service k after all demand prior to day t has been scheduled. γk,τt,n (i, j)
can be expressed as follows:
γk,τt,n (i, j) =
(
j − δk,τt,n (i)
)+
j
· 100%,∀i ∈ I,∀j ∈ J ,∀n ∈ N (3.39)
=
(
1− δ
k,τ
t,n (i)
j
)+
· 100%,∀i ∈ I,∀j ∈ J ,∀n ∈ N (3.40)
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where the set J ⊂ N represents the sample space of all the Dk,τt random variables (excluding
the outcome equal to 0) but with |J | < ∞: |J | will be chosen such that P(Dk,τt = |J |) < κ
where κ is very close to 0.
In order to have linear constraints, we need to alter equations 3.38 and 3.40. In the
optimization, there is an incentive to keep γk,τt,n (i, j) small to meet the access delay constraints
(or because we are minimizing it in our objective). This allows us to replace Eq. 3.40 by
constraints 3.41.
γk,τt,n (i, j) ≥
(
1− δ
k,τ
t,n (i)
j
)
· 100%, γk,τt,n (i, j) ≥ 0,∀i ∈ I,∀j ∈ I,∀n ∈ N (3.41)
The same cannot be said for Eq. 3.38, since the optimization has the incentive to increase
δk,τt,n (i) in order to get a smaller γ
k,τ
t,n (i, j) that will meet the access delay constraints. There-
fore, we introduce a binary variable xk,τt,n (i) that equals 1 when
(∑TFAV k,τn
l=0 Θ
k,τ
t⊕l
)
−βk,τt (i) ≥ 0
and equals 0 otherwise. The following constraints will assure xk,τt,n (i) will take the correct
values:
−M · (1− xk,τt,n (i)) ≤
TFAV k,τn∑
l=0
Θk,τt⊕l
− βk,τt (i),∀i ∈ I,∀n ∈ N (3.42)
M · xk,τt,n (i) ≥
TFAV k,τn∑
l=0
Θk,τt⊕l
− βk,τt (i),∀i ∈ I,∀n ∈ N (3.43)
With the help of those binary variables, we can now have a set of linear inequalities equivalent
to Eq. 3.38:
δk,τt,n (i) ≥
TFAV k,τn∑
l=0
Θk,τt⊕l
− βk,τt (i),∀i ∈ I, ∀n ∈ N (3.44)
δk,τt,n (i) ≤
TFAV k,τn∑
l=0
Θk,τt⊕l
− βk,τt (i) +M · (1− xk,τt,n (i)),∀i ∈ I, ∀n ∈ N (3.45)
δk,τt,n (i) ≤M · xk,τt,n (i),∀i ∈ I,∀n ∈ N (3.46)
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We can then employ our grid approximation, but this time capturing the joint distribution
between Dk,τt and δ
k,τ
t,n (which is simplified by their independence). Because the approxima-
tion still takes the form of Riemann integration, as above, the result will converge to Gk,τt,n in
the limit:
Gk,τt,n =
∑
i∈I
∑
j∈J
γk,τt,n (i, j) ·Ψk,τt (i) · F k,τt (j),∀n ∈ N (3.47)
where F k,τt (j) is the probability that there are j exogenous type τ requests for service k on
day t, based on historical data.
3.7.3 Workload excess and overtime
From Eqs. 3.4, 3.7, and 3.27, the linear expression (subject to Θ) of the mean number of
type τ patients scheduled for a first visit in service k, A¯k,τt , follows immediately in Eq. 3.48.
A¯k,τt = DIP
k,τ
t − B¯k,τt⊕1 = Dk,τt + B¯k,τt − B¯k,τt⊕1 (3.48)
This linear formulation of the daily mean number of patients scheduled can now be replaced
in Theorems III.1 and III.2, and our expression of the mean workload (Theorem III.1) is now
shown to be linear in our decision variables. Similarly, the linear expression of A˜k,τt (see Eq.
3.37) now incorporated into Theorem III.2 shows that the variance on the daily workload
can be expressed linearly in our decision variables Θ as well.
Next we use the offered load, W kt , to approximate the number of patient hours that
will have to be performed in overtime due to insufficient capacity at specialty k on day t.
To calculate the offered workload random variable, we propose to adapt the discrete grid
approximation from Section 3.6.3 to estimate the workload distribution at each specialty in
the network under template Θ. We approximate the distribution of the offered workload W kt
by a Normal distribution with means and variances expressed in Theorems III.1 and III.2.
This approximation has been commonly used in healthcare settings to describe workloads and
census distributions in a wards of a hospital. Based on the Normal distribution properties,
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the probability that our random variables will have realizations within one standard deviation
above the workload mean (i.e., in the interval [W
k
t ,W
k
t +
√
W˜ kt ) is 34.1 %. For the previously
defined grid m(i), the probability of being in the interval [W
k
t ,W
k
t +m(i) ·
√
W˜ kt ] is known
from the standard normal CDF as Φ (m(i+ 1))− Φ (m(i)).
Using this approximation, we are able to capture okt (i), the number of downstream work-
load hours that are overflowed (e.g. processed in overtime) at a given grid point i on day t
at service k:
okt (i) =
(
W
k
t +m(i) ·
√
W˜ kt − Ckt
)+
(3.49)
=
(
W
k
t +
1
2
m(i) ·
(
W˜ kt
Wˆ kt
+ Wˆ kt
)
− Ckt
)+
, (3.50)
where Ckt is the total capacity of specialty k on day t, and Wˆ
k
t is the standard deviation
historical estimate of the total workload on day t in specialty k. Eq. 3.50 follows from the
one step Newton approximation detailed in Section 3.6.3.
Moreover, as I →∞ and m(i+ 1)−m(i)→ 0,∀i ∈ I, Okt defined as:
O
k
t =
∑
i∈I
okt (i)
(
Φ (m(i+ 1))− Φ (m(i))
)
(3.51)
will converge the expected overflow/overtime hours of the offered workload. Note that we
can also limit the violation probability of exceeding service k’s capacity on a given day by
amount qkt . First, we select the smallest i
∗ ∈ I such that 1−Φ(m(i∗+ 1)) ≤ qkt , then we can
constrain the workload level at this grid point i∗ to be less or equal than capacity:
W
k
t +
1
2
m(i∗) ·
(
W˜ kt
Wˆ kt
+ Wˆ kt
)
≤ Ckt . (3.52)
3.8 Numerical case study
The following case study illustrates the decision support that our methodology can pro-
vide. By optimizing the template, our model provides a managerially focused perspective of
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the operations and can support “what if” analysis. It can also be used to help implement
tactical level changes in scheduling, but that is not the intended focus of this paper. The
template process must be validated and show improvements over current scheduling policies.
In this section, we go through a possible exchange between our team and the care provider
in the implementation process. This tool and our template recommendations need to be
tuned to the managerial staff’s specific needs while also providing a wide range of information
that will help them in their own decision process of which template to use. In Section 3.8.1,
we use the information provided by the managerial staff to recommend one specific template.
3.8.1 Generating a template to fit specific needs
First, we consider the case where the managerial staff knows exactly what performance
level they wish to achieve, but are lacking the engineering tools to build such a template
that would assure that all their constraints are met. To provide them with the template that
would satisfy those constraints, our first step will be to ask them which objectives they want
to optimize and which constraints they want to satisfy. Consider the following scenario:
• We wish to minimize the mean access delay for our urgent cases, but it is important
that:
• The mean access delay for less urgent cases does not exceed 5 weeks, and
• Patient downstream visits in their itinerary are not performed in overtime too often:
– The offered workload generated from the template does not exceed capacity more
than with 10% probability, and
– The expected number of downstream visits performed in overtime are less than 5
per day across the medical specialty
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In addition to the above inputs, a second input to this model is the historical data
that will calibrate the parameters of the Mixed Integer Program. This includes: (1) the
cumulative distribution function of the various demand streams (for each patient class), (2)
the downstream demand distribution that will characterize patient flow (see Section 3.5.1),
(3) the total daily capacity for each medical specialty.
Figure 3.8: (Left) Optimal template for the two urgency classes considered and the down-
stream appointments of those patients’ itinerary, and (Left) violation probability
on access delay for the two urgency levels
With all the above inputs, we can run our model to determine a template that will
satisfy the targets of the medical specialty. Note that in this case study, we only consider
one department for a proof of concept. The results are provided in Fig. 3.8. After providing
this template, one natural question that will arise from the managerial staff’s side is: how
accurate is your template?
3.8.2 How accurate is your template?
Before actual implementation of a template, every health care institution will require
some analysis on how well this methodology predicts the critical metrics they are trying
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to optimize and/or control. Does the template really generate such performance if it was
implemented in practice? Rather than the option of implementing the template first and
monitoring the performance metrics to see if our forecasts match reality as it unfolds, it is
more common to first use simulation in order to reassure care providers that the methodology
is accurate enough that it deserves a pilot.
In Section 3.6.1, we detailed how we modeled the simulation used here for validation.
The goal was to capture most of the elements in the scheduling process to ensure that the
simulation would be a good representation of reality. After inputing the optimized template
from Section 3.8.1, we use the simulation to compute the performance of the metrics that
are critical to the institution.
Figure 3.9: Analytical model and simulation comparison for the access delay of (Left) Urgent
cases, and (Right) Non-urgent cases
n (in weeks) 1 2 3 4 5 6
Urgent Access Delay APE (%) 2.58 1.91 1.01 2.18 3.98 1.95
Non-Urgent Access Delay APE (%) 3.90 4.84 5.47 5.39 5.67 4.16
Table 3.5: Absolute Percentage error of the expected percentage of urgent and non-urgent
patients exceeding n weeks of access delay
In Fig. 3.9 we show the differences in the access delay metric between our analytical
estimations and the simulation. The absolute percentage errors of our estimations are also
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summarized in Table 3.5. We can see a slight raise in our APEs around 4 and 5 weeks access
delay (around the mode of the access delay distribution) since most of the density lies around
those points, and this results in increased errors if our density approximations are slightly
off.
Similarly, Fig. 3.10 and Table 3.6 show the validation results for the mean and standard
deviation of our workloads. Our estimations for mean and standard deviation of the work-
loads is very accurate mostly due to the predictability of those metrics. Based on historical
data, patients tend to wait more than a day for an appointment, therefore resulting in a high
probability of our variable αk,τt , the daily number of patients scheduled for each type, being
equal to our template Θk,τt . This also results in a low and predictable variance around α
k,τ
t .
Our mean estimation of the workload is almost exact due to the predictability of patients
filling up the slots we reserved for them. Our estimations of the workload standard deviation
have more errors around them largely due to the approximation we had to make on variance
to make our problem tractable.
Day of Week Mo Tu We Th Fr
Mean Workload APE (%) 0.29 0.28 0.04 0.15 0.36
Workload St.Dev. APE (%) 3.13 2.4 4.01 3.57 1.49
Table 3.6: Absolute Percentage error of the expected percentage of urgent and non-urgent
patients exceeding n weeks of access delay
If the health institution is satisfied with the accuracy of our forecasting approximations,
the next question that might come up is: how would our template change if we were to
vary the targets we imposed on our metrics? Can we investigate the tradeoffs between our
metrics?
3.8.3 Can we investigate various control scenarios and their impact?
Effective sensitivity analysis is a critical part of meeting the advisory and managerial
decision support goals. Based on our interactions with physicians and the managerial staff,
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Figure 3.10: Analytical model and simulation comparison for the access delay of (Left) Ur-
gent cases, and (Right) Non-urgent cases
it seems that this sensitivity analysis feature is the most important component of this new
methodology. Rather than being blindly referred to one template, a health institution would
rather analyze many different template scenarios and see their impact on the metrics. This
allows their experience, and general knowledge of their department to be a valuable input to
our tradeoff analysis component, and give them the control and information needed to make
the “best” decision.
To give a very detailed example, we can identify how increasing the volume of new
patients in internal medicine impacts physicians in neurology due to the cross-flow between
them. It can deal with the sensitivity of how many more clinicians are needed to increase our
throughput for breast cancer patients by some percentage. In particular, what-if questions
for capacity management will, for the first time, be able to be addressed. For example: How
many urgent cases can be accommodated in a week? What will the downstream impacts be?
116
First, we will show how we can achieve a higher level of control on patient access if
needed. Then, we will give an example on the impact of varying constraints on one metric,
and how it affects other metrics and the template.
Imposing constraints on the access distribution
After seeing the results of the first template we provided to the medical specialty (see
Fig. 3.8), they realize that even though their initial constraints were met (for the mean
access of the two patient urgency levels), it is unacceptable that more than 10% of their
urgent patients have to wait longer than three weeks to get a root appointment. But the
managerial staff realizes that achieving this new goal will negatively impact the non-urgent
access levels. Hence, they would like to add another constraint assuring that no more than
20% of their non-urgent cases will have to wait longer than 5 weeks.
Figure 3.11: Impact on the access delay violation probability curves when two constraints
(horizon lines in the left part of the figure) are imposed on the system. (Left)
Access delay curves under the constraints defined in Section 3.8.1, and (Right)
Access delay curves when we wish that (i) no more than 10% of the urgent
patients wait longer than three weeks to get a root appointment, (ii) no more
than 20% of the non-urgent patients wait longer than five weeks to get a root
appointment
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In Fig. 3.11, we investigate the impact on the access delay distribution of those two
urgency levels when those additional constraints are imposed on the system: in the left
part of the graph, we can see (1) the constraint that assures that no more than 10% of the
urgent cases will exceed three weeks access delay for a root appointment, represented by
the horizontal solid line, and (2) the constraint that assures that no more than 20% the
non-urgent cases will exceed three weeks access delay for a root appointment, represented
by the horizon dashed line. After running our optimization, the results are represented in
the right part of Fig. 3.11. We first see how the access delay curve drops for the urgent
cases that wait less than three weeks in order to meet those new targets. This significantly
increases the number of non urgent cases that will wait longer than three weeks for a root
appointment (from 40% to 54%). But we see a noticeable drop in the non-urgent access
delay curve after three weeks: this is because our constraint on urgent access has been met,
and the second constraint on non-urgent access delay starts to kick in.
This allows the health institution to have more control over their access delay metrics,
and influence the shape of those violation probability access curves.
Varying targets for our constrained metrics
Another scenario is to investigate the impact on mean access for urgent cases when the
constraint on the mean access for less urgent cases varies. The health institution may want
to see the tradeoffs between those two metrics, and how it affects the template, in order to
make the best control decision for their patients. As we discussed, the access delay metrics
across various urgency patient types are competing metrics, and increasing the access for
urgent patients will have negative impact on non-urgent access delays. In Fig. 3.12, we
show how the optimized template changes when the constraint on mean access delay for
non-urgent patients is increased from 5 weeks to 6 weeks.
The first thing to notice is that we see a slight overall decrease in slot reservations for
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Figure 3.12: (Left) Optimized template under the constraints defined in Section 3.8.1, and
(Right) Optimized template when the mean access delay constraint on non-
urgent patients is increased to 6 weeks
less-urgent patients since we are have more flexibility of when to schedule them. Reducing
the number of slots reserved for them will of course affect their access delay metric, and this is
why we are still constraining the mean to be less than 6 weeks. Since the objective of our MIP
is to maximize the mean access for urgent patients, we also see an increase in slot reservations
for urgent cases. By reserving more slots for them, we will be able to achieve higher access.
However, notice that we are also reserving more capacity for downstream appointments. This
is largely due to the fact that urgent patients tend to use up more downstream resources
than non-urgent cases (due to their condition and/or case complexity). We can see that the
increase in capacity reservation for urgent cases (and the reduction of capacity reservation for
non-urgent) towards the beginning of the week results in the need to reserve more capacity
for downstream appointments towards the middle and end of the week. Note that we are
using the same total capacity in this medical specialty under those two cases. Although the
graph shows an increase in slot reservations (on the right side), this is largely due to the fact
that downstream appointment slots tend to be much shorter than root appointments (for
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urgent and non-urgent patients).
This analysis is very useful for a health institution since intuition and experience are
unable to understand the correlation between the number of urgent, non-urgent, and down-
stream reservations needed to satisfy a set of constraints on our metrics.
We can also investigate the impact on the access delay for urgent cases when the con-
straint on the probability of exceeding capacity varies or the constraint on overtime is
changed. We omit those results here, but the same procedure could be applied.
Therefore, by being able to test different scenarios, and vary the constraints they impose
on the system, the sensitivity analysis feature of this methodology could provide valuable
information that could be used to make the right template decision in order to achieve the
institution’s needs.
3.9 Conclusions
Today’s appointment based services such as healthcare have very limited research sup-
porting effective control of waits for an appointment. In contrast to common-sense ap-
proaches to capacity plans for how departments or individual clinicians create a template
plan for allocating their mix of services/procedure types by day of week, our research takes
a fundamental operations-based approach. We model service itineraries and control access
delays even with multi-visit itineraries of service. These problems naturally appear to be
complex queueing network admission control and scheduling problems, but we model and
optimize them using mixed integer programing, which solves relatively larger problems, uti-
lize commercial solvers, and offer modeling capabilities that are useful for these problems.
It will greatly increase the ability to manage complex tradeoffs involving (1) operational
efficiency and cost metrics, and (2) offer integrated outpatient care with increased value.
We emphasize the (2a) control of access delay times (the key being reduced access delays
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for urgent patients while accepting that some patient types may wait longer) and (2b) more
rapidly executed care itineraries/pathways that complete the episode of care sooner. These
objectives are not new to leading organizations; however, effective methods to accomplish
them are in their infancy. This research and those methodologies will be a useful step toward
gaining better managerial control over outpatient healthcare delivery and making it more
effective at limiting the amount of access delay for various types of services or patients.
CHAPTER IV
Patient flow modeling and control for differentiated
itinerary of care lengths
4.1 Introduction
Fast diagnosis and an early start to treatment is a critical aspect of care delivery that can
impact the fate of many patients. Due to the rapid progression of life threating diseases (e.g.,
many types of cancer), the longer it takes to establish the diagnosis and determine the appro-
priate treatment plan, the higher the probability this could have irreversible repercussions
on the patient’s health state (see [35]). Poor patient access significantly affects the main
stakeholders’ experience. “Patients are harmed in the process of delay, not only through
wasted time, but through unnecessary suffering, and through adverse medical outcomes.
Health care providers are harmed through the added cost and reduced efficiency resulting
from the complications of handling delayed patients” states [22]. Moreover, long waits for
care has been shown to have adverse effects on patient satisfaction (see [13]). Most health
care institutions are well aware of the need to improve patient access to their resources.
As [43] points out, “Delays and restricted access are properties of poorly designed, costly
systems. The same changes that reduce delays and increase access can also reduce costs.”
Health operations management has been shown to have the potential to significantly improve
patients and providers’ experience in health care systems while also reducing costs (e.g., see
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[55]). But this usually requires a system redesign that mitigates the issues/limitations of
common practices [48].
Within the scope of our research, the length of time it takes to get a diagnosis can be
broken up into two periods of time: (1) the time from a primary care physician referral to
a medical specialty root appointment, and (2) the length of time for a medical specialty to
provide a clear diagnosis for the patient. After the root appointment (item (1)) for cases
that are identified as “more urgent”, in Chapter III, we now focus on the length of time it
might take to establish a diagnosis (item 2).
In this chapter, we will forecast and control a metric that we call the “itinerary flow
time.” An itinerary refers to a set of diagnostic tests/visits and a follow-up visit the patient
has to go through before a diagnosis is established and a treatment plan is determined (if
needed). The time it takes from the conclusion of the patient’s initial specialty visit to a
diagnosis at the end of the follow-up appointment is the itinerary flow time. The itinerary can
vary significantly based on the medical specialty, the patient condition (e.g., urgency level),
and the information (or lack of information) we have on the patient. For example, a patient
seeking a diagnosis in the breast diagnostic clinic will likely require more tests/visits than a
patient in General Internal Medicine (GIM). Even within a medical specialty, a patient with a
medical record that hints that it could be urgent (e.g., family history) will likely need more
tests/visits than another. Moreover, patients with very little medical record information
(e.g., new patients to the institution) will tend to require more testing and information
building to get to a diagnosis.
The dependence of the itinerary flow time on the number of visits required by specific
patient characteristics (e.g., urgency, medical specialty, etc...) is something we cannot control
because this number of visits required is determined by medical need. Although we do
address/consider this dependence in our models, we are much more concerned about another
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factor that affects itinerary flow time: the resource capacity management of the health
institution’s services. We will use the term “access delay” to a specific service/visit to
capture the time it takes the patient to get an appointment in a downstream service. The
above operational outcomes are the result of the institution’s capacity management decisions.
Finally, we will also consider a metric that we call the “diagnostic flow time.” This
captures the time it takes for a patient to go through all the diagnostic tests/services required
in her itinerary, leaving out the amount of time it will take to get a follow-up visit with the
specialty physician to reveal a diagnosis and the next steps. A good estimate of this metric
can add significant value for the specialty physician and the patient. Currently, at the time of
the initial appointment, it is difficult for the specialty physician to determine when a follow-
up visit should occur, given that diagnostic test results need to be in hand prior to it. They
currently have to rely on experience and limited information. If the follow-up appointment
is scheduled to a time before the patient is able to go through all the diagnostic services
required then a reschedule needs to happen. This is undesirable for the specialty clinic
because its an inefficient use of their resources (which might result in under-utilization). If
the estimate for the follow-up visit is too early, this will result in further delay to reschedule
the follow-up (since in the meantime, other patients will have been scheduled to use those
same resources). But, being conservative and scheduling the follow-up visit too far into the
future will result in unnecessary delays for the patient to determine their diagnosis. Our
models will provide this valuable information which should improve service levels for the
patient, and help the institution make better/more efficient use of their resources.
By controlling these three critical access metrics (itinerary flow time, diagnostic flow time,
and access delay), our methodology is able to provide better service levels for the patients
by reducing their wait time to a diagnosis (and possibly, start of treatment). However, we
should note that we do not consider the following research question that might also have
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an impact on the level of service provided to patients: how can we limit the number of
patient trips to the hospital during an itinerary of care (e.g., coordinate resources such that
multiple diagnostic tests can be done on the same day)? Sometimes, it might be more
desirable to have a condensed itinerary of care (e.g., all downstream visits happen 11 days
from now) vs. visits that are spread out but lead to a shorter itinerary flow time (e.g.,
diagnostic visits happen on days 1, 4 and 7, and the follow-up visit on day 10). Considering
this additional layer of service level adds significant complexity to this problem, especially
since the preference between shorter itinerary flow times vs. condensed (few hospital visits)
itineraries will vary case by case. Another practical concern can be the desire to avoid
itineraries of care that extend over a weekend. Because many services shut down or reduce
their capacity on weekends, it can be desirable to have itineraries complete in the same week
in which they begin, an issue treated in [26].
In this research, we assume that getting to a follow-up visit (diagnosis) as soon as possible
is the most important metric. We do not provide methods to limit the probability of requiring
a weekend stay to complete the itinerary. The number of visits to the hospital, and the
interval between them is only a secondary issue to a patient: rapid diagnosis, which enables an
earlier start of treatment and better health outcomes is taken as paramount. To optimize the
other issues mentioned above, it is likely important to incorporate the explicit coordination
of visits between diagnostic services. Because our model is a planning model that provides
a decision input that could be used by real time schedulers, our methods do not prevent the
scheduler from taking such patient preferences in to account. Certainly, the scheduler may
defer an appointment until such as time as two or more visits can be provided on the same
day or even back to back during the day. The scheduler can delay the root appointment
to the next available Monday or Tuesday to increase the chances of itinerary completion
within a week. Note that our methods can control the access delay at each downstream
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service, which can serve as a proxy to limit how spread out the itinerary will actually be.
However, we acknowledge that in this research, we will limit our scope to the three metrics
defined in the previous paragraphs, and leave it to future research to analyze the complexities
involved in patients’ preferences of when each visit should happen in relation to others and
the undesirability of itineraries that cross one or more weekends.
In Section 4.2, we identify the scope of our research and describe the high level charac-
teristics of the system considered. Section 4.4 formulates the itinerary flow time, diagnostic
flow time, and access delay random variables when downstream resource capacity is not dif-
ferentiated by patient urgency levels. In other words, we consider the case (which is a close
representation of current practice) where the total capacity at each service is available to any
patient (as opposed to have reserved resource capacity for urgent cases). We then simulate
patient flows through their resource needs and provide motivation to provide “fast track”
access to urgent cases via optimization. In Section 4.5, we differentiate patient demand and
capacity by urgency level and optimize this capacity reservation scheme in a Mixed Integer
Program (MIP). We translate the nonlinear stochastic equations developed in Section 4.4
into a set of deterministic linear constraints subject to our decision variables. Finally, a
numerical case study is presented in Section 4.6 to show the benefits of our Mixed Integer
Program (Section 4.5) by comparing the results to those of the simulation in Section 4.4.
4.2 Problem description
The scope of this research is on a system optimization model for patients’ episodes of
care through the diagnostic process without regard to any particular disease. Our models
operate at the daily level and focus on a time period that starts when a patient is first referred
to a specialty service k ∈ K (e.g. Neurology, Medical Oncology, Internal Medicine, etc...)
and ends when a diagnosis is determined (during the a follow-up visit with the specialty
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physician in medical specialty k). An example of the patient flow structure considered here
can be seen in Fig. 4.1. Patients can either be referred internally to the specialty service
needed, or could be referred from another hospital that doesn’t have the necessary resources
and expertise to diagnose the patient. This referral visit to a specialty service k is what we
call a root appointment in a patient itinerary. The access delay from the referral request to
this root appointment has been studied in Chapter III. It is rare that diagnostic tests are
performed during this initial visit: the specialty physician usually meets the patient, reviews
the medical record, asks questions, and informs the patient about the next steps to be taken.
The physician will then refer the patient to a set of diagnostic services that will provide
more information on the patient’s condition. The set of all diagnostic services s in the
health care institution will be represented as S (e.g. blood draw, MRI, X-Ray, CT Scan,
etc...). Every visit/service required after the root appointment (i.e. diagnostic service or
follow-up specialty visit) will be referred to as downstream services/appointments and will
belong to the set S ∪ K. By using the model developed in Chapter III, we can estimate
the distribution of the number of patients requiring those downstream services (see the αk,τt
random variable for specialty k patients with urgency level τ on day t). The urgency level
τ belongs to a discrete set T (e.g. τ = 1 for urgent, τ = 2 for non-urgent). In principle, a
scalar τ is sufficient to include other dimensions of patient type such as new patients versus
established patients, or national vs. local patients. Since demand for diagnostic services
is generated after the patient’s specialty k root visit, it is defined by the random variable
αk,τt that represents the total number of specialty k, urgency level τ patients scheduled for
a root appointment on day t. It will be modeled using the empirical distribution defined
by our grid approximation of the set of outcomes {αk,τt (i) : i ∈ I} (see Chapter III). That
is, P(αk,τt = α
k,τ
t (i)) = Ψ
k,τ
t (i),∀i ∈ I. If the Chapter III model is not used, one could use
historical data on the number of root appointments scheduled in each specialty k to capture
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the downstream demand.
Figure 4.1: Visit precedence structure example in a patient’s itinerary
The set of diagnostic services required can be captured probabilistically using historical
data. Generally speaking, we can create sets Sk ⊆ S,∀k ∈ K that represent the list of
diagnostic services that specialty k patients have a nonzero probability of needing at some
point in their itinerary. Based on our historical data analysis to identify the patients’ resource
requirements through the network, it is clear that not all patients of specialty k will require
every diagnostic service in the set Sk. We incorporate in our diagnostic flowtime formulation
the fact that diagnostic services can be “skipped” with a given probability. This probability
is calculated based on historical data as the random variable κτ ,ks that follows a Bernoulli
r.v. with the probability of success determined by pτ ,ks (see an example in Table 4.1). This
128
random variable is assumed to be independent of everything else in our system, and also
does not depend on our decision variables since it is based on historical data.
Specialty k /Diagnostic Service s Blood Draw X-Ray CT Scan MRI ECG EEG
Neurology 0.29 0.62 0.26 0.39 0 0.88
Medical Oncology 0.44 0.71 0.24 0 0 0.19
Cardiology 0.66 0.33 0.72 0.32 0.96 0
General Internal Medicine 0.92 0.16 0.12 0.24 0.26 0.29
Table 4.1: Probability pτ ,ks that a specialty patient of urgency level τ requires this set of
diagnostic services during their itinerary
The diagnostic services required are assumed to be performed in parallel without any
precedence constraints (see Fig. 4.1). This assumes that all diagnostic testing appointments
are independent of each other, and can be performed in any sequence. The parallel visit
precedence structure for diagnostic services is considered a reasonable assumption by our
partnering hospital. In future work, it may be possible to extend the methods developed
here to more complex visit precedence structures for the diagnostic appointments portion of
a patient’s itinerary; however, we caution that the data requirements to create general visit
precedence structures may be quite challenging.
Discussion: Note that in practice, it is possible that a diagnostic test is canceled
dynamically after the results from another diagnostic service become available. Although
we only consider static resource requirement distributions (e.g., Table 4.1), we are able
to capture the probability that a test might not be needed after all, or “skipped” (based
on historical data). Our methodology does already capture some of these dynamics but
future research could be more precise by incorporating dynamic updating of the resource
requirement distributions based on the outcomes of diagnostic tests. This is beyond our
scope however, and this work considers only static resource requirements based on historical
data.
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Finally, once all the diagnostic services have been performed on the patient, a follow-
up appointment will be necessary with the specialty physician to reassess the situation,
determine a diagnosis and possibly start treatment. Note that the follow-up location is
always consistent with the patient’s medical specialty: a specialty k patient will always
have a follow-up visit in medical specialty k. The scope of this research does not consider
the treatment portion of a patient’s itinerary of care, because it is often performed by
a different set of resources (e.g., chemotherapy, radiotherapy, infusion, etc...). Here, we
assume the patient will be scheduled for her follow-up visit as soon as all required diagnostic
appointments have been performed.
It is important to note that those diagnostic services are usually not performed by physi-
cians, but rather by nurses, technicians, and physician assistants. Therefore the capacity C
s
t
of a diagnostic service s ∈ S is modeled as separate from the capacity at a given medical
specialty. We define C
k
t , k ∈ K as the total capacity available in specialty service k ∈ K on
day t. We assume that, as explained in Chapter III, the capacity has been set aside for the
root visits of all specialty patients and each urgency type: this is what we called our template
Θk,τt . Then, for the downstream follow-up visits of their itinerary, we only need to consider
the remaining capacity available at each specialty service k ∈ K: Ckt = Ckt −
∑
τ Θ
k,τ
t . As
mentioned above, this does not apply to the capacity of diagnostic services s ∈ S.
4.3 Literature Review
Most of the literature in outpatient scheduling focuses on a single clinic, and does not
consider the visit precedence in patient flows through their itinerary of care (see the survey
paper [7]). Most research uses queueing theory approaches (e.g., [16]) or simulation (e.g., [6]).
Queueing models are simpler to use, and have well known waiting time formulas. However,
queueing theory has its limitations when we need to capture complex patient flows through
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a network of resources, or when we consider a system at a discrete daily level (as opposed to
continuous time). In those cases, discrete event simulation is the most appropriate modeling
tool.
In recent years, the allocation of outpatient resources has emerged as one of the most
critical/challenging research topics in outpatient scheduling (see [56]). They state: “most
researchers consider cost and revenue as their goals. However, from the customer perspective,
patients’ waiting time is the most important issue to consider in an outpatient scheduling
system.” [16] analyzes the correlations between access delays, resource workload/utilization
and the number of servers in classic M/M/s queueing systems (with some extensions). They
study how the number of servers affects waiting times, and how much capacity should be
available to meet access targets (and consider flexible/time varying capacity by hour of day
to meet demand patterns). Similarly to most of the published literature, waiting time is
defined as the time from the arrival to the healthcare practice to the time of treatment
(measured in minutes/hours). We consider the time from a request to the occurrence of the
appointment, at the daily level.
To consider access delays at the daily level, we need to also consider the concept of
blocking in queueing networks (e.g., ICU blocking [40]) and resource bottleneck analysis (see
[37]). As opposed to the common idea of blocking (where demand is lost), we consider the
“overflow” (demand in queue that exceeds the daily capacity) as carryover to the next day.
This concept was used in outpatient practices, where patients required a number of service
tasks (with various visit precedence structures) that had to be completed by the end of a
work week for urgent cases (see [26]). They use phase type distributions to capture the
length of an itinerary while approximating the blocking probability at each resource/visit.
Our model considers: (1) access delays measured in days (as opposed to minutes/hours
within a day), (2) multi-class patient demand varying by day of week, (3) patients’ proba-
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bilistically flowing through a network of resources, (4) a specific visit precedence structure
including visits in parallel and in series, (5) resource/capacity reservation by patient class
varying by day of week, (6) itinerary flow times through the stochastic queueing network,
and (7) resource bottleneck analysis. See the more detailed literature review of Chapter III
for additional background.
4.4 Itinerary flow time forecasting to approximate common prac-
tice
In this section, we will express the itinerary flow time random variable Ξτ ,kt for a specialty
k ∈ K and urgency level τ ∈ T patient starting her itinerary on day t = 1, 2, .... Here,
we forecast the itinerary flow times assuming that the total capacity within a downstream
service s ∈ S∪K (i.e., diagnostic and specialty services) will be available to serve all patients,
regardless of the different urgency level τ . This means that all urgency levels are treated the
same, and requests for a diagnostic or specialty service will be processed in the order they
were received. This simple/intuitive policy is very close to common practice, and to analyze
its impact on itinerary flow times for various urgency level classes gives us the motivation
to provide “fast track” access to higher urgency patients by reserving a portion of the total
capacity exclusively for them at a given downstream service.
Based on the visit precedence structure described in the previous section, the itinerary
flow time can be expressed as:
Ξτ ,kt = χ
τ ,Sk
t + χ
τ ,k
t+1+χ
τ ,Sk
t
(4.1)
where χτ ,kt is the access delay of a patient in specialty service k ∈ K that requested an
appointment on day t and χ
τ ,Sk
t is the diagnostic flow time through the diagnostic services
in the set Sk of a type k patient having her root appointment on day t. Notice that the
itinerary flow time random variable of a specialty k, urgency level τ patient finishing her
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root appointment on day t will be the sum of (1) the diagnostic flow time of a specialty k,
urgency level τ patient that starts diagnostic testing on day t, and (2) the access delay to
specialty service k given this follow-up visit is requested on day t+ χ
τ ,Sk
t + 1 (i.e., after the
patient has go through all diagnostic services required). Here, we assume that a follow-up
visit to specialty service k has to happen at least one day after the patient finished the last
diagnostic service required. In practice, it is not common to have a follow-up visit with the
specialty physician on the same day of the last diagnostic service required, since most of
these services take some time to have the results processed and analyzed by the physician.
In the following subsections, we express the access delay and diagnostic flow time random
variables in order to get the itinerary flow time random variable.
4.4.1 Access delay random variable for a downstream service
In order to calculate the itinerary flow time of patients in this stochastic queueing net-
work, we first start by expressing the access delay that will occur at each diagnostic and
specialty service. Given that a patient requires a downstream service on day t, how many
days will she have to wait for an appointment? We extend the definition of the access delay
random variable χτ ,st to all services (diagnostic and follow-up specialty) with s ∈ S ∪ K.
The access delay in a downstream service s ∈ S ∪ K will be a function of the future
available capacity at the time of the request. For the policy considered in this section, a day
t request for a downstream service s will be scheduled on the first day in the future that has
enough available capacity. Hence, it is important to keep track of the current availability in
our schedule (for days t and later) by calculating the capacity remaining on each of those
days after all earlier patient requests have been scheduled. In our model, the capacity at each
downstream service can be measured in number of patients per day since appointments in
each service are the same predictable length (e.g., a blood draw will always be scheduled in
a 15 minute time slot, an MRI appointment will always be scheduled in a 45 min time slot).
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Hence, at the time of the request on day t, one can get a snapshot of the capacity available
on days t′ ≥ t by considering the number of patient requests that came on or prior to day
t and have been scheduled on or after day t. We call this random variable Lst , which can
be thought of our downstream demand in progress similar to the DIP in Chapter III. Since
all urgency levels τ are using the same capacity at service s and their appointment lengths
are the same, there is no need to differentiate Lst by urgency level τ . But this notation will
be updated to Lτ ,st in Section 4.5 when we allocate capacity at each downstream service s
based on the urgency level τ ∈ T . At the time of a patient request on day t, the amount of
the available capacity for downstream service s ∈ S ∪ K on day t′ ≥ t will then be:(
t′∑
m=0
Cst+m − Lst + 1
)+
(4.2)
Discussion: The above expression of Lst tries to capture the number of patient requests
that are “ahead” of a request that arrived on day t. But this variable only captures snapshots
at the daily level, which makes it unclear how many requests arrived earlier in the day than
the current request which we are forecasting the access delay. The random variable Lst
captures the number of patients “in queue” at service s at the beginning of day t after all
the day t demand has arrived. Hence, this model is conservative and places the patient
request considered as the last one of the day, which will have the longest access delay out of
all the day t arrivals. In practice, this seems like a reasonable way to forecast access delay
since the patient could be told a conservative estimate of how long she is likely to wait for
a service regardless of when the request is made at the hourly level on day t.
Now that we know the state of our available capacity for the following days, the access
delay random variable of the last request of day t follows directly by identifying the first day
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that has non-zero capacity.
χτ ,st = arg min
l≥0
{(
l∑
m=0
Cst+m − Lst + 1
)+
> 0
}
(4.3)
= arg min
l≥0
{
l∑
m=0
Cst+m ≥ Lst
}
(4.4)
Eq. 4.4 follows simply because Lst is an integer random variable. Note that the access
delay forecasting provided in this research can be used on its own to identify the main
bottlenecks in the system. With this information, each downstream service (diagnostic and
follow-up specialty) has the ability to make the proper capacity expansion adjustments to
mitigate the delays they are imposing on patient flow in the system as a whole.
Note that the access delay random variable for a given downstream service s ∈ S∪K does
not depend on the urgency level τ ∈ T in this policy since the capacity at each downstream
service is pooled to service all urgency levels in order of request. We still consider the
superscript τ here since this random variable will depend on the urgency level in the next
section. In subsection 4.4.4, we will express the random variable Lst , which we call the
downstream demand in progress, to fully characterize this access delay metric.
4.4.2 Diagnostic flow time random variable
We now focus on the diagnostic flowtime formulation χ
τ ,Sk
t , that captures for a specialty
k, urgency level τ patient, the time from the root appointment of an itinerary to the end
of the set of diagnostic services the patient has to perform. We incorporate the possibility
that a specialty k patient will require multiple diagnostic visits after her initial appointment
with the set Sk ⊂ S. Moreover, based on historical data, the need for a service s ∈ Sk
is not deterministic and depends on the urgency level τ of the patient (e.g., more urgent
patient usually require more diagnostic tests which leads to higher probabilities). We defined
κτ ,ks , s ∈ Sk as a Bernoulli random variable that equals 1 if and only if a specialty k, urgency
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level τ patient requires diagnostic service s in her care itinerary. Note that κτ ,ks = 0,∀s /∈ Sk
by definition of the set Sk. Hence, the diagnostic flow time for an urgency level τ and
specialty k patient finishing her root appointment on day t is expressed as:
χ
τ ,Sk
t = max
s∈Sk
κτ ,ks · χst (4.5)
= max
s∈Sk
{
κτ ,ks · arg min
l≥0
{
l∑
m=0
Cst+m ≥ Lst
}}
. (4.6)
In Equation 4.5, we characterize the diagnostic flow time as the maximum of the access
delays at each diagnostic service s that is required in the care itinerary of a type (τ , k)
patient on day t. We assume here that all diagnostic requests are made on the same day t
as the root appointment, which is common in practice since the specialty physician usually
internally refers the patient to diagnostic services at the end of this initial visit. Multiplying
the projected access delay at each diagnostic service s ∈ Sk by the Bernoulli random variable
(which is binary) assures that we do not consider the delays that might occur in diagnostic
services that are not required for this specific patient. Finally, 4.6 uses the access delay
formulation established in 4.4.
As mentioned earlier, proper forecasting of the diagnostic flow time is critical in practice.
By using the modeling tools developed here, the physician will then be able to schedule
a follow-up appointment with his/her patient using this diagnostic flow time forecast. In
current practice, the physician either (1) schedules the follow-up many weeks later with
extra lead time to make sure time is left for the patient to complete all required diagnostic
appointments, or (2) has to reschedule the follow-up appointment when the patient is delayed
longer than expected at some diagnostic services. Case (1) is not ideal for the patient,
especially for urgent ones. Typically, a patient will want to know the test results and get a
diagnosis as soon as possible without having to wait longer than needed for a follow-up visit.
Case (2) is very inefficient for the healthcare provider and usually wastes resources and time
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due to rescheduling mechanisms.
4.4.3 Itinerary flow time random variable
Although forecasting (and later, controlling) the access delay and diagnostic flow time
metrics can have practical value for a medical practice (as mentioned in the previous subsec-
tions), the main metric of concern is arguably the itinerary flow time. This metric of course
depends on the other two, but summarizes the true service level provided to a patient during
her entire itinerary of care.
Based on Eqs. 4.1, 4.4, and 4.6, we formulate the itinerary flow time random variable of
a specialty k ∈ Sk and urgency τ ∈ T patient starting her itinerary on day t:
Ξτ ,kt = χ
Sk
t +
∞∑
n=0
1{χSkt = n} · χkt+n+1 (4.7)
= max
s∈Sk
{
κτ ,ks · arg min
l≥0
{
l∑
m=0
Cst+m ≥ Lst
}}
+
∞∑
n=0
1
{
max
s∈Sk
{
κτ ,ks · arg min
l≥0
{ l∑
m=0
Cst+m ≥ Lst
}}
= n
}
· χkt+n+1 (4.8)
In Eq. 4.7, we first use Eq. 4.1. To avoid having a random variable in a subscript, we consider
every possible realization of the diagnostic flow time random variable χ
Sk
t = n,n ≥ 0. Based
on the actual realization of χ
Sk
t , we use the indicator variable to determine which day the
follow-up visit in specialty k will be, and use our access delay formulation. Eq. 4.8 follows
by replacing our expressions by Eqs. 4.4 and 4.6. We now have expressed the three random
variables we wish to forecast/control as a function of the demand in progress Lst on day t at
each downstream service s ∈ S ∪ K. We will characterize the demand in progress random
variables in the next subsection.
4.4.4 Demand in progress random variable at each downstream service
The demand in progress random variable Lst defined in subsection 4.4.1 captures the
main dynamics of our system. It identifies the number of requests in downstream service
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s ∈ S ∪ K that have arrived before or on day t but haven’t been processed prior to day t.
This quantity solely depends on the daily capacity at downstream service s and on the daily
demand random variable for that service. If we let Dτ ,st,k be the day t number of requests in
downstream service s ∈ S ∪ K for type (τ , k) patients, we can formulate Lst recursively as:
Lst+1 = (L
s
t − Cst )+ +
∑
k∈K
∑
τ∈T
Dτ ,st+1,k (4.9)
where we have the initial condition Ls0 = 0. In Eq. 4.9, the demand in progress on day t+ 1
is the sum of (1) the demand in progress from the previous day that could not be processed
on day t due to capacity restrictions Cst , and (2) the new requests (over all specialty patients
and all urgency levels) on day t+1 for a service k. (2) will depend on the number of patients
that either completed their root appointment on day t+ 1 which produces new requests for
diagnostic services s ∈ S, or that completed their set of required diagnostic services on day t
and will then request a follow-up appointment the next day in their specialty service s ∈ K.
First, let’s focus solely on this demand Dτ ,st,k in the diagnostic services s ∈ S. The type
(τ , k) demand random variable Dτ ,st,k in diagnostic service s ∈ S on day t can be expressed
as:
Dτ ,st,k =
ατ ,kt∑
j=1
1{s ∈ Sk} · κτ ,ks (4.10)
where ατ ,kt was defined in Section 4.2 as the number of urgency level τ patients scheduled
for their root appointment in specialty k on day t. Hence, each one of those patients will
require diagnostic service s based on our Bernoulli random variable κτ ,ks .
Now, to determine Dτ ,st,k , s ∈ K, the number of urgency level τ , specialty k new requests
on day t for a follow-up appointment in specialty service s (note that in this case s is always
equal to k), we will need to use the diagnostic flow time random variable (see Eq. 4.6) as
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follows:
Dτ ,st,k =
t−1∑
l=0
ατ ,kt−l−1∑
j=1
1
{
χ
τ ,Sk
t−l−1 = l
}
(4.11)
=
t−1∑
l=0
ατ ,kt−l−1∑
j=1
1
{
max
s∈Sk
{
κτ ,ks · arg min
l≥0
{ l∑
m=0
Cst+m ≥ Lst
}}
= l
}
(4.12)
In Eq. 4.11, we consider all the patients ατ ,kt−l−1 that started their itinerary on day t−l−1 and
had a diagnostic flow time of l days. Hence, each of these patients considered will generate
a follow-up demand for their specialty service k on day t. If we do this for every possible
diagnostic flow time l = 0, ..., t − 1 and link it to patients that started their itineraries on
t − l − 1, then we will have considered all the demand for a follow-up appointment on day
t. In Eq. 4.12, we simply use Eq. 4.6 to replace the diagnostic flow time random variable.
In this section, we formulated (1) the demand in progress random variable at each down-
stream service s ∈ S ∪K. This allowed us to determine (2) the access delay random variable
at each downstream service, which in turn helped us to express (3) the diagnostic flow time
random variable for each specialty k, urgency level τ patient class. Finally, (2) and (3)
determined (4) the itinerary flow time random variables for each specialty k, urgency level
τ patient class. All metrics were expressed as a function of the demand in progress random
variables Lst of (1), which we determined recursively as a function of the exogenous demand
in the system.
4.4.5 Forecasting current metrics via simulation
Now that we have defined our three metrics and expressed them as a function of the
basic demand random variables, we will focus on calculating the “historical” itinerary flow
time. By historical, we mean that no differentiated access based on the urgency level τ is
provided at each downstream service, and the capacity is available to be used by all urgency
levels for each downstream service (as we assumed in the previous subsections). This will
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allow us to quantify common practice system performance, identify service bottlenecks, and
the impact that this current policy has on itinerary flow times for urgent cases. Specifically,
we are interested in observing the differences in itinerary flow times across patient urgency
levels.
We constructed a simulation that reproduces patient demand for diagnostic testing, and
mimics patients’ flows through the diagnostic services and specialty follow-up visits accord-
ing to the distributions described in this section. This simulation is at the daily level of
granularity. The main inputs to our simulation will be (1) the daily demand distribution
for downstream appointments, which is equivalent to the distribution of the daily number
of patients scheduled for a root appointment in each specialty k ∈ K, (2) the total daily
capacity (in number of patients per day) at each diagnostic service s ∈ S, (3) the remaining
daily capacity (in number of patients per day) available for follow-up appointments at each
specialty service k ∈ K: the total capacity available at specialty service k minus the amount
allocated to root appointments (see Chapter III)), and (4) each specialty k, urgency level
τ patient diagnostic service requirement distribution (i.e., the sets Sk and the probabilities
pτ ,ks ).
With all this information, we can simulate probabilistic patient arrivals (i.e., the start of
diagnostic testing) for specialty k and urgency level τ , and determine upon arrival their prob-
abilistic diagnostic service needs according to their type (τ , k). The realization of patients’
specific resource needs will route them to the queue of their required diagnostic services
where a first come first served approach across all patient specialties and urgency levels will
be used. In other words, the simplifying approximation to our daily load model exploits
the unmodeled hours in each day by “cloning” the patients that require multiple diagnostic
services, and send each clone to one of these services. On every day t, and at each diag-
nostic service s ∈ S, the minimum of the demand in progress Lst and capacity Cst will be
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processed. For each patient, the simulation waits until every clone has been processed, and
then generates a request for a follow-up appointment in the specialty service k determined
by their type k (i.e. the specialty of their root appointment). Again, a first come first served
approach is used there, and finally, the patient leaves the system.
The outputs of the simulation in equilibrium will be the critical metrics discussed in
this section: (1) the itinerary flow time distribution and mean for each specialty k, urgency
level τ patient, (2) the diagnostic flow time distribution and mean for each specialty k,
urgency level τ patients, and (3) the access delay distribution and mean at each downstream
service s ∈ S ∪ K. We will also be interested in estimating the distributions, means, and
standard deviations of the daily demand in progress random variables for each urgency level
τ in the downstream services considered. This information will be used in Section 4.5.3
to feed iterations of our optimization model. Note that all our metrics are estimated in a
cyclo-stationary model at the weekly level in equilibrium.
We compute our desired metrics over an evaluation horizon that reached equilibrium (e.g.,
after a warm-up period of 500 days), and use a “batch means output analysis” method to get
the desired statistics. We also consider a number of independent replications (warm-up and
evaluation horizons) in order to get more accurate estimates of the metrics’ distributions.
We selected the number of replications, the number of batches, and their sizes in a way that
guarantees a 95% confidence interval on our sample metrics (means and variances) indicating
sufficient accuracy that we don’t need to put confidence intervals in our reports.
Based on preliminary analysis, we show the itinerary flow time distribution in Fig. 4.2
for a given patient specialty, and look at the distribution differences between non-urgent and
urgent cases. On the left side of Fig. 4.2 we represent the probability mass function of the
itinerary flow time: each point represents the probability (y-axis) that the patient’s itinerary
flow time will be a certain number of days (x-axis). On the right side of Fig. 4.2 we represent
141
the cumulative distribution function of the itinerary flow time: by taking any point on the
x-axis (which represents a given number of days), one could determine the probability that
the patient has already completed her itinerary by that time. Note that the diagnostic flow
time distributions can be computed similarly, and such graphs could provide the necessary
information for the specialty physician on the cumulative probability that the patient has
finished all required diagnostic services by a given day. Further, the access delay distribution
at each downstream service (diagnostic or specialty) could also be represented with similar
graphs to determine the bottlenecks in the current system, and understand what specific
services are the major drivers of itinerary flow times.
Figure 4.2: Quantification of FCFS scheduling via simulation to represent (Left) the proba-
bility mass function, and (Right) cumulative distribution function of the itinerary
flow time random variable differentiated by patient urgency level
Based on these initial results, we see that urgent cases are usually more complex and
require more services which affects their diagnostic and itinerary flow times significantly. By
being treated the same as less urgent cases, we see slots being used by patients who could
wait a few days longer without affecting their health, while urgent cases’ flow times increase
nonlinearly as a result.
This motivates the critical need to allocate capacity at each of the downstream services
(diagnostic or specialty for follow-up) based on the urgency level of the patient. Exercising
the control resulting from an efficient capacity management methodology will allow health
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care institutions to provide the shortest itinerary flow time possible for their urgent cases
given a certain service level for other less urgent cases (e.g., the probability that itineraries
of less urgent cases exceed two weeks has to be less than 10%).
4.5 Linearization for the control of itinerary flow time in a Mixed
Integer Program
Similar to the template optimization in Chapter III, we now want to divide/allocate each
service’s capacity between the different patient urgency levels to provide differentiated access
delays for diagnostic and specialty services. As we discussed in Section 4.4, the access delay
at each service is going to be a major driver of the diagnostic flow time and itinerary flow time
metrics. In this section, we will identify ways to capture the distributions of these random
variables (see Section 4.4), their means, linearize them subject to our decision variables, and
optimize them in a Mixed Integer Program.
4.5.1 Decision variables
Let the set {1, ...,T} be a finite planning horizon (e.g. one week). The health care
institution will reserve capacity for each patient urgency level at each of the downstream
services (diagnostic and specialty for follow-up) over this planning horizon. The dynamics
of our system will be analyzed over an equilibrium cyclo-stationary planning horizon of T
days. This is a very convenient approach for purposes of this paper. On the other hand, in
practice one could update the cyclo-stationary model periodically or one could even employ
a time-varying planning model and a rolling planning horizon. Since demand patterns and
capacity are usually similar from week to week, this model assumes T = 5 to represent one
week.
We define the downstream admission plan decision variables Ω := (Ωs,τt , s ∈ S ∪
K), τ ∈ T , t ∈ {1, 2, ...,T} as the number of patient slots in downstream s allocated specif-
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ically to the urgency level τ during diagnostic testing and follow-up appointments. We do
not reserve capacity in each diagnostic service s ∈ S based on the patient’s specialty k ∈ K
to keep a fair access to all diagnostic resources. Rather, the focus here is to provide “fast
track” access to downstream resources for the more urgent patients (rather than basing this
on specialty/condition). But each specialty will have different downstream resource require-
ments so it is important to model their care paths/resource needs individually for an accurate
representation of patient flows.
The total capacity at each diagnostic service s ∈ S will be optimally divided across
urgency levels to meet the constraints and optimize the objective set by the health institution.
Therefore, Cst =
∑
τ∈T Ω
s,τ
t , ∀s ∈ S. As explained earlier, we assume that capacity for
specialty services was already set aside for root appointments (in Chapter III). The remaining
capacity available for follow-up visits for specialty k ∈ K can also be divided across urgency
levels: Ckt =
∑
τ∈T Ω
k,τ
t .
4.5.2 High level description of the Mixed Integer Program
The goal of this methodology is to analyze tradeoffs between type τ patients based on
our scheduling template Ωs,τt for each one of the following metrics:
• (M1) The “violation” probability that the itinerary flow time exceeds l days for the
typical specialty k, urgency level τ patient that started her itinerary on day t.
• (M2) The mean itinerary flow time of a specialty k, urgency level τ patient given the
itinerary started on day t.
• (M3) The “violation” probability that the diagnostic flow time exceeds l days for the
typical specialty k urgency level τ patient that started her itinerary on day t.
• (M4) The mean diagnostic flow time of a specialty k, urgency level τ patient given the
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itinerary started on day t.
• (M5) The “violation” probability that the access delay exceeds l days in downstream
service s for an urgency level τ patient that started her itinerary on day t.
• (M6) The mean access delay in downstream service s for an urgency level τ patient
given the itinerary was started on day t.
Multi-objective optimization has been shown to be difficult to implement in practice.
For example, the weighted method could be used here, but determining the desired weights
while understanding the relationships between all metrics is difficult for a health institution.
Therefore, we will use one metric as an objective with constraints on the others. This
methodology has value for a health institution since it is flexible and can provide answers to
many “what if” scenarios based on various constraint and objective choices. For example,
we could minimize M1 for urgent patients with a constraint on M2, M4, and M6 for less
urgent cases. The main output from the optimization will be a weekly schedule Ωs,τt . If used
for a long period of time, this schedule will guarantee that the optimal objective is achieved
while satisfying the constraints on the other metrics.
Based on the previous section, we can formulate the itinerary flowtime distribution
differentiated by the urgency level τ as a function f τ ,kt of our capacity reservation plan
Ω := (Ωs,τt , s ∈ S ∪ K), τ ∈ T , t ∈ {1, 2, ...,T}:
The formulations in Section 4.4 of the random variables that determine metrics M1-M6
were non-linear with respect to the capacity Cst , hence are non-linear subject to our capacity
reservation plan Ω. We will show how to express M1-M6 linearly in our decision variables
Ω to incorporate those metrics in a deterministic Mixed Integer Program as an objective or
constraint. Moreover, we will need to translate these stochastic system dynamics into a set
deterministic constraints that can be incorporated in our MIP.
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4.5.3 Deterministic and linear approximation of demand in progress
Our ultimate goal is to translate all the non-linear (subject to Ω) stochastic equations
expressed in Section 4.4 into a set of deterministic linear constraints. As was discussed in
Section 4.4, the randomness in our metrics is exclusively due to the stochasticity of the daily
demand in progress variables Lst , s ∈ S ∪ K at each downstream service s. Note that in
our controlled system where capacity is specifically allocated to urgency levels, the demand
in progress now has to be defined as a function of the urgency level τT : we update our
notation to Lτ ,st , s ∈ S ∪ K, τ ∈ T . Hence, the first step is to transform the stochastic
demand in progress dynamics into deterministic and linear constraints while still capturing
this randomness in the system dynamics.
First, using the same concepts as Eq. 4.9, we formulate the stochastic demand in progress
recursive equations for each downstream service s ∈ S ∪K under a controlled system where
capacity is differentiated by urgency level τ :
Lτ ,st+1 = (L
τ ,s
t − Ωτ ,st )+ +
∑
k∈K
Dτ ,kt⊕1,s (4.13)
where the operator ⊕ is the modulo T operator to assure that all our variables will have their
subscripts in our cyclo-stationary planning horizon {1, ...,T} (e.g., if t = T then t⊕ 1 = 1).
Notice now that the capacity available to serve the urgency level τ demand in progress
Lτ ,st is limited to our decision variables Ω
τ ,s
t . To translate these recursive equations into
a deterministic set of constraints, an estimate of the demand in progress distribution is
necessary.
Capturing the distribution of the demand in progress random variable analytically can be
quite challenging, and is non-linear in our decision variables Ωτ ,st . Based on the simulation
analysis in Section 4.4.5, we can get a good estimation of the equilibrium distribution of the
demand in progress for each urgency level in an uncontrolled system where capacity is not
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allocated based on urgency levels τ . However, by optimizing a capacity reservation plan Ω
based on urgency levels, the type τ demand in progress distribution will not be the same
as in an uncontrolled system. Therefore, we will rely on a heuristic developed in Chapter
III that allows us to use information provided via simulation on the demand in progress
distribution and adjust/scale it to the new schedule controlled by Ω.
First, we construct a discrete grid m(i), i ∈ I taking values in (−∞,∞) similarly to Table
3.4. In the simulation, we extract the probability φτ ,st (i) that the demand in progress (having
mean µk,τt and standard deviation σ
k,τ
t ) for patient specialty k, urgency level τ on day t of
our planning horizon takes values between µk,τt +m(i) ·σk,τt and µk,τt +m(i+1) ·σk,τt . We will
assume that this uncontrolled demand in progress distribution can now be adjusted/scaled
to characterize the demand in progress controlled by our decision variable Ω. Specifically,
after calculating L
τ ,s
t , the demand in progress mean under schedule Ω, and L˜
τ ,s
t its variance
under schedule Ω, we can define Lτ ,st (i), the demand in progress at grid level i, as follows:
Lτ ,st (i) = L
τ ,s
t +m(i) ·
√
L˜τ ,st . (4.14)
Our assumption above implies that the random variable Lτ ,st under schedule Ω takes values
between Lτ ,st (i) and L
τ ,s
t (i + 1) with probability φ
τ ,s
t (i). We omit the linear formulations of
L
τ ,s
t and
√
L˜τ ,st subject to our decision variables Ω in this chapter since this was developed
and analyzed in Chapter III.
With this methodology, we can now capture the randomness in the demand in progress
variables as well as their distribution, by considering |I| realizations Lτ ,st (i) (based on the
discrete grid m(i)) and assigning a probability φτ ,st (i) to each one.
4.5.4 Access delay linearization
In this subsection, we focus on expressing the access delay distribution for a downstream
service s ∈ S ∪ K linearly in our decision variables Ω. The access delay distribution can be
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controlled in our MIP to assure that the probability of exceeding l days of delay for urgency
level τ patients at a service s will be lower than a set target (see metric M5). Although this
control is at the micro level (only one specific service in an itinerary), it could be a good
way to identify the service bottlenecks in the health system.
Moreover, this subsection’s main goal is to lay down some ground work that can then be
used in the following subsections to express the diagnostic and itinerary flow times linearly in
Ω. Since the access delays at the diagnostic and specialty services are the main drivers of flow
times in the system (see Section 4.4), we start by building our modeling formulations at this
micro level (diagnostic and specialty service) to leverage this foundation in the diagnostic
and itinerary flow time linear formulations.
The probability of having the access delay in service s ∈ S ∪ K exceeding l days for
urgency level τ patients requesting a (diagnostic or specialty) service on day t is calculated
as follows:
P (χτ ,st > l) = P
(
arg min
l′≥0
{
l′∑
m=0
Ωτ ,st⊕m ≥ Lτ ,st
}
> l
)
(4.15)
= P
(
Lτ ,st >
l∑
m=0
Ωτ ,st⊕m
)
(4.16)
=
∑
i∈I
P
(
Lτ ,st >
l∑
m=0
Ωτ ,st⊕m|Lτ ,st = Lτ ,st (i)
)
· P (Lτ ,st = Lτ ,st (i)) (4.17)
=
∑
i∈I
1
{
Lτ ,st (i) >
l∑
m=0
Ωτ ,st⊕m
}
· φτ ,st (i) (4.18)
=
∑
i∈I
xτ ,st,l (i) · φτ ,st (i) (4.19)
where xτ ,st,l (i) is a binary helper variable that satisfies the following linear equations in our
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decision variables Ω, for a large integer M :
M · xτ ,st,l (i) ≥ Lτ ,st (i)−
l∑
m=0
Ωτ ,st⊕m (4.20)
−M · (1− xτ ,st,l (i)) ≤ Lτ ,st (i)−
l∑
m=0
Ωτ ,st⊕m. (4.21)
In Eq. 4.15, we first use the definition of the access delay random variable provided in
Eq. 4.4. The probability that the access delay random variable is greater than l days is
equivalent to the probability that the type τ demand in progress at service s is greater than
the total capacity allocated for urgency level τ patients from days t to t+ l, as expressed in
Eq. 4.16. In Eq. 4.17, we condition this probability on the realizations of the type τ demand
in progress random variable which makes Lτ ,st deterministic. Therefore this probability is
now an indicator function equal to 1 if and only if the urgency level τ demand in progress
realization Lτ ,st (i) is greater than the total capacity allocated to urgency level τ patients from
day t to t + l (Eq. 4.18). Finally xτ ,st,l (i) can be interpreted as the conditional probability
of exceeding l days of access delay for an urgency level τ patient who requests service s on
day t given that the type τ demand in progress level is Lτ ,st (i) on day t. This conditional
probability is actually either equal to 0 or 1 since the access delay becomes deterministic.
Eq. 4.20 and Eq. 4.21 assure that xτ ,st,l (i) takes the appropriate binary value based on L
τ ,s
t (i).
The above equations allow us to express and control the access delay distribution in our MIP
since all constraints will be linear in our decision variables Ω.
Finally, we can also calculate the expected value for the access delay of an urgency level
τ patient requesting an appointment in service s ∈ S∪K on day t (see metric M6) as follows:
E [χτ ,st ] =
∞∑
l=0
P (χτ ,st > l) (4.22)
=
∞∑
l=0
∑
i∈I
xτ ,st,l (i) · φτ ,st (i) (4.23)
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where Eq. 4.22 follows from the definition of the expected value, and Eq. 4.23 replaces this
probability by Eq. 4.19.
4.5.5 Diagnostic flow time linearization
The diagnostic flow time distribution will be a function of the access delays at the di-
agnostic services s ∈ S. As can be seen in Eq. 4.5, we will have to take the maximum
of multiple access delay distributions at the required diagnostic services. This subsection
will focus on how to linearly compute this metric subject to our decision variables Ω while
keeping our problem tractable (such that common optimization solvers like CPLEX will be
able to solve our problem).
A specialty k, urgency level τ patient finishing her root appointment on day t of our
planning horizon will have to go through each element of the set Sk with a probability pτ ,ks
of requiring diagnostic service s ∈ Sk. Our methodology wants to capture the probability
that the diagnostic flow time will exceed l days, which will give us the diagnostic flow time
distribution. To do this, we would need binary variables that inform us under any given
scenario (realizations of our random variables) if the diagnostic flow time exceeds the level
l or not. This “excess probability” will depend on (1) the demand in progress realizations
Lτ ,st (is), is ∈ I at each diagnostic service s ∈ Sk that might be required for a specialty k
patient, (2) the combination of diagnostic services s ∈ Sk that are required for the specific
patient (i.e., the realizations of the κτ ,ks ∈ {0, 1},∀s ∈ Sk), and (3) the integer violation level
l = 1, 2, ..., l, where l is chosen such that the probability of the diagnostic flow time exceeding l
is close to 0. Hence, our model would need to consider T ·K·l·I |Sk|2 scenarios/binary variables
in order to get an estimate on the diagnostic flow time distribution of a specialty k, urgency
τ patient. In a mid-size health care institution, patients could have diagnostic flow times
that last up to a month (l = 30), since for example, MRIs have long waiting times. Being
very conservative, let’s say we only model 5 diagnostic services, two urgency levels and two
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specialty patient types. We need at least 10 grid levels i ∈ I for a reasonable representation
of the downstream demand in progress random variables Lτ ,st (i). Then, even with a very
small problem, we will require binary variables of size: 2× 2× 30× 15102 = 1.2× 1027. This
is obviously a too large number of binary variables for CPLEX to handle. Hence, we will
approximate the diagnostic flow time distribution in a tractable way.
We start by making the following assumption:
Assumption IV.1. The demand in progress random variables across all diagnostic services
s, {Lτ ,st : s ∈ S} are assumed to be mutually independent.
Discussion: This assumption is good under heavy traffic. In such settings, there will
be multi-day access delays to a root appointment in a medical specialty. Based on our
industry partners’ data and the results presented in Chapter III, the access delays for a root
appointment in a specialty k ∈ K are rarely one day or less, and tend to be on the order of
multiple weeks. This means that the demand in progress for a root appointment (see DIP τ ,kt
in Chapter III) will be large, which leads to a near 0 probability of having the template Θτ ,kt
(for root appointments) exceed the demand in progress level DIP τ ,kt . In other words, α
τ ,k
t ,
the number of specialty k, urgency level τ patients scheduled for a root appointment on
day t in our planning horizon will closely match the planned number of root appointment
admissions Θτ ,kt (with probability close to 1), therefore its variance will be close to 0. α
τ ,k
t
also is the demand for downstream appointments (since they are generated at the time of
the root appointment with the patient), and based on various practical/realistic scenarios
analyzed through simulation, the demand ατ ,kt does indeed have very low variance. Hence,
most of the variability in Lτ ,st comes from the number and location of the clones generated
for subsequence diagnostic visits (i.e., the variability around our Bernoulli random variable
κτ ,ks ). The random variables {κτ ,ks : s ∈ S} being mutually independent, and having ατ ,kt
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being close to deterministic allows us to make a good case for Assumption IV.1: {Lτ ,st : s ∈ S}
are mutually independent across all diagnostic services.
Based on this assumption, we now introduce Lemma IV.2, which allows us to capture the
diagnostic delay distribution linearly in our decision variables, Ω, for the simple case where
the number of diagnostic services in the health institution is limited to two. The proofs of
this lemma, and the following theorems and corollaries, can be found in 4.8.
Lemma IV.2. Under Assumption IV.1 and assuming Sk = {s1, s2}, the diagnostic flow
time distribution for an urgency level τ , specialty k patient in a system with two diagnostic
services is computed as:
P
(
χ
τ ,Sk
t > l
)
=
∑
i∈I
∑
j∈{0,1}
y
(2),τ ,k
t,l (i, j) · φτ ,s2t (i) · P
(
κτ ,ks2 = j
)
(4.24)
where y
(2),τ ,k
t,l (i, j) can be expressed as a set of linear constraints subject to our decision
variables Ω and is computed as follows:
y
(2),τ ,k
t,l (i, j) = max
{
pτ ,ks1 ·
∑
i′∈I
xτ ,s1t,l (i
′) · φτ ,s1t (i′), j · xτ ,s2t,l (i)
}
, (4.25)
and this distribution can be expressed as a set of linear constraints subject to our decision
variables Ω.
Now that we have shown how to calculate the diagnostic flow time distribution in the
simpler case where a health institution has only two possible diagnostic services, we generalize
our methodology to a set of diagnostic services Sk, k ∈ S that can be of any dimension for
each specialty k patient. We can leverage the ideas, methods, and equations of Lemma IV.2
to the general case without increasing the dimensionality of our problem.
Theorem IV.3. Under Assumption IV.1, the diagnostic flow time distribution for an ur-
gency level τ , specialty k patient starting the itinerary on day t (Metric M3) is computed
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as:
P
(
χ
τ ,Sk
t > l
)
=
∑
i∈I
∑
j∈{0,1}
y
(|Sk|),τ ,k
t,l (i, j) · φτ ,|Sk|t (i) · P
(
κτ ,k|Sk| = j
)
(4.26)
where y
(n),τ ,k
t,l (i, j) can be expressed as a set of linear constraints subject to our decision
variables Ω and is computed recursively as follows ∀n = 3, ..., |Sk|:
y
(n),τ ,k
t,l (i, j) = max
{∑
i′∈I
∑
j′∈{0,1}
y
(n−1),τ ,k
t,l (i
′, j′) ·φτ ,sn−1t (i′) ·P
(
κτ ,ksn−1 = j
′) , j ·xτ ,snt,l (i)}, (4.27)
with y
(2),τ ,k
t,l (i, j) satisfying Eq. 4.25 and where Sk = {s1, s2, ..., s|Sk|}.
From Theorem IV.3, we can formulate metric M4, the expected value for the diagnostic
flow time of an urgency level τ and specialty k patient given the itinerary started on day t
as follows:
E
[
χ
τ ,Sk
t
]
=
∞∑
l=0
P
(
χ
τ ,Sk
t > l
)
(4.28)
=
∞∑
l=0
∑
i∈I
∑
j∈{0,1}
y
(|Sk|),τ ,k
t,l (i, j) · φτ ,|Sk|t (i) · P
(
κτ ,k|Sk| = j
)
(4.29)
where Eq. 4.28 follows from the definition of the expected value, and Eq. 4.29 uses the result
from Theorem IV.3 (see Eq. 4.26).
4.5.6 Itinerary flow time linearization
Finally, we will now formulate the itinerary flow time distribution linearly in our decision
variables Ω. The methods developed in IV.5 will use results from Theorem IV.3, and the
definition provided in Eq. 4.19. The key difficulty here is to formulate linearly the access
delay for the follow-up visit in specialty service k given the realizations of the diagnostic flow
time of the patient, which affects when the patient starts waiting for a follow-up appointment.
We will start with the following assumption.
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Assumption IV.4. Given diagnostic testing ends on day t ⊕ l1, the access delay random
variable χτ ,kt⊕l1⊕1 for a follow-up visit in specialty k ∈ K is independent of the diagnostic flow
time random variable χ
τ ,Sk
t .
Discussion The access delay for a follow-up visit will depend on the day of week the
request for a follow-up will occur (see Eq. 4.1) since the request for a follow-up is made after
all diagnostic tests have been made. We will consider this dependence. However, Assumption
IV.4 claims that given we have this information, there will be very little correlation between
the diagnostic flow time of a patient that ends diagnostic testing on t⊕l1 and the access delay
from her request for a follow-up visit on day t ⊕ l1 ⊕ 1 to the occurrence of that follow-up.
The use of diagnostic resources is spread around a very large number of patient types in a
clinical setting. Hence, the wait for say, an MRI diagnostic test, is unlikely to affect the wait
for a follow-up visit in the GI department once all diagnostic tests are done. In practice,
your wait in diagnostic resources is mostly due to other patient specialties who need the
MRI, as opposed to patients of your same specialty.
Corollary IV.5. Under Assumptions IV.1 and IV.4, the itinerary flow time distribution
for an urgency level τ , specialty k patient starting the itinerary on day t (Metric M1) is
computed as:
P
(
Ξτ ,kt > l
)
= P
(
χ
τ ,Sk
t > l
)
+
l∑
l1=0
∑
i∈I
zτ ,kt,l1,l(i) · φτ ,kt⊕l1⊕1(i) (4.30)
where zτ ,kt,l1,l(i, j) can be expressed as a set of linear constraints subject to our decision variables
Ω and is computed as follows:
zτ ,kt,l1,l(i, j) = min
{∑
i′∈I
∑
j∈{0,1}
(
y
(|Sk|),τ ,k
t,l−1 (i
′, j)− y(|Sk|),τ ,kt,l (i′, j)
)
· φτ ,|Sk|t (i′) · P
(
κτ ,k|Sk| = j
)
,
xτ ,kt⊕l1⊕1,l−l1(i)
}
. (4.31)
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From Corollary IV.5, we can formulate metric M2, the expected value for the itinerary
flow time of an urgency level τ and specialty k patient given the itinerary started on day t
as follows:
E
[
Ξτ ,Skt
]
=
∞∑
l=0
P
(
Ξτ ,kt > l
)
(4.32)
=
∞∑
l=0
P
(
χ
τ ,Sk
t > l
)
+
l∑
l1=0
∑
i∈I
zτ ,kt,l1,l(i) · φτ ,kt⊕l1⊕1(i) (4.33)
= E
[
χ
τ ,Sk
t
]
+
∞∑
l=0
l∑
l1=0
∑
i∈I
zτ ,kt,l1,l(i) · φτ ,kt⊕l1⊕1(i) (4.34)
where Eq. 4.32 follows from the definition of the expected value, and Eq. 4.33 uses the result
from Theorem IV.5 (see Eq. 4.30). Finally, from Eq. 4.28, Eq. 4.34 follows.
4.6 Numerical case study
For validation and tradeoff analysis, we will calibrate/parameterize our model to a system
that is a good representation of common practices by using historical data. We focus on only
one medical specialty in our optimization for simplicity of exposition, but we still consider
the demand of other specialty patients (in aggregate) for diagnostic resources. We will not
optimize/control this aggregate demand and assume it will follow historical patterns. We
consider the downstream demand distribution that is generated from the scheduling of root
appointments (see the template methodology developed in Chapter III). The parameters of
this downstream demand are summarized later in this section in Table 4.2.
4.6.1 Tradeoff Analysis
Mean Itinerary flow time tradeoff analysis
First we will consider an optimization formulation that minimizes the mean itinerary
flow time of urgent patients with respect to some constraint on the mean itinerary flow time
of non-urgent cases. In Fig. 4.3, we first see that with a very tight constraint on the mean
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itinerary flow time for non-urgent cases (e.g., consider 3 days on the x axis), the access
delay for the follow-up visit, 7 days, is a big contribution to the large mean itinerary flow
time for urgent cases which is around 15 days. Clearly, the specialty follow-up service will
be the bottleneck resource. In this extreme scenario, most of the resource capacity at each
downstream service has to be allocated to the non-urgent cases, since the probability of
receiving service within a day at each downstream service has to be close to 1 (i.e., the non-
urgent demand in progress exceeds the capacity allocated to them with very low probability).
Urgent patients’ diagnostic flow time will of course be affected by this, but not as much as
their waiting time for the follow-up appointment. The reason is that urgent and non-urgent
patients always use the same specialty service for a follow-up appointment (with probability
1) but, during the diagnostic portion of the itinerary, the routing probabilities do not send
every patient to all diagnostic resources and, can send urgent cases to services not often
used by non-urgent cases, which mitigates the congestion seen at the specialty services. As
we move along the x axis of the graph, we see that the gap between diagnostic flow time
and itinerary flow time diminishes. When we allow poor access to non-urgent cases (e.g.,
mean itinerary flow times of 10 days), we see the gap between the diagnostic flow time
and itinerary flow time curves is very small, and most of patients’ delay will be during the
diagnostic testing portion of their itinerary since they usually require multiple visits in high
demand diagnostic services (since the condition might be serious).
Moreover, in Fig. 4.3, we compare the itinerary flow times of the FCFS policy to our
efficient frontier of solutions (when the constraint on mean itinerary flow time of non-urgent
patients varies), we realize that we can improve in both itinerary flow time metrics (for
urgent and non-urgent cases). The reason we are able to improve in both metrics is because
resource requirements between the two classes of patients are not the same. Note that more
value seems to be gained by allowing the mean itinerary flow time for non-urgent patients to
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Figure 4.3: Tradeoff Analysis: optimal mean itinerary flow time and mean diagnostic flow
time for urgent patients when varying the constraint on the non-urgent mean
itinerary flow time, and comparison with the itinerary flow times of the First
Come First Served (FCFS) policy (see Fig. 4.2)
be 6 days: this is only increasing it by 0.5 days on average from the FCFS policy, while the
mean itinerary flow time of urgent patients is being reduced by 28% (from 9.9 to 7.1 days).
Itinerary flow time distribution tradeoff analysis
Although we were able to provide the desired control on the mean itinerary flow times,
this may lead to some undesired behaviors in our system. For example, if we take a closer
look at the itinerary flow time distributions associated with the optimized solution (6, 7.1) in
Fig. 4.3, we may not get the patient prioritization behavior that we were hoping for. In Fig.
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4.4, we illustrate the itinerary flow time distributions (probability that patients complete
their itinerary within a certain number of days) of our “controlled-mean” policy that result
from optimizing a formulation that constrains only the means and not the tail probabilities
of the itinerary flow times (this lead to the (6, 7.1) solution in Fig. 4.3). What happens
here is that the optimization will choose to schedule “enough” non-urgent patients quickly
for short itinerary flow times (e.g., 2, 3, 4 days), and the rest of the non-urgent patient
population (speaking of the right tail of the itinerary flow time distribution) has relatively
large itinerary flow times (e.g., 15 or more days): specifically, close to 60% of non-urgent
cases have an itinerary flow time of 5 days or less, but only 9% will have an itinerary flow
time between 5 and 10 days. This increases the itinerary flow time variability, while still
meeting the constraints we imposed on the mean (here, 6 days). At the same time, we see
that most urgent cases obtain an itinerary flow time around the mean of 7.1 days: 66% of
urgent cases will have an itinerary flow time between 6 and 8 days. This behavior might be
undesirable if we wish to have more urgent patients with shorter itinerary flow times (e.g.,
a higher probability to complete an itinerary within 5 days), even if it means sacrificing a
portion of the urgent (or non-urgent) population. Note that the behavior observed here is
not guaranteed to happen in all cases, in fact, the exact opposite scenario (between urgent
and non-urgent patients) could occur as well. Ultimately, we have very little control on
our system if we consider only the mean of our metrics, i.e., the schedule generated by our
optimization is quite unpredictable. In Fig. 4.4, we also compare these itinerary flow time
distributions generated by the “controlled-mean” policy to the distributions rendered by the
FCFS policy.
Based on the results/insights provided in Fig. 4.4, we may want to improve on our
solutions by exercising a more specific control on our system. Most non-urgent patients
don’t necessarily need short itinerary flow times. Controlling the mean itinerary flow time
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Figure 4.4: “Controlled-mean” policy (which resulted to the solution (6, 7.1) in Fig. 4.3)
itinerary completion probability within n days, and comparison to the FCFS
policy benchmark (see Fig. 4.2)
of non-urgent cases, and minimizing the mean itinerary flow time for urgent cases might not
be the most efficient way to extract the desired performance of our system. To allow more
flexibility in our system so as to provide expedited service to a higher number of urgent cases,
and improve the overall performance, we can constrain our model in a way that non-urgent
itinerary flow times would be less than t days with x% probability while maximizing the
probability that urgent cases will complete their itinerary in t days or less. We will call such
optimization formulations “controlled-distribution” policies.
We now maximize the 5-day itinerary completion probability of urgent patients subject to
a given constraint on the 5-day itinerary completion probability of non-urgent cases. In Fig.
4.5 we study the tradeoffs between the probability of having an itinerary flow time of one
week (5 days) or less for our two patient classes. We provide an efficient frontier of solutions
159
Figure 4.5: Tradeoff Analysis: optimal 5-day itinerary completion probability for urgent pa-
tients when varying the constraint on the non-urgent 5-day itinerary completion
probability under the controlled-distribution policy, and comparison to the FCFS
(Fig. 4.2) and controlled-mean (Fig. 4.4) policies
by varying the constraint set on the probability that non-urgent patients complete their
itinerary within 5 days (see the solid curve). The two additional data points compare that
efficient frontier with 5-day itinerary completion probability under (1) the FCFS policy, and
(2) the controlled-mean policy optimized above. Recall from Fig. 4.3 that the controlled-
mean policy renders a 28% decrease in the urgent mean itinerary flow time compared to
the FCFS policy while keeping the mean of the non-urgent itinerary flow time nearly the
same. However, we can see that in terms of the metrics analyzed in Fig. 4.5 (i.e., probability
of completing an itinerary within 5 days), the controlled-mean policy seems to be more
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desirable than the previously optimized policy (2).
We can see that improvements can be made to our two policies in relation to this cho-
sen metric by using a controlled-distribution policy. If we were to implement solution A,
(50, 34.2) on the efficient frontier, this would lead to a 45% increase in the urgent 5-day
itinerary completion probability compared to the FCFS policy while seeing only a 3% de-
crease in non-urgent itinerary completion within 5 days. If we were to consider solution B,
(60, 22.6) on the efficient frontier, we would be able to achieve: (1) 13% improvement in
our metric for urgent patients, and 16.5% improvement for non-urgent patients compared
the FCFS policy, and (2) 33.7% improvement in our metric for urgent patients, and 2.5%
improvement for non-urgent patients in comparison the controlled mean policy. However,
all these improvements on the 5-day itinerary completion probability comes at a cost on
the mean itinerary flow times: solution A renders a mean itinerary flow time of (8.4, 7.8),
Solution B has a mean itinerary flow time of (10.6, 6.9), while the FCFS and controlled mean
policies achieved (7.1, 6).
As we mentioned in Section 4.5.2, this tradeoff and sensitivity analysis illustrates a key
contribution of our method to practice. Rather than providing one capacity reservation plan,
it will be useful to let the managerial staff experiment with different objectives and con-
straints. This approach can provide a rich portfolio of various policies that inform decision-
making and tailor the solutions to the application. Our new methodologies will share an
efficient frontier of optimal solutions with the health institution, and can provide insights
about the dynamics/interactions between all metrics considered.
4.6.2 Validation
In this section, we will validate our methodology. Having used some approximations on
the demand in progress distribution (see Section 4.5.3), and having made two independence
assumptions (Assumptions IV.1 and IV.4), it is important to analyze the absolute percentage
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errors of our analytical metrics’ estimates. After optimizing our system, which resulted in
a capacity reservation plan Ω, we will simulate this new controlled system. This simulation
will be similar to the one described in Section 4.4.5, but we will now consider different formu-
lations to yield various control policy solutions for capacity reservations at each downstream
service. We compare our analytical estimations of the optimized performance metrics to
the simulated ones, to get a sense of how accurate our approximations and how valid our
assumptions were.
Having validated the access delay metric for root appointments in Chapter III (see Section
in 3.8.2), and therefore the approximations made on the demand in progress distributions at
a given service (see Sections 3.6.4 and 4.5.4), we do not to validate these metrics again (i.e.
M5 and M6).
Diagnostic flow time
The diagnostic flow time metric’s errors will be caused by Assumption IV.1 (independence
of the demand in progress across diagnostic services). As we discussed in the paragraph
following this assumption, we consider a healthcare scenario where the capacity reserved for
root appointments has a high probability of being filled up completely. As long as we are in a
setting where the waiting time for a root appointment is in the order of multiple days/weeks,
then the approximation we make with this assumption should perform well. In Table 4.2, we
show the mean and variance of the number of patients scheduled for a root visit according to
a template optimized in Chapter III’s case study. The mean number of patients scheduled
for a root appointment on day t in our planning horizon, is also the number of patients
requiring diagnostic appointments requested on day t for subsequent fulfillment.
As can be seen in Table 4.2, the variance of the number of patients requiring down-
stream services will be close to 0, due to the multi-week access delay for a root appoint-
ment, and the fact that the total reserved capacity is used with high probability. Therefore,
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Day of Week Mo Tu We Th Fr
Mean Urgent Downstream Demand 15.89 18.52 12.80 9.95 7.99
Mean Non-Urgent Downstream Demand 9.90 11.39 8.57 6.78 3.99
Urgent Downstream Demand Variance 0.64 3.67 0.99 0.16 0.04
Non-Urgent Downstream Demand Variance 0.32 2.97 1.36 0.61 0.01
Table 4.2: Mean and Variance of the number of patients requiring downstream (diagnostic)
appointments based on the template developed for root visits in Chapter III
the variability of the demand for a specific diagnostic resource will mostly depend on the
Bernoulli/multinomial random variables κτ ,ks (i.e., relating to the routing probability for
downstream resources) and not on the flow of root visits. Since these random variables are
independent of each other, and everything else in the system, Assumption IV.1 does not
yield large errors in our metric estimations, as we can see in Fig. 4.6.
Figure 4.6: Validation of the accuracy of the n-day diagnostics completion probability esti-
mates for the controlled-probability policy solution B in Fig. 4.5
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Itinerary flow time
Finally, the validation of the itinerary flow time metric emphasizes the validity of As-
sumption IV.4 (independence of the demand in progress between diagnostic and follow-up
services). In Fig. 4.7, we validate our metric estimates computed in the tradeoff analysis of
Fig. 4.5 which led to an efficient frontier of solutions. We do not validate the entire itinerary
flow time distribution (similarly to what was done in Fig. 4.5 for the diagnostic flow time
distribution) but rather, validate across multiple formulations (i.e., different constraints on
non-urgent itinerary flow time) of our optimization program.
Figure 4.7: Validation of the accuracy of the 5-day itinerary completion probability estimates
under multiple controlled-probability policies generated in Fig. 4.5 when varying
the constraint on the 5-day itinerary completion probability for non-urgent cases
The larger errors (that go up to 9-10%) for the tightly constrained system (i.e., 5-day
itinerary completion probability of 60-70% for non-urgent patients) are partly due to the
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smaller values obtained for the 5-day itinerary completion probability of urgent patients in
those scenarios. But, having a tight constraint on our system also yields higher variability
in urgent itinerary flow times (since they will have longer and less predictable itinerary flow
times), which makes it more difficult for our model to accurately forecast tail probabilities.
4.7 Conclusion
Today’s appointment based services such as healthcare have very limited research sup-
porting effective control of waits for an appointment. This research generates fundamental
operations-based methodology to facilitate complex tradeoffs involving (1) cost-efficiency
and (2) differentiated levels of wait to serve urgent cases.
This research focused on patient flows through diagnostic and specialty resources/services
of a health institution. The motivation for this study was to provide differentiated access to
the resources based on the urgency level of the patient. Experiencing delays to a diagnosis,
and in many cases, to the start of treatment, can have drastic effects for some patients.
Allocating/reserving resource capacity between various urgency levels provides a control
that health care institutions can leverage to provide more efficient and effective service to
their patients.
We focused our analysis on three critical metrics to forecast and control: (i) the access
delay patients experience at each downstream service along their itinerary of care (diagnostic
testing and specialty follow-up services), (ii) the diagnostic flow time of patients which
captures the time from the root appointment to the end of diagnostic testing, and (iii)
the itinerary flow time of patients, which captures the total length of an itinerary of care.
Being able to estimate and control those metrics across various patient types can help heath
institutions manage their supply and demand in a more efficient way. An optimized capacity
reservation plan developed in this research will assure that the performance targets desired
165
by the institution will be met. This capacity plan has a nice simple structure that can be
implemented in practice, but optimized methods to do that are beyond our scope. The
tradeoff analyses, and what if scenarios provided with this new methodology will also be a
valuable tool for decision making in health institutions.
Future research could involve more complex itinerary visit precedence structures. The
tools developed here could be extended to these more complex scenarios if the data require-
ments can be provided.
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4.8 Apppendix
4.8.1 Proof of Lemma IV.2
Our goal here is to show that P
(
χ
τ ,Sk
t > l
)
can be expressed in terms of linear constraints
subject to our decision variables Ω. We first start by using our definition of the diagnostic
flow time random variable (see Eq. 4.5) in Eq. 4.35. Based on our assumption that |Sk| = 2,
we will refer to the two elements of the set Sk as s1 and s2, and therefore Eq. 4.36 follows.
P
(
χ
τ ,Sk
t > l
)
= P
(
max
s∈Sk
κτ ,ks · χst > l
)
(4.35)
= P
(
max{κτ ,ks1 · χs1t ,κτ ,ks2 · χs2t } > l
)
(4.36)
=
∑
i∈I
∑
j∈{0,1}
P
(
max{κτ ,ks1 · χs1t ,κτ ,ks2 · χs2t } > l|κτ ,ks2 = j,Lτ ,s2t = Lτ ,s2t (i)
)
· P (κτ ,ks2 = j,Lτ ,s2t = Lτ ,s2t (i)) (4.37)
=
∑
i∈I
∑
j∈{0,1}
max
{
P
(
κτ ,ks1 · χs1t > l|Lτ ,s2t = Lτ ,s2t (i),κτ ,ks2 = j
)
,
j · 1
{
Lτ ,s2t (i) >
l∑
m=0
Ωτ ,s2t⊕m
}}
· φτ ,s2t (i) · P
(
κτ ,ks2 = j
)
(4.38)
In Eq. 4.37, without loss of generality, we condition our probability on the realizations of
the demand in progress Lτ ,s2t and the service/resource requirement κ
τ ,k
s2
random variables in
diagnostic service s2. Based on this conditioning, the requirement of service s2 along the
patient’s care path as well as the access delay in service s2 become deterministic. Specifically,
the access delay in service s2 will be greater than l with probability 1 if (1) s2 is a diagnostic
service required in the patient’s itinerary (i.e., j = 1), and (2) the demand in progress at
service s2 is greater than the total amount of capacity reserved for type τ patients from day t
to t+ l (i.e., Lτ ,s2t (i) >
∑l
m=0 Ω
τ ,s2
t⊕m). Otherwise, the probability of the access delay in service
s2 being greater than l will be 0. Therefore, the conditional probability of the diagnostic
delay exceeding l days (given the information on diagnostic service s2) will be the probability
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that the access delay in diagnostic service s1 exceeds l days if the access delay in s2 does not
exceed l, and will be 1 otherwise. Moreover, since the resource need for service s2 random
variable κτ ,ks2 is independent of the current state of the system (e.g., the current demand in
progress at s2), Eq. 4.38 follows. Using Eq. 4.19, and the independence assumption of the
demand in progress across diagnostic services, we can write P
(
χ
τ ,Sk
t > l
)
=
=
∑
i∈I
∑
j∈{0,1}
max
{
P
(
κτ ,ks1 · χs1t > l
)
, j · xτ ,s2t,l (i)
}
· φτ ,s2t (i) · P
(
κτ ,ks2 = j
)
(4.39)
=
∑
i∈I
∑
j∈{0,1}
max
{∑
i′∈I
∑
j′∈{0,1}
P
(
κτ ,ks1 · χs1t > l|Lτ ,s1t = Lτ ,s1t (i′),κτ ,ks1 = j′
)
· φτ ,s1t (i′) · P
(
κτ ,ks1 = j
′) , j · xτ ,s2t,l (i)
}
· φτ ,s2t (i) · P
(
κτ ,ks2 = j
)
(4.40)
=
∑
i∈I
∑
j∈{0,1}
max
{∑
i′∈I
1
{
Lτ ,s1t (i
′) >
l∑
m=0
Ωτ ,s1t⊕m
}
· φτ ,s1t (i′) · P
(
κτ ,ks1 = 1
)
, j · xτ ,s2t,l (i)
}
· φτ ,s2t (i) · P
(
κτ ,ks2 = j
)
(4.41)
=
∑
i∈I
∑
j∈{0,1}
max
{
pτ ,ks1 ·
∑
i′∈I
xτ ,s1t,l (i
′) · φτ ,s1t (i′), j · xτ ,s2t,l (i)
}
· φτ ,s2t (i) · P
(
κτ ,ks2 = j
)
(4.42)
=
∑
i∈I
∑
j∈{0,1}
y
(2),τ ,k
t,l (i, j) · φτ ,s2t (i) · P
(
κτ ,ks2 = j
)
(4.43)
In Eq. 4.40, we now condition on the demand in progress in diagnostic service s1 and the
resource need for service s1 random variables (while again using the independence property
of the demand in progress and κτ ,ks1 ). This conditional probability (given information on
diagnostic service s1) will be equal to 1 if and only if j
′ = 1 and Lτ ,s1t (i
′) >
∑l
m=0 Ω
τ ,s1
t⊕m
(similarly to the concept that gave us Eq. 4.38 above) which justifies Eq. 4.41. Again, using
Eq. 4.19, Eq. 4.42 follows directly. We now have proven 4.24 thanks to 4.25.
Since our goal is to minimize those probabilities of exceeding access/flow time targets, it
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is sufficient for y
(2),τ ,k
t,l (i, j) to satisfy the following linear equations in x
τ ,s
t,l (i):
y
(2),τ ,k
t,l (i, j) ≥ j · xτ ,s2t,l (i) (4.44)
y
(2),τ ,k
t,l (i, j) ≥ pτ ,ks1 ·
∑
i′∈I
xτ ,s1t,l (i
′) · φτ ,s1t (i′). (4.45)
Eqs. 4.19, 4.20, and 4.21 have expressed xτ ,st,l (i) as a a linear set of constraints (subject to our
decision variable Ω), therefore we have shown that P
(
χ
τ ,Sk
t > l
)
can be expressed linearly
in our Mixed Integer Program.
4.8.2 Proof of Theorem IV.3
We start this proof by assuming that |Sk| = 3, with s1, s2, s3 ∈ Sk (see Eq. 4.46). We
then condition this probability in Eq. 4.47 on the realizations of the demand in progress
Lτ ,s3t and the resource requirement κ
τ ,k
s3
random variables in diagnostic service s3.
P
(
χ
τ ,Sk
t > l
)
= P
(
max{κτ ,ks1 · χs1t ,κτ ,ks2 · χs2t ,κτ ,ks3 · χs3t } > l
)
(4.46)
=
∑
i∈I
∑
j∈{0,1}
P
(
max{κτ ,ks1 · χs1t ,κτ ,ks2 · χs2t ,κτ ,ks3 · χs3t } > l|κτ ,ks3 = j,Lτ ,s3t = Lτ ,s3t (i)
)
· P (κτ ,ks3 = j,Lτ ,s3t = Lτ ,s3t (i)) (4.47)
=
∑
i∈I
∑
j∈{0,1}
max
{
P
(
max{κτ ,ks1 · χs1t ,κτ ,ks2 · χs2t } > l|Lτ ,s3t = Lτ ,s3t (i),κτ ,ks3 = j
)
,
j · 1
{
Lτ ,s3t (i) >
l∑
m=0
Ωτ ,s3t⊕m
}}
· φτ ,s3t (i) · P
(
κτ ,ks3 = j
)
(4.48)
=
∑
i∈I
∑
j∈{0,1}
max
{
P
(
max{κτ ,ks1 · χs1t ,κτ ,ks2 · χs2t } > l
)
, j · xτ ,s3t,l (i)
}
· φτ ,s3t (i) · P
(
κτ ,ks3 = j
)
(4.49)
=
∑
i∈I
∑
j∈{0,1}
max
{∑
i′∈I
∑
j′∈{0,1}
y
(2),τ ,k
t,l (i
′, j′) · φτ ,s2t (i′) · P
(
κτ ,ks2 = j
′) , j · xτ ,s3t,l (i)
}
· φτ ,s3t (i) · P
(
κτ ,ks3 = j
)
(4.50)
=
∑
i∈I
∑
j∈{0,1}
y
(3),τ ,k
t,l (i, j) · φτ ,s3t (i) · P
(
κτ ,ks3 = j
)
(4.51)
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The conditional probability in Eq. 4.47 (given the information on diagnostic service s3) will
be equal to 1 if and only if j = 1 and Lτ ,s3t (i) >
∑l
m=0 Ω
τ ,s3
t⊕m (similarly to the concept that
gave us Eq. 4.38 above). This allows us to transition to Eq. 4.48. In Eq. 4.49, we use the
independence assumption of the demand in progress across diagnostic services, and leverage
the result presented in Eq. 4.19. Finally, the result from Lemma IV.2 allows us to obtain
Eq. 4.50, and from the definition of y
(3),τ ,k
t,l (i, j) in Eq. 4.27, Eq. 4.51 follows. This proves
Theorem IV.3 for the case |Sk| = 3.
We can repeat this procedure up to the true dimension of the set Sk, while still being
able to express the diagnostic flow distribution similarly. Notice that P
(
χ
τ ,Sk
t > l
)
can be
expressed linearly in y
(|Sk|),τ ,k
t,l (i, j) and x
τ ,|Sk|
t,l (i) similarly to constraints 4.44 and 4.45. Hence,
P
(
χ
τ ,Sk
t > l
)
can be modeled as linear constraints subject to y
(2),τ ,k
t,l (i, j) (see Eq. 4.27),
therefore linearly subject to our decision variables Ω as well (from the result of Lemma
IV.2). This proves Theorem IV.3.
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4.8.3 Proof of Corollary IV.5
We use the definition of the itinerary flow time random variable (see Eq. 4.1) to express
the itinerary flow time distribution as follows:
P
(
Ξτ ,kt > l
)
= P
(
χ
τ ,Sk
t + χ
τ ,k
1⊕t⊕χτ ,Skt
> l
)
(4.52)
=
∞∑
l1=0
P
(
χτ ,kt⊕l1⊕1 > l − l1|χ
τ ,Sk
t = l1
)
· P
(
χ
τ ,Sk
t = l1
)
(4.53)
= P
(
χ
τ ,Sk
t > l
)
+
l∑
l1=0
P
(
χτ ,kt⊕l1⊕1 > l − l1|χ
τ ,Sk
t = l1
)
· P
(
χ
τ ,Sk
t = l1
)
(4.54)
= P
(
χ
τ ,Sk
t > l
)
+
l∑
l1=0
∑
i∈I
P
(
χτ ,kt⊕l1⊕1 > l − l1|Lτ ,kt⊕l1⊕1 = Lτ ,kt⊕l1⊕1(i)
)
· φτ ,kt (i)
·
(
P
(
χ
τ ,Sk
t > l1 − 1
)
− P
(
χ
τ ,Sk
t > l1
))
(4.55)
= P
(
χ
τ ,Sk
t > l
)
+
l∑
l1=0
∑
i∈I
1
{
Lτ ,kt (i) >
l−l1∑
m=0
Ωτ ,kt⊕m
}
· φτ ,kt (i)
·
∑
i′∈I
∑
j∈{0,1}
(
y
(|Sk|),τ ,k
t,l−1 (i
′, j)− y(|Sk|),τ ,kt,l (i′, j)
)
· φτ ,|Sk|t (i′) · P
(
κτ ,k|Sk| = j
)
(4.56)
= P
(
χ
τ ,Sk
t > l
)
+
l∑
l1=0
∑
i∈I
xτ ,kt⊕l1⊕1,l−l1(i) · φτ ,kt⊕l1⊕1(i)
·
∑
i′∈I
∑
j∈{0,1}
(
y
(|Sk|),τ ,k
t,l−1 (i
′, j)− y(|Sk|),τ ,kt,l (i′, j)
)
· φτ ,|Sk|t (i′) · P
(
κτ ,k|Sk| = j
)
(4.57)
In Eq. 4.53, we condition the itinerary flow time probability on realizations of the diagnostic
flow time. Given the diagnostic flow time is l1 days, we are now interested to see the
probability of the access delay in specialty k being greater than l − l1 (given the specialty
service request for a follow-up happened on day t ⊕ l1 ⊕ 1). For l1 > l, the first term in
Eq. 4.53 will always be 1. Therefore, in Eq. 4.54 we can make the sum go to l and add the
probability that the diagnostic flow time itself will be greater than l days. In Eq. 4.55, we
first use the independence assumption of the demand in progress random variables across
all services (see Assumption IV.1), and then condition our probability on the demand in
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progress in specialty service k on day t⊕ l1⊕ 1. This conditional probability will result in a
binary variable equal 1 if and only if Lτ ,kt (i) >
∑l−l1
m=0 Ω
τ ,k
t⊕m, and we use the result from IV.3
to express the diagnostic flow time probability in Eq. 4.56. Finally, using Eq. 4.19, Eq. 4.57
follows.
Since xτ ,kt⊕l1⊕1,l−l1(i) is a binary variable, and it is multiplied by an expression between 0
and 1, we can convert Eq. 4.57 as follows, by using the definition of zτ ,kt,l1,l(i, j) provided in
Eq. 4.31:
P
(
Ξτ ,kt > l
)
= P
(
χ
τ ,Sk
t > l
)
+
l∑
l1=0
∑
i∈I
zτ ,kt,l1,l(i) · φτ ,kt⊕l1⊕1(i) (4.58)
where zτ ,kt,l1,l(i) can be expressed as follows, for a large enough M > 0:
zτ ,kt,l1,l(i) ≤ xτ ,kt⊕l1⊕1,l−l1(i) (4.59)
zτ ,kt,l1,l(i) ≥
∑
i′∈I
∑
j∈{0,1}
(
y
(|Sk|),τ ,k
t,l−1 (i
′, j)− y(|Sk|),τ ,kt,l (i′, j)
)
−M · (1− xτ ,kt⊕l1⊕1,l−l1(i)) (4.60)
Eq. 4.59 assures that zτ ,kt,l1,l(i) will be 0 when x
τ ,k
t⊕l1⊕1,l−l1(i) = 0, and Eq. 4.60 constrains
zτ ,kt,l1,l(i) to be at least
∑
i′∈I
∑
j∈{0,1}
(
y
(|Sk|),τ ,k
t,l−1 (i
′, j)− y(|Sk|),τ ,kt,l (i′, j)
)
when xτ ,kt⊕l1⊕1,l−l1(i) = 1.
In this case, since our objective is to minimize itinerary flow time, this constraint will be
binding. Hence, from Eqs. 4.59 and 4.60 we are able to express Eq. 4.31 linearly in the
xτ ,kt⊕l1⊕1,l−l1(i) and y
(|Sk|),τ ,k
t,l (i, j) variables. From Theorem IV.3, Eq. 4.20 and Eq. 4.21, we
have shown how to compute the the itinerary flow time distribution linearly in our decision
variables Ω.
CHAPTER V
Conclusions
To conclude this dissertation, we discuss the integration of clinical care and clinical
research under shared resources. This dissertation has focused on providing differentiated
access to a set of resources based on patient characteristics and urgency levels. This was
done by using operations engineering tools to optimize a patient schedule so that it allocates
system capacity in a way that meets the health institution’s goals. We considered this general
idea in three different settings: (1) Access management in Clinical Research Units (CRUs)
where resources are entirely focused on clinical research visits and participants, (2) Access
delay control for a root appointment of an itinerary of care in a health institution with
resources devoted entirely to clinical care visits and patients, and (3) Itinerary/Diagnostic
flow time and access delay control for downstream visits of a care itinerary in a clinical
care setting. The access and patient flow management tools we provided in the above three
settings are useful independently, and address the entire scope provided in the introduction.
One question that remains is how to manage a system’s capacity so that it can provide
differentiated access to care patients and research participants, in a shared resource setting
where both for clinical care and clinical research visits occur. Specifically, the patient can
become a research participant to a clinical trial after waiting for access to an initial ap-
pointment in a medical specialty and either before or after going through all the necessary
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referrals and downstream visits (for disease diagnosis). Patients that have gone through
this process will, according to an i.i.d. Bernoulli process, enroll in the clinical trial with
probability that based on (1) the patient being eligible to participate in this trial, and (2)
the patient accepting to be part of it. The patient can be recruited for a clinical trial either
at the initial visit (if there is enough data on the patient to assure that she will meet the
trial inclusion criteria) or at the time of the follow up visit (when the diagnostic tests have
provided enough information about inclusion/exclusion criteria). If the patient becomes a
research participant of a given clinical trial, then she will follow a trial-specific protocol of
research visits as described in Chapter II. Note that portfolio selection and admission control
(BRPlan) decisions can be optimized to guarantee differentiated access by trial (see Chapter
II).
Given a commitment to the ongoing care needs of the patient panel/population, the
question regularly arises as to which clinical research studies/trials can be conducted within
the limited resources of the organization. With the operational dexterity provided by the
different methodologies of this dissertation and their integration with smart health IT, this
research can tackle the thorny problem of how to properly plan and manage the integration
of clinical care with clinical research when it occurs in the same clinic (such as the Michi-
gan Clinical Research Unit). Many patients benefit greatly from participating in a clinical
research program that is integrated into the patient’s regular clinical care visits. The ca-
pacity planning and multi-visit scheduling methodology can serve a role as an integrating
mechanism for accomplishing both the care and research dimensions of many diseases in a
manner that maximizes the value to patient and research communities while managing costs
by optimizing efficiency.
The goal is to determine which clinical trials should be performed in the site given (i)
clinical care patients’ access delays to a root appointment are limited to a given target
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(specified by the patient’s urgency level), (ii) clinical care patients’ diagnostic and itinerary
flow times (waiting times to a diagnosis) satisfy specific targets (e.g., urgent patients will
require much tighter constraints), and (iii) clinical research participants will be guaranteed
a certain access level (the Time to First Available Visit) based on their type (urgent vs. non
urgent) and trial they enroll in.
To develop methods to manage the joint delivery of clinical care and clinical research,
methods will need to be put into place to answer the following questions. (1) What is
the minimum capacity required for clinical care visits while assuring access delay to a root
appointment, diagnostic flow time, and itinerary flow time targets for each of our patient
types? (2) Given the remaining capacity available for clinical research visits, which portfo-
lio of clinical trials could/should be conducted in our infrastructure while assuring certain
access levels to the trials? Answering these two questions in an integrated way can be quite
computationally challenging, and results in non-linearity issues. This is why we built our
methodologies tackling each problem independently.
Given that a institution’s main priority is to guarantee proper access to resources for
clinical care patients, one could answer the above two questions in a multi-stage mixed-integer
optimization approach. In a first stage, one could use the methods developed in Chapter
III to minimize the capacity that needs to be allocated for clinical care root appointments
of an itinerary while still meeting the differentiated access levels desired for various patient
types. Then, in a second stage, one could use the methods from Chapter IV to once again
minimize the capacity required to perform downstream care visits such that itinerary and
diagnostic flow time constraints are met for each patient class. Both steps increase the
efficiency as much as possible while addressing the desired access and service/delay levels.
This would then result in the minimization of the clinical care capacity required to meet our
desired access constraints which is equivalent to maximizing the remaining capacity that can
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then be allocated for clinical research visits and participants (while still meeting the clinical
care standards we set on our system). Once we know the remaining available capacity
that can be used for clinical research and the resulting demand streams for clinical research
trials (that depend on when/how many patients of each type are scheduled for an initial
or follow up appointment, optimized in Stages 1 and 2), we can then determine in Stage 3
how much clinical research demand to accept (by answering the trial portfolio decision) and
how to create the BRPlan to provide differentiated access by type/trial. The methods from
Chapter II could be used for that last optimization stage.
Combining the ideas and methods developed in this dissertation will allow health insti-
tutions to conduct clinical care and clinical research efficiently under shared resources. The
new methods help provider organizations to understand (1) how to allocate system resources
between (1a) care appointments and research visits, (1b) urgent cases and less urgent ones;
(2) how much clinical research workload can be allowed, and (3) how each capacity decision
affects patient flow and access to care/research/diagnosis. These methods and insights are
fundamentally relevant to any health care institution that decides to tackle these complex
problems of access, efficiency, and cost control.
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